data_2l0z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l0z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 483' ' ' ARG . 20.2 p . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -95.76 142.74 27.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.597 ' CD ' ' HB ' ' A' ' 479' ' ' THR . 3.9 ttt180 -100.7 146.27 27.41 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.265 0.555 . . . . 0.0 111.632 -172.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -103.56 137.21 41.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.734 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 21.2 pt -87.54 13.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 109.802 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 451' ' ' ARG . 39.1 ttt85 69.4 88.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.531 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.08 60.22 1.14 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.259 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 456' ' ' PRO . 0.0 OUTLIER -136.91 1.74 2.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.807 0.337 . . . . 0.0 111.103 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 66.34 30.45 8.91 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.335 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 31.6 t 72.73 113.92 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.857 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.595 ' HG3' ' HG3' ' A' ' 453' ' ' GLU . 2.2 Cg_endo -82.51 21.41 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 113.683 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 53.8 mt -73.55 159.8 83.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.649 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 63.8 Cg_endo -88.14 21.5 26.63 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 113.455 2.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -83.02 143.43 30.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 110.067 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 117.81 32.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.912 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.3 mp -90.1 145.35 25.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.208 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -95.73 -167.25 1.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.281 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' SER . . . . . 0.45 ' HA ' HH11 ' A' ' 448' ' ' ARG . 3.3 p -68.92 -15.08 63.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.2 -3.77 57.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.264 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.74 4.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.58 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -166.96 166.49 39.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.814 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.817 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 25.6 p -114.1 124.07 51.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.195 0.497 . . . . 0.0 110.327 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 468' ' ' ARG . 6.4 mtp180 -52.09 -35.72 48.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.819 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.1 p -69.35 105.63 2.63 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -22.17 104.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.195 0 O-C-N 124.924 1.39 . . . . 0.0 115.355 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.817 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 56.5 tptt -172.85 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -0.807 . . . . 0.0 110.918 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -129.77 122.64 20.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.65 -167.83 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.125 2.55 . . . . 0.0 113.074 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 474' ' ' ASN . 0.9 OUTLIER -83.75 90.43 7.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.012 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.87 -30.05 18.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.52 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 21.1 tptm 53.2 77.99 0.16 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.756 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -123.72 165.01 25.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.816 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.46 86.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.242 1.961 . . . . 0.0 110.764 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.597 ' HB ' ' CD ' ' A' ' 448' ' ' ARG . 0.3 OUTLIER -87.98 132.3 34.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.654 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.48 132.52 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.048 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.484 ' CE3' ' HG3' ' A' ' 448' ' ' ARG . 54.0 m95 -76.4 109.96 10.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -118.21 125.74 50.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.394 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.592 ' HB2' HG23 ' A' ' 446' ' ' THR . 0.0 OUTLIER -153.15 13.47 0.5 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.252 0.548 . . . . 0.0 110.004 173.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -79.23 -1.57 85.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.212 177.788 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.686 HG22 ' HB2' ' A' ' 483' ' ' ARG . 90.8 m . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -111.33 141.56 44.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.469 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 51.7 mtt180 -73.97 153.13 39.88 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 111.102 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 482' ' ' ARG . 1.7 m-70 -124.8 119.61 29.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.092 170.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.49 134.9 29.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.18 99.89 0.15 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.191 0.52 . . . . 0.0 110.607 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 128.97 -9.7 6.31 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.36 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.25 139.17 34.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 110.563 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -79.12 -40.81 30.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.742 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 25.3 t 173.35 117.59 0.08 OUTLIER Pre-proline 0 N--CA 1.462 0.165 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 459' ' ' HIS . 68.8 Cg_endo -72.83 -22.37 20.23 Favored 'Trans proline' 0 C--O 1.223 -0.23 0 C-N-CA 122.499 2.133 . . . . 0.0 114.748 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.0 mt -55.47 145.25 49.67 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.42 11.32 26.73 Favored 'Cis proline' 0 C--N 1.356 0.956 0 C-N-CA 123.819 -1.325 . . . . 0.0 113.718 4.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.489 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 2.6 m-70 -84.05 152.81 24.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -135.94 153.78 51.31 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.861 -0.524 . . . . 0.0 111.116 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.649 ' HB3' ' HA2' ' A' ' 465' ' ' GLY . 1.4 mm? -100.73 113.58 26.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.425 ' CG ' ' H ' ' A' ' 463' ' ' SER . 2.9 p30 -59.59 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.267 0.354 . . . . 0.0 110.715 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 462' ' ' ASN . 5.9 p -148.28 -30.58 0.29 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.044 0.45 . . . . 0.0 109.794 174.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.13 -1.65 55.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.716 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 461' ' ' LEU . . . 79.81 47.8 6.98 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.139 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -141.53 150.86 22.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.538 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.683 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -103.95 128.91 51.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 117.191 0.495 . . . . 0.0 109.703 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -44.62 -36.07 2.89 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.838 0.712 . . . . 0.0 110.616 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.04 82.03 7.87 Favored 'General case' 0 C--O 1.303 3.882 0 CA-C-O 117.932 -1.032 . . . . 0.0 108.458 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 29.48 69.99 0.07 OUTLIER Glycine 0 C--N 1.304 -1.229 0 C-N-CA 128.494 2.949 . . . . 0.0 117.584 158.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.683 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 87.8 tttt -150.38 -80.45 0.12 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.579 0.689 . . . . 0.0 110.886 164.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.631 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 92.2 m-85 -68.41 124.13 89.18 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.42 170.31 10.59 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.61 2.207 . . . . 0.0 112.262 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.12 87.63 3.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.096 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.41 ' HB3' ' HG2' ' A' ' 477' ' ' LYS . 95.3 mt -100.39 -29.15 12.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.9 tttm 59.09 49.17 9.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 475' ' ' LEU . 72.9 mmtt -90.85 157.98 42.77 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.81 109.62 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.243 2.629 . . . . 0.0 111.816 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.39 137.8 41.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.11 159.27 5.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.469 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 88.4 m95 -97.18 102.99 14.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.281 0.562 . . . . 0.0 111.352 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.474 ' HB2' ' CD2' ' A' ' 449' ' ' HIS . 33.6 mmt180 -112.38 120.24 40.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 122.209 1.004 . . . . 0.0 110.406 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.686 ' HB2' HG22 ' A' ' 446' ' ' THR . 10.5 tpt180 -145.17 -13.62 0.53 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.362 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -87.55 59.61 4.34 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.131 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.057 175.549 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -92.13 144.16 25.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.173 -171.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.872 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 57.4 mtt-85 -85.16 140.29 31.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.18 -172.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.4 m170 -107.41 122.35 46.44 Favored 'General case' 1 C--N 1.212 -5.371 0 C-N-CA 127.15 2.18 . . . . 0.0 111.576 173.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 450' ' ' ILE . 3.0 mp -82.76 122.13 36.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 451' ' ' ARG . 10.8 mmm180 -49.45 100.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.577 0.548 . . . . 0.0 111.126 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 137.02 -30.5 2.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.237 -0.983 . . . . 0.0 113.241 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -113.14 156.28 23.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.229 0.514 . . . . 0.0 110.669 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.82 -78.13 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.643 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 23.0 t -145.36 120.77 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.0 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.465 ' HB3' ' CE2' ' A' ' 472' ' ' TYR . 28.6 Cg_exo -65.66 -8.88 20.69 Favored 'Trans proline' 0 N--CA 1.477 0.503 0 C-N-CA 123.681 2.921 . . . . 0.0 114.411 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.73 150.28 87.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.478 0.18 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 20.55 23.32 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.811 -1.329 . . . . 0.0 113.818 4.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -84.44 157.4 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.8 mpt_? -127.39 134.64 49.91 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.097 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -100.06 106.87 18.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.538 HD21 ' N ' ' A' ' 463' ' ' SER . 0.4 OUTLIER -67.25 -23.06 65.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.814 -175.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' SER . . . . . 0.538 ' N ' HD21 ' A' ' 462' ' ' ASN . 17.5 p -174.87 -76.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' A' ' 476' ' ' LYS . 79.1 mt -70.46 4.53 2.29 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 94.74 16.06 43.66 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.486 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 472' ' ' TYR . . . -106.03 147.97 16.36 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.884 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 29.5 p -111.55 -10.9 14.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 71.93 -53.26 0.69 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.893 0.745 . . . . 0.0 111.915 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.7 -18.65 8.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 467' ' ' CYS . . . 133.22 127.63 2.8 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.075 -164.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.496 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 73.2 tttt 106.94 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 126.514 1.926 . . . . 0.0 109.777 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.535 ' HB3' ' HA2' ' A' ' 466' ' ' GLY . 78.3 m-85 -92.13 117.25 67.6 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.531 ' HD2' ' HG ' ' A' ' 475' ' ' LEU . 2.2 Cg_endo -83.03 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.984 2.456 . . . . 0.0 111.366 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . 0.418 ' H ' ' HB2' ' A' ' 473' ' ' PRO . 11.3 m120 -125.33 -69.6 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.531 ' HG ' ' HD2' ' A' ' 473' ' ' PRO . 97.9 mt 71.14 -51.36 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.647 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.53 ' HG3' HD21 ' A' ' 464' ' ' LEU . 88.2 tttt 68.73 61.63 0.34 Allowed 'General case' 0 N--CA 1.532 3.652 0 O-C-N 126.16 2.162 . . . . 0.0 108.096 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 475' ' ' LEU . 7.6 mptt -102.02 152.7 38.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.828 175.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 110.99 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.161 1.907 . . . . 0.0 111.288 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.872 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 19.4 p -94.28 132.1 39.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.529 . . . . 0.0 111.679 -174.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 2.7 t -96.74 133.44 38.17 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.238 0 CA-C-O 123.739 1.733 . . . . 0.0 110.558 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 33.2 m95 -78.62 109.96 13.31 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.811 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.429 ' HD2' ' C ' ' A' ' 481' ' ' TRP . 1.1 mpt_? -113.4 118.34 34.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.318 0.58 . . . . 0.0 111.587 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -130.59 2.97 4.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.76 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -72.67 -16.81 77.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.123 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.247 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.635 HG22 ' HB2' ' A' ' 483' ' ' ARG . 12.8 p . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -83.12 142.83 30.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.54 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.536 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 44.7 mtt180 -75.92 128.57 35.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.378 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.533 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.2 m170 -104.14 119.51 39.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.433 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.586 HG13 HD21 ' A' ' 461' ' ' LEU . 47.5 mt -69.52 125.42 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.04 95.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.204 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 138.85 -18.18 3.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.766 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.89 156.08 40.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 0.0 109.854 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -68.68 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 13.0 t -137.73 115.39 9.62 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 36.6 Cg_exo -61.62 -25.45 79.19 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.286 2.657 . . . . 0.0 113.754 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.419 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 92.9 mt -51.14 144.79 14.11 Favored Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 123.07 0.231 . . . . 0.0 111.069 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.89 15.71 12.83 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.945 -1.273 . . . . 0.0 114.099 5.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.43 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 91.3 m-70 -83.26 132.05 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 109.867 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -107.36 125.3 51.02 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 7.8 mp -85.02 137.23 33.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.432 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.83 -174.42 4.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.835 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' SER . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 11.6 p -74.4 0.14 15.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 0.0 111.406 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 474' ' ' ASN . 91.8 mt -105.13 4.05 30.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.734 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.24 26.42 61.77 Favored Glycine 2 C--O 1.142 -5.603 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -133.01 -178.78 15.77 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 110.267 -2.967 . . . . 0.0 111.765 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 13.4 p -138.18 141.44 40.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 117.514 0.657 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 469' ' ' CYS . 71.8 ttt180 -55.75 147.85 17.86 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 1.6 p 108.31 -22.28 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.723 1.609 . . . . 0.0 109.542 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 85.9 36.81 9.82 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.115 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 1.1 tmtp? -95.11 -61.28 1.51 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.4 m-85 -99.71 118.79 61.34 Favored Pre-proline 0 C--O 1.167 -3.255 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.419 ' O ' HD11 ' A' ' 475' ' ' LEU . 59.6 Cg_endo -75.57 169.02 23.22 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.091 1.86 . . . . 0.0 111.04 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . 10.6 m120 -86.07 76.34 9.8 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.305 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 473' ' ' PRO . 4.0 mp -69.05 -25.36 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.676 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 65.7 28.54 11.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.78 150.99 46.93 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.23 130.44 34.15 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.432 2.088 . . . . 0.0 111.565 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.02 157.14 20.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.095 0.474 . . . . 0.0 111.739 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 28.1 t -84.93 140.28 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.22 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.536 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 8.3 m95 -92.51 106.86 18.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 0.0 112.012 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -135.56 118.17 15.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.635 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.4 ttt180 -100.3 -64.54 1.03 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.866 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -102.28 131.41 10.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.887 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.343 178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.918 HG21 ' HB2' ' A' ' 483' ' ' ARG . 2.1 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -97.3 148.76 22.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.182 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 448' ' ' ARG . 66.9 mtt-85 -83.67 142.55 30.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.624 0.726 . . . . 0.0 112.406 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.474 ' HB3' ' HA2' ' A' ' 452' ' ' GLY . 4.8 m-70 -118.28 116.98 27.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.968 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.45 HG22 HD22 ' A' ' 475' ' ' LEU . 2.8 mp -59.8 105.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 451' ' ' ARG . 1.5 tpm_? 56.42 17.73 3.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.664 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 449' ' ' HIS . . . 78.12 43.92 12.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.566 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 -163.76 0.47 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -52.87 -69.32 0.12 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-O 123.053 1.406 . . . . 0.0 112.172 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 35.0 t 170.32 106.58 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 120.643 -1.285 . . . . 0.0 109.239 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.538 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 52.8 Cg_exo -59.2 -18.6 45.35 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.377 2.718 . . . . 0.0 114.406 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 63.7 mt -65.63 154.11 89.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.586 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 5.4 Cg_exo -77.52 7.97 19.12 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 124.227 -1.156 . . . . 0.0 114.141 7.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 92.1 m-70 -78.94 107.16 11.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 0.0 110.385 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -86.67 127.29 34.94 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.821 -170.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 456' ' ' PRO . 1.1 mm? -87.03 150.87 23.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.083 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.3 -52.76 4.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.389 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.8 p -156.07 -66.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.09 33.41 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.399 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.53 2.96 82.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.11 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -98.13 157.56 20.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.325 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 30.7 p -121.42 110.46 16.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.01 -19.56 19.2 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.57 -6.7 27.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.648 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 91.07 123.61 2.86 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.3 tmtm? 156.13 -75.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.43 1.492 . . . . 0.0 108.629 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.538 ' HH ' ' HA ' ' A' ' 456' ' ' PRO . 65.1 m-85 -84.57 132.28 47.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.902 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.6 -164.64 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.18 2.587 . . . . 0.0 111.684 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.41 97.64 10.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 0.0 110.199 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.45 HD22 HG22 ' A' ' 450' ' ' ILE . 4.6 mp -103.17 83.6 2.22 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -72.68 78.36 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.368 0.604 . . . . 0.0 109.88 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -149.54 138.66 12.65 Favored Pre-proline 0 C--O 1.212 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.456 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.67 102.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.873 3.049 . . . . 0.0 114.426 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.09 135.95 33.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.146 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.5 t -98.59 140.3 18.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.194 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -89.5 106.93 18.78 Favored 'General case' 1 C--N 1.232 -4.539 0 O-C-N 124.938 1.399 . . . . 0.0 113.428 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -118.67 116.84 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.046 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.918 ' HB2' HG21 ' A' ' 446' ' ' THR . 45.6 ttt-85 -108.87 97.88 7.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.069 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 93.36 157.57 33.46 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.157 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -96.5 123.89 40.31 Favored 'General case' 1 N--CA 1.551 4.583 0 CA-C-O 124.454 2.073 . . . . 0.0 107.969 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.494 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 9.3 ptm180 -72.83 132.79 44.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.442 -2.163 . . . . 0.0 111.678 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 479' ' ' THR . 2.5 m-70 -90.87 154.78 19.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.519 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.471 HG12 HD13 ' A' ' 475' ' ' LEU . 1.1 tp -90.52 -1.37 9.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.963 0.887 . . . . 0.0 108.974 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 73.38 92.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.392 -1.731 . . . . 0.0 111.772 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 101.4 42.79 2.29 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.206 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 455' ' ' CYS . 0.0 OUTLIER -127.95 -164.81 1.41 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 455' ' ' CYS . . . -98.48 27.94 4.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.704 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.54 ' H ' ' HG2' ' A' ' 453' ' ' GLU . 46.4 t 71.75 118.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.856 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.616 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 54.5 Cg_exo -53.78 -31.7 62.76 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.589 2.859 . . . . 0.0 114.665 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.24 142.84 47.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.17 23.9 20.76 Favored 'Cis proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.58 -1.425 . . . . 0.0 114.302 5.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.3 151.15 19.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 109.62 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -123.03 128.65 50.46 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.44 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -91.73 138.39 31.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.319 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.76 -177.87 5.1 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p -62.38 -15.2 47.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.7 3.36 52.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.486 0.184 . . . . 0.0 111.493 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 475' ' ' LEU . . . 87.29 9.86 72.19 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.25 171.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -109.28 171.55 15.37 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.803 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 12.2 p -126.85 148.24 49.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.684 0.742 . . . . 0.0 109.861 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -56.65 142.04 41.35 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 0.4 OUTLIER 84.22 141.92 0.06 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -170.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -72.56 59.35 1.62 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.102 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 469' ' ' CYS . 8.7 tmtm? -110.05 -62.02 1.57 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.616 ' HH ' ' HA ' ' A' ' 456' ' ' PRO . 49.6 m-85 -107.43 124.85 33.85 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-O 120.553 0.216 . . . . 0.0 110.95 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.2 177.55 8.5 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.733 2.288 . . . . 0.0 111.652 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.37 95.17 1.71 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.471 HD13 HG12 ' A' ' 450' ' ' ILE . 78.3 mt -109.42 93.77 4.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -82.22 16.63 1.92 Allowed 'General case' 1 CA--C 1.632 4.103 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.593 ' HG3' ' HD2' ' A' ' 478' ' ' PRO . 36.5 ttmt -68.4 142.47 94.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.155 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.593 ' HD2' ' HG3' ' A' ' 477' ' ' LYS . 2.7 Cg_exo -35.72 99.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.575 3.517 . . . . 0.0 113.244 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 448' ' ' ARG . 3.4 p -83.14 127.59 33.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -92.34 111.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.241 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.494 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 97.9 m95 -75.58 105.43 6.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.904 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -124.19 134.76 53.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -142.46 30.15 1.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.166 0.984 . . . . 0.0 108.794 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.76 69.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.553 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.019 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 483' ' ' ARG . 18.8 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -96.2 158.0 15.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.35 0.595 . . . . 0.0 111.261 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -88.39 150.41 23.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.552 -175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -123.18 126.03 46.22 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.277 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.5 114.7 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -44.74 113.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.804 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.12 26.22 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.44 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -90.36 149.04 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.968 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -64.0 -62.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 42.0 t 179.6 106.96 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.593 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 20.5 Cg_endo -60.86 -2.27 2.05 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.048 3.165 . . . . 0.0 115.135 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.85 150.77 75.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.231 -0.293 . . . . 0.0 110.246 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.01 28.35 12.28 Favored 'Cis proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.919 -1.284 . . . . 0.0 113.418 4.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -95.46 167.35 11.37 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 460' ' ' ARG . 39.3 ttp180 -141.84 124.1 15.6 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.586 -171.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -83.72 111.74 19.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.116 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -59.42 -38.93 81.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.98 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -164.78 -71.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 111.858 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.5 37.98 0.71 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.44 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.19 29.15 68.97 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.352 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -129.8 163.8 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.928 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.1 p -135.1 140.15 45.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 469' ' ' CYS . 37.9 ttp-105 -62.5 88.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.603 0.564 . . . . 0.0 110.85 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER 160.28 157.01 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -74.28 56.88 2.39 Favored Glycine 0 C--N 1.308 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.154 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.537 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 1.8 tmtp? -123.39 -56.97 1.69 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.593 ' HH ' ' HA ' ' A' ' 456' ' ' PRO . 82.7 m-85 -118.54 112.1 37.49 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.391 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.53 -178.83 2.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.776 2.318 . . . . 0.0 111.279 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -74.64 80.22 2.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 110.316 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.88 75.59 9.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.785 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -75.62 79.2 2.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.247 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 0.0 OUTLIER -132.24 164.53 42.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 2.2 Cg_endo -41.93 103.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.244 2.629 . . . . 0.0 113.362 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 3.9 p -86.21 127.29 34.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.273 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.18 129.97 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.896 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -81.32 109.19 15.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.069 0.462 . . . . 0.0 110.897 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -132.63 123.55 26.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.077 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.554 ' HB2' HG21 ' A' ' 446' ' ' THR . 36.9 ttt180 -120.04 -38.2 2.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.099 0.476 . . . . 0.0 109.908 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -104.35 144.22 15.81 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.016 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.63 178.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -93.89 139.68 30.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.291 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 448' ' ' ARG . 23.1 mtt180 -71.96 142.81 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.41 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -119.35 102.44 8.68 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.609 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.463 ' HA ' HG23 ' A' ' 479' ' ' THR . 56.9 mt -65.31 136.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -59.91 105.08 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 122.68 -21.13 7.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.839 -0.695 . . . . 0.0 111.557 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.58 142.17 27.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -80.06 -47.47 14.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.221 0.534 . . . . 0.0 110.154 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 20.5 t -178.35 112.25 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 -4.27 11.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.166 2.578 . . . . 0.0 114.238 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.575 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 48.8 mt -60.68 152.01 69.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.03 16.11 10.22 Favored 'Cis proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.042 -1.232 . . . . 0.0 114.278 8.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.575 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 52.8 m-70 -91.83 104.5 16.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -82.61 127.0 32.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.522 0.677 . . . . 0.0 110.192 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 467' ' ' CYS . 7.5 mp -87.63 141.13 28.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.994 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -82.89 -176.58 6.39 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -65.69 -13.41 59.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.12 7.01 36.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.45 15.16 54.2 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.448 -0.882 . . . . 0.0 114.452 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.15 141.5 15.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 29.0 p -84.35 114.17 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER -50.67 -32.8 20.26 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.584 0.552 . . . . 0.0 112.207 -174.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.13 -30.22 70.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 122.8 128.88 3.45 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.127 -171.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 77.2 tttt 148.59 -71.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.034 1.734 . . . . 0.0 108.942 169.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 67.0 m-85 -88.93 131.6 40.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.901 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 1.8 Cg_endo -82.71 175.53 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.997 2.465 . . . . 0.0 111.854 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -84.22 66.33 9.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 C-N-CA 127.305 2.242 . . . . 0.0 107.266 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.6 -5.95 57.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.987 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? 46.62 32.94 1.83 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.188 0.995 . . . . 0.0 112.964 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -70.43 156.45 91.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.364 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.14 126.68 21.04 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.997 2.464 . . . . 0.0 112.305 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 450' ' ' ILE . 16.7 p -140.65 140.61 35.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.034 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.7 142.21 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -90.33 108.13 19.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.146 0.498 . . . . 0.0 111.075 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -109.74 133.32 53.27 Favored 'General case' 1 N--CA 1.372 -4.348 0 CA-C-O 116.791 -1.576 . . . . 0.0 111.814 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -134.23 5.35 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.512 1.505 . . . . 0.0 111.785 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -162.09 119.47 0.88 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.433 175.267 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 483' ' ' ARG . 15.2 m . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -118.06 135.57 54.1 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.393 -0.817 . . . . 0.0 110.18 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.619 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 10.1 mtm180 -78.93 138.94 38.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.493 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.65 119.96 41.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.419 ' HA ' HG23 ' A' ' 479' ' ' THR . 49.0 mt -69.68 89.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.829 0.347 . . . . 0.0 110.212 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 58.4 -92.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.972 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -130.37 21.39 4.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.798 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.64 162.31 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.829 0.452 . . . . 0.0 110.114 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.01 163.64 5.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 18.5 t -65.02 131.66 95.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.063 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.588 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . 74.7 Cg_endo -85.14 17.84 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.899 2.399 . . . . 0.0 113.318 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.435 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 71.0 mt -87.13 155.35 54.98 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 51.0 Cg_endo -89.75 15.68 46.49 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.717 -1.368 . . . . 0.0 113.623 3.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.517 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 72.5 m-70 -68.94 -42.73 76.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 72.88 123.06 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.306 1.003 . . . . 0.0 111.138 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 41.2 mt -89.2 124.38 34.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -83.03 -171.58 3.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.8 p -50.63 -38.36 45.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.7 0.7 56.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.828 0.347 . . . . 0.0 111.918 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . 0.407 ' HA2' ' HE ' ' A' ' 448' ' ' ARG . . . 88.49 21.67 43.37 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.884 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -120.9 -172.31 14.51 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.1 p -126.05 121.34 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -52.63 -31.31 36.09 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.474 0.484 . . . . 0.0 111.828 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -24.78 67.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 109.39 134.26 6.95 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.101 -170.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 50.0 tttm 148.37 -65.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.82 1.648 . . . . 0.0 109.628 167.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -85.46 131.58 47.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.773 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.79 153.35 29.56 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.031 2.487 . . . . 0.0 112.865 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 474' ' ' ASN . 0.9 OUTLIER -71.04 99.13 1.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.04 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.78 -27.43 12.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.407 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.598 ' HZ3' ' HB3' ' A' ' 476' ' ' LYS . 9.9 mtpm? 63.21 6.81 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -65.91 150.34 96.6 Favored Pre-proline 0 C--O 1.236 0.349 0 O-C-N 122.472 -0.142 . . . . 0.0 110.943 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.73 145.72 22.58 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.466 2.777 . . . . 0.0 112.756 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 450' ' ' ILE . 1.1 p -145.21 154.42 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.957 -171.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.11 132.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.619 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 91.2 m95 -84.31 102.8 12.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.556 . . . . 0.0 111.712 -174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.78 118.51 36.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.636 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.419 ' HA ' HG22 ' A' ' 446' ' ' THR . 18.1 mtp180 -58.31 -79.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.919 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -159.55 141.76 7.76 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.956 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.849 0 CA-C-O 119.061 -0.495 . . . . 0.0 109.929 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 483' ' ' ARG . 8.2 m . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.64 141.05 29.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.414 0.626 . . . . 0.0 111.173 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.649 ' HD3' HG23 ' A' ' 479' ' ' THR . 69.2 mtt180 -77.52 123.14 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.255 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -89.04 109.38 20.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.006 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.63 107.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 15.2 ptm180 -55.1 110.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.341 0.591 . . . . 0.0 110.937 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 130.66 -27.14 3.96 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -103.6 178.73 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -93.78 -76.84 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.206 0.527 . . . . 0.0 111.405 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.5 118.06 4.83 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.441 ' HB2' HD13 ' A' ' 461' ' ' LEU . 11.7 Cg_endo -58.32 -23.55 63.47 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.739 2.293 . . . . 0.0 114.002 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.416 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 72.5 mt -59.07 149.61 65.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.539 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.21 18.88 14.04 Favored 'Cis proline' 0 C--N 1.351 0.674 0 C-N-CA 124.128 -1.197 . . . . 0.0 114.138 6.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 41.6 m-70 -101.82 106.37 17.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -78.86 135.42 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.175 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 466' ' ' GLY . 6.8 mp -95.32 142.98 27.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.901 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.76 -167.11 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.2 p -78.16 26.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 476' ' ' LYS . 95.4 mt -121.61 -71.74 0.72 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.67 66.27 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.609 ' N ' ' HG ' ' A' ' 461' ' ' LEU . . . 175.61 155.22 12.42 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 459' ' ' HIS . 6.1 p -99.53 6.6 45.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.754 0.777 . . . . 0.0 111.886 -174.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 56.06 33.46 21.94 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.086 0.469 . . . . 0.0 111.25 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.4 p -177.9 131.87 0.15 Allowed 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.858 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 21.01 100.87 0.01 OUTLIER Glycine 0 C--O 1.242 0.594 0 O-C-N 124.758 1.286 . . . . 0.0 115.655 164.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.508 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 44.8 tttm 126.83 -64.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.43 1.492 . . . . 0.0 111.5 164.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.508 ' CE2' ' HD3' ' A' ' 471' ' ' LYS . 83.5 m-85 -108.81 101.16 42.83 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -174.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.69 174.16 9.86 Favored 'Trans proline' 0 N--CA 1.466 -0.091 0 C-N-CA 122.572 2.181 . . . . 0.0 111.352 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . 0.436 HD21 ' HA3' ' A' ' 466' ' ' GLY . 13.7 m120 -83.58 97.32 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.573 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 79.9 mt -105.21 -24.38 12.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.14 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.736 ' HB3' ' HZ1' ' A' ' 476' ' ' LYS . 8.7 mtpm? 65.25 -103.88 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.997 0.811 . . . . 0.0 110.149 -175.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 75.9 mttt 62.28 169.72 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.174 0.59 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.9 Cg_endo -58.89 100.05 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.501 2.134 . . . . 0.0 112.067 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.649 HG23 ' HD3' ' A' ' 448' ' ' ARG . 16.7 p -92.64 135.96 33.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.036 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.99 141.75 14.2 Favored 'Isoleucine or valine' 1 C--O 1.132 -5.103 0 C-N-CA 116.647 -2.021 . . . . 0.0 108.406 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -91.82 110.92 22.27 Favored 'General case' 0 N--CA 1.387 -3.617 0 O-C-N 128.789 3.805 . . . . 0.0 111.246 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -133.15 131.88 40.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.979 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.617 ' HB2' HG22 ' A' ' 446' ' ' THR . 28.0 ttp180 -123.38 -88.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.447 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -76.44 107.45 2.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.814 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.608 175.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.715 HG23 ' HB2' ' A' ' 483' ' ' ARG . 17.8 p . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -97.97 146.88 25.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.21 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.42 ' HB3' HD13 ' A' ' 461' ' ' LEU . 89.0 mtt180 -72.35 142.23 48.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.898 -168.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.758 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 8.6 m170 -121.31 158.15 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.397 169.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.52 136.92 29.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -62.04 101.25 0.2 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.027 0.441 . . . . 0.0 110.774 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.53 6.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.904 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.97 159.22 15.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.836 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -82.79 -45.99 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.538 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.28 122.53 0.38 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.406 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 31.4 Cg_exo -62.4 -31.01 81.16 Favored 'Trans proline' 0 CA--C 1.525 0.06 0 C-N-CA 122.587 2.191 . . . . 0.0 113.175 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.466 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 66.6 mt -56.03 147.22 45.81 Favored Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 123.297 0.373 . . . . 0.0 111.203 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.73 16.76 10.87 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.906 -1.289 . . . . 0.0 114.081 4.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.466 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 48.0 m-70 -88.65 141.74 28.27 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -106.14 146.52 30.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 65.3 mt -102.58 127.73 49.55 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.99 0.181 . . . . 0.0 110.995 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -58.69 -56.81 17.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.625 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 45.9 p -178.97 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.046 0.538 . . . . 0.0 109.747 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.03 12.25 9.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.898 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.7 56.52 3.83 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.651 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -156.6 168.74 33.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.213 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 31.7 p -137.71 124.44 21.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 468' ' ' ARG . 4.3 mpt_? -55.62 -30.95 61.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.695 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 29.5 p -74.9 70.77 1.99 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.106 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.5 70.78 0.27 Allowed Glycine 0 N--CA 1.462 0.408 0 N-CA-C 115.199 0.84 . . . . 0.0 115.199 163.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.824 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 21.3 tptm -162.02 -72.97 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.073 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.563 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 46.8 m-85 -104.73 133.37 20.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.464 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.66 -177.37 2.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.842 2.362 . . . . 0.0 111.997 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -78.98 80.04 5.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.8 -15.2 59.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.742 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 58.36 68.82 0.79 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.975 0.416 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -132.4 143.33 48.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.663 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -59.2 126.0 19.67 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.007 2.472 . . . . 0.0 111.091 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 449' ' ' HIS . 20.3 p -79.5 134.75 36.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.994 0.426 . . . . 0.0 111.766 -176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 46.2 t -84.82 126.07 40.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.248 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.51 ' HB3' ' HG1' ' A' ' 446' ' ' THR . 88.6 m95 -89.7 105.82 18.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.829 0.347 . . . . 0.0 111.558 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -136.04 141.51 44.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.897 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.715 ' HB2' HG23 ' A' ' 446' ' ' THR . 47.0 ttt180 -139.23 134.02 32.13 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 81.58 138.84 2.63 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.849 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.659 178.716 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 483' ' ' ARG . 43.1 p . . . . . 0 C--O 1.238 0.449 0 CA-C-O 120.675 0.274 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.9 138.6 50.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.983 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.433 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 3.7 mtm180 -83.12 144.49 29.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.652 -172.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -112.7 121.69 45.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.05 117.7 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -51.8 105.49 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.425 0.631 . . . . 0.0 111.967 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 120.4 -23.78 7.91 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.46 152.35 23.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -65.52 -69.65 0.28 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 43.7 t -173.37 121.88 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -17.34 50.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.275 . . . . 0.0 113.529 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.442 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 67.5 mt -54.54 143.16 49.21 Favored Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.089 0.243 . . . . 0.0 111.133 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.06 18.37 14.61 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.643 -1.399 . . . . 0.0 114.426 7.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.442 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 27.8 m-70 -97.76 165.72 11.82 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.67 141.36 28.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -172.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -80.65 -174.8 4.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 13.1 p -58.72 -28.42 65.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.73 8.4 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.146 -0.346 . . . . 0.0 111.627 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.62 20.12 64.57 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.164 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.09 156.36 15.72 Favored Glycine 1 C--O 1.315 5.187 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.964 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 6.2 p -110.95 149.06 31.2 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 120.552 -1.558 . . . . 0.0 109.819 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.467 ' O ' ' SG ' ' A' ' 469' ' ' CYS . 90.2 mtt180 -58.85 156.74 10.82 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 468' ' ' ARG . 0.8 OUTLIER 87.49 -18.75 0.27 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.93 1.292 . . . . 0.0 111.294 -174.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.78 72.9 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 8.9 tmtm? -124.29 -43.1 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.52 123.86 33.15 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.01 164.52 31.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.595 2.196 . . . . 0.0 111.897 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.37 91.07 3.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.901 0.382 . . . . 0.0 110.1 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.78 -6.52 26.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.661 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? 46.77 37.25 4.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.462 1.105 . . . . 0.0 112.589 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 35.1 mtpt -84.56 162.17 51.54 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 50.1 Cg_exo -51.95 122.81 11.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.47 2.78 . . . . 0.0 112.103 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.61 143.49 48.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.855 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.07 158.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.433 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 75.4 m95 -101.95 113.85 27.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 0.0 111.139 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 36.9 mmt180 -111.97 128.27 56.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.532 ' HB3' ' CG2' ' A' ' 446' ' ' THR . 10.0 ptm180 -140.21 5.07 2.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.923 -177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -90.11 -5.98 69.74 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.422 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.81 -179.397 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 483' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . 0.401 ' HB2' ' NH1' ' A' ' 460' ' ' ARG . 36.0 p-80 -84.88 129.11 34.86 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.42 -171.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.642 ' NH1' ' HA ' ' A' ' 463' ' ' SER . 33.6 mtt85 -66.16 132.2 47.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.205 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.6 m170 -109.18 152.41 25.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.422 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 41.8 mt -91.74 146.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -68.76 80.34 0.29 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 0.0 110.718 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.12 49.81 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -162.55 136.28 6.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -70.32 -39.66 74.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.795 -178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 6.0 t 176.68 109.68 0.11 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.37 10.6 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.293 2.662 . . . . 0.0 113.939 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.648 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 68.1 mt -73.97 161.75 77.11 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.9 Cg_endo -84.38 19.97 21.08 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 124.151 -1.187 . . . . 0.0 113.915 6.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -84.38 131.71 34.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.7 tpm_? -99.65 105.58 17.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.053 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 465' ' ' GLY . 7.6 mp -70.15 133.54 47.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.97 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.59 -163.66 1.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' SER . . . . . 0.642 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 8.2 p -60.63 -33.83 73.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.6 mt -92.17 -3.97 54.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.673 0.273 . . . . 0.0 111.641 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . 0.442 ' O ' ' HG ' ' A' ' 461' ' ' LEU . . . 103.35 -16.49 52.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.319 -0.944 . . . . 0.0 113.187 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -73.62 152.76 46.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.609 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 14.2 p -111.24 25.06 12.12 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.088 -0.654 . . . . 0.0 111.129 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 74.44 -36.79 0.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 3.9 p -97.24 13.35 29.72 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 116.103 -2.239 . . . . 0.0 109.234 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 89.02 -28.88 6.27 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.852 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 7.4 tmtt? -47.29 -51.39 19.28 Favored 'General case' 0 N--CA 1.389 -3.501 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.53 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.3 m-85 -111.66 121.19 40.59 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 112.722 -2.035 . . . . 0.0 109.156 170.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.09 167.28 9.48 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 112.302 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -75.16 95.19 3.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.281 0.563 . . . . 0.0 109.997 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.99 -27.82 26.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.54 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 476' ' ' LYS . 27.7 tptp 62.53 28.77 16.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.711 0.767 . . . . 0.0 110.736 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 43.4 mtmt -98.65 163.07 19.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.8 Cg_endo -57.57 118.33 5.19 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.573 2.182 . . . . 0.0 112.221 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.49 HG22 ' HD3' ' A' ' 448' ' ' ARG . 11.8 p -97.99 146.38 25.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.966 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.4 t -92.32 134.91 28.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.967 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.33 108.27 20.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.74 0.305 . . . . 0.0 110.994 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.29 134.87 54.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 110.633 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.463 ' HB2' HG23 ' A' ' 446' ' ' THR . 42.2 ttt-85 -130.29 102.99 6.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 98.73 154.78 28.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.832 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.301 178.43 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.434 HG21 ' HB2' ' A' ' 483' ' ' ARG . 2.2 p . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.861 0.363 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -132.4 146.12 51.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.973 0.416 . . . . 0.0 110.163 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 68.2 mtt180 -89.23 139.45 30.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.509 -176.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 25.9 m170 -98.62 133.6 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 461' ' ' LEU . 12.5 tt -80.54 14.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.117 0.484 . . . . 0.0 111.66 -173.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 69.28 16.39 8.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.419 0.628 . . . . 0.0 110.688 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -146.55 -52.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.04 132.81 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.38 69.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.724 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 11.8 t -171.7 102.19 0.38 Allowed Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.4 38.04 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.815 3.01 . . . . 0.0 113.984 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.497 ' HA ' ' H ' ' A' ' 459' ' ' HIS . 59.8 mt -104.3 157.71 33.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 29.3 Cg_endo -91.2 45.84 1.73 Allowed 'Cis proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.471 -1.054 . . . . 0.0 112.9 1.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 36.4 m-70 -94.38 -61.72 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.007 0.432 . . . . 0.0 109.923 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 81.78 126.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.028 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 55.5 mt -86.59 110.82 20.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.75 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -63.33 -62.95 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.521 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 7.6 p -152.89 -58.73 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.773 0.32 . . . . 0.0 111.403 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.44 19.02 0.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.42 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 74.89 36.16 48.07 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.694 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -119.74 176.54 16.17 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.269 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 22.1 p -142.23 126.37 17.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.697 0.249 . . . . 0.0 110.438 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -75.32 76.49 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.6 p 174.11 -2.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 95.57 123.5 4.17 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.761 -170.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 146.59 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.799 1.64 . . . . 0.0 109.414 164.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 465' ' ' GLY . 87.3 m-85 -101.9 123.37 44.02 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.353 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -90.24 -158.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.126 2.551 . . . . 0.0 111.23 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -86.76 83.77 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.127 0.489 . . . . 0.0 109.826 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.9 -39.39 12.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.371 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt 55.72 77.24 0.24 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.987 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.76 149.06 58.24 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.39 107.18 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.82 2.347 . . . . 0.0 111.824 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -105.12 140.93 37.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.235 0.541 . . . . 0.0 111.94 -172.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.8 t -93.31 131.98 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.515 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.58 110.82 20.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.016 0.436 . . . . 0.0 110.997 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -125.99 141.55 51.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.546 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.434 ' HB2' HG21 ' A' ' 446' ' ' THR . 48.1 ttp180 -121.4 -55.51 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.433 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.3 130.06 10.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.916 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.803 175.744 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.847 HG23 ' HG2' ' A' ' 483' ' ' ARG . 10.1 p . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -112.88 176.71 4.9 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.93 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.936 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 49.3 mtt180 -117.86 143.32 46.4 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.49 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -110.05 138.14 46.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.504 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 11.2 tt -83.63 22.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.341 0.591 . . . . 0.0 111.055 -176.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 450' ' ' ILE . 8.8 ptm180 53.92 12.89 0.48 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.712 1.205 . . . . 0.0 112.889 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -149.45 31.44 1.14 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.55 152.04 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.47 -42.07 71.91 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 117.835 -1.546 . . . . 0.0 107.963 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 44.2 t -175.51 108.85 0.26 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 10.4 Cg_exo -73.79 29.9 0.32 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.549 2.832 . . . . 0.0 114.067 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.33 152.14 39.95 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.61 19.05 37.77 Favored 'Cis proline' 0 C--O 1.169 -2.93 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.956 2.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -65.67 -58.18 6.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 71.96 133.36 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.375 1.047 . . . . 0.0 111.27 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.9 mm? -86.18 130.74 34.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.222 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 464' ' ' LEU . 2.0 p-10 -80.66 47.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.672 0.272 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 89.8 p 59.88 -1.88 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.971 1.308 . . . . 0.0 113.431 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 462' ' ' ASN . 90.7 mt -107.29 4.93 27.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.21 67.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.446 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -125.1 177.38 16.92 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.413 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 29.9 p -125.79 121.77 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.48 -29.76 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 111.649 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.31 -9.14 57.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 96.12 124.87 4.64 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.147 -173.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.1 tmtp? 159.44 -48.01 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.83 1.652 . . . . 0.0 107.933 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.515 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 49.1 m-85 -123.26 128.43 25.28 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.703 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.75 157.57 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.329 2.019 . . . . 0.0 111.004 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.38 92.41 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 109.868 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.09 -6.34 45.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.274 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.4 mttm 64.3 28.65 13.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.861 0.362 . . . . 0.0 111.383 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 74.2 mmtt -89.5 140.99 28.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.4 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 477' ' ' LYS . 39.3 Cg_exo -61.77 115.19 2.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.063 2.509 . . . . 0.0 111.994 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.936 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 16.5 p -80.57 128.52 33.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.406 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.86 132.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.127 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -80.46 105.79 11.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.008 0.433 . . . . 0.0 111.807 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -126.02 139.15 53.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.469 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.847 ' HG2' HG23 ' A' ' 446' ' ' THR . 0.0 OUTLIER -166.27 164.33 17.69 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.117 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 103.94 8.37 39.49 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.817 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -95.23 131.47 41.24 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.553 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.678 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 67.9 mtt180 -71.9 132.76 44.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.475 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.868 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.9 m170 -97.8 111.94 24.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.384 170.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.97 109.02 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -43.59 106.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.746 0.654 . . . . 0.0 111.687 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.45 -19.92 6.63 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.321 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -106.64 153.91 21.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.601 0.36 . . . . 0.0 110.169 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -81.15 -49.21 11.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.706 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 34.1 t -174.09 102.29 0.29 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.35 33.49 0.36 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.409 2.74 . . . . 0.0 114.22 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 33.2 mt -75.22 158.86 83.5 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 4.1 Cg_endo -86.77 33.66 5.57 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.255 -1.144 . . . . 0.0 113.206 3.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.435 ' H ' ' HA ' ' A' ' 457' ' ' LEU . 87.8 m-70 -103.4 116.21 31.99 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.282 0.563 . . . . 0.0 110.205 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -95.96 121.4 37.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.132 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 2.5 mm? -82.54 135.62 35.05 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.902 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -77.18 -168.6 1.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.42 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.2 p -77.83 11.67 2.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.883 0.373 . . . . 0.0 111.665 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.8 mt -120.5 1.29 10.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.0 110.209 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 75.86 35.88 43.74 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.446 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -133.76 164.98 24.34 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -129.57 120.67 25.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.74 0.77 . . . . 0.0 110.882 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -46.88 -40.98 15.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 124.2 0.937 . . . . 0.0 110.806 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 26.0 p -69.04 74.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 32.45 75.89 0.04 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 124.151 0.907 . . . . 0.0 115.127 166.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 16.6 tppt? -167.92 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.994 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -76.16 119.94 79.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 111.394 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.52 43.74 1.1 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.672 2.915 . . . . 0.0 113.11 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 63.08 94.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 111.311 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.0 mt -117.78 84.49 2.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.572 ' HB3' ' HZ2' ' A' ' 476' ' ' LYS . 6.8 mtpm? -62.07 95.01 0.06 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.45 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -144.08 155.66 58.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.274 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -50.48 124.35 13.07 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 111.58 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.501 HG23 ' HD3' ' A' ' 448' ' ' ARG . 0.9 OUTLIER -132.21 159.94 37.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.838 -171.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.868 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 49.0 t -96.09 141.28 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.846 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -100.51 106.8 18.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.111 0.482 . . . . 0.0 111.803 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -132.23 131.43 42.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.47 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 484' ' ' GLY . 2.7 ptp85 -96.42 -52.66 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.243 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 483' ' ' ARG . . . -133.22 155.18 21.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.449 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.032 -179.729 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.234 0.289 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -91.68 138.12 31.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.771 -168.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 39.7 mtt180 -71.24 130.08 40.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.686 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.621 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m170 -98.31 105.73 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.935 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.1 115.47 5.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -47.51 107.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.4 14.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.594 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.11 -5.15 58.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 110.967 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 62.6 -98.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.426 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 456' ' ' PRO . 35.7 t -127.04 97.08 32.93 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 455' ' ' CYS . 13.3 Cg_endo -57.48 -1.95 0.57 Allowed 'Trans proline' 0 N--CA 1.477 0.526 0 C-N-CA 124.255 3.304 . . . . 0.0 114.869 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.572 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 54.1 mt -61.62 152.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.317 0 O-C-N 122.159 -0.338 . . . . 0.0 110.09 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.47 25.94 4.83 Favored 'Cis proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.063 -1.224 . . . . 0.0 114.494 6.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.572 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 71.8 m-70 -96.56 134.81 39.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 45.3 ttp180 -118.86 124.93 48.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.106 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 1.8 mm? -91.38 138.36 31.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.933 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.414 ' O ' ' HD2' ' A' ' 448' ' ' ARG . 10.1 p30 -86.97 -171.78 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.8 p -68.14 -7.56 30.93 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.8 mt -95.2 -4.82 45.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 110.492 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.42 45.24 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.868 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -123.39 152.05 17.0 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.16 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 28.0 p -101.52 116.12 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.37 0.585 . . . . 0.0 110.582 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -49.04 -33.57 11.65 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.823 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.91 -13.01 61.26 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 98.13 124.66 5.04 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.837 -173.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 1.2 tmtp? 156.03 -55.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.256 1.422 . . . . 0.0 109.457 166.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.504 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 97.9 m-85 -97.92 125.62 43.53 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.98 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.11 167.39 27.47 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.824 2.349 . . . . 0.0 111.865 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.49 97.31 3.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -98.41 -20.13 17.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 39.1 mttm 67.95 -1.92 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.814 0.446 . . . . 0.0 112.053 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.69 152.17 96.53 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -170.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.96 125.43 18.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.494 2.796 . . . . 0.0 112.173 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 448' ' ' ARG . 5.2 p -123.23 157.03 33.99 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 36.6 t -89.9 141.82 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.75 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.454 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 36.0 m95 -94.45 105.37 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.554 ' HG3' ' CE1' ' A' ' 449' ' ' HIS . 39.7 mmt180 -123.39 118.16 26.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -87.82 -48.86 7.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -140.17 171.94 23.69 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.023 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.177 -2.713 0 CA-C-O 122.309 1.052 . . . . 0.0 109.918 -179.657 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 483' ' ' ARG . 33.7 m . . . . . 0 C--O 1.231 0.097 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -92.38 144.15 25.67 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.08 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.495 ' HB3' ' CG2' ' A' ' 479' ' ' THR . 68.2 mtt180 -76.77 125.49 29.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.312 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.733 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 6.2 m170 -91.71 117.88 30.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.867 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 59.7 mt -72.78 115.94 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.664 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 13.3 ptm180 -57.33 101.86 0.08 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.609 0.718 . . . . 0.0 110.185 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.68 4.62 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.155 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.95 136.11 54.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.03 -60.54 3.62 Favored 'General case' 1 N--CA 1.349 -5.483 0 O-C-N 119.242 -2.162 . . . . 0.0 111.125 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.436 ' SG ' ' HG ' ' A' ' 457' ' ' LEU . 34.4 t -155.8 107.17 2.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.27 29.56 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.873 2.382 . . . . 0.0 113.877 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 42.0 mt -83.46 162.85 52.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.668 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.1 Cg_endo -84.94 18.38 27.02 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 124.32 -1.117 . . . . 0.0 113.346 3.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.462 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 76.3 m-70 -77.81 132.47 38.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.353 0.596 . . . . 0.0 110.267 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -94.42 108.58 20.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.098 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.8 mp -76.23 110.83 11.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.466 ' C ' HD21 ' A' ' 462' ' ' ASN . 0.2 OUTLIER -69.31 -178.55 1.37 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.075 175.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.3 p -68.92 -1.45 7.36 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.406 ' CB ' HD21 ' A' ' 474' ' ' ASN . 5.5 mp -98.23 5.8 48.05 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.205 -0.31 . . . . 0.0 111.034 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.81 49.57 22.7 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.853 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . 177.94 -165.51 35.1 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 19.0 p -145.69 128.36 16.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.16 0.48 . . . . 0.0 110.192 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.02 -22.75 61.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.163 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.07 -24.32 64.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.79 84.3 1.79 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.122 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -168.42 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.462 ' HE2' ' HB2' ' A' ' 459' ' ' HIS . 73.8 m-85 -124.74 117.37 26.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.42 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 2.9 Cg_exo -73.13 166.32 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.613 2.209 . . . . 0.0 111.883 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . 0.406 HD21 ' CB ' ' A' ' 464' ' ' LEU . 14.7 m120 -77.23 81.86 3.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.2 mt -106.87 -1.57 22.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.989 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 65.19 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.622 0.576 . . . . 0.0 110.485 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 63.04 152.36 0.11 Allowed Pre-proline 0 N--CA 1.466 0.332 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.664 ' HG2' ' HD3' ' A' ' 451' ' ' ARG . 28.0 Cg_endo -65.48 105.24 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.299 1.999 . . . . 0.0 111.208 171.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -113.79 144.27 43.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.43 -174.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 9.0 t -94.52 140.08 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.459 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -96.45 109.44 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.888 0.375 . . . . 0.0 111.888 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -132.3 127.39 35.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.506 ' HB3' ' HA ' ' A' ' 446' ' ' THR . 11.2 ptm180 -131.66 -1.32 3.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.575 0.226 . . . . 0.0 110.906 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -59.69 -26.94 63.23 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.492 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.343 175.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' THR . . . . . 0.443 HG21 ' HB3' ' A' ' 483' ' ' ARG . 7.8 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -97.94 143.99 27.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.362 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -73.99 137.64 43.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.523 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 455' ' ' CYS . 1.5 m-70 -110.99 148.46 32.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.692 171.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 477' ' ' LYS . 22.3 mt -77.17 1.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.808 0.813 . . . . 0.0 109.597 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 57.71 78.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.319 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 154.46 -7.37 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.159 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -178.75 3.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.927 0.394 . . . . 0.0 110.466 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . 0.434 ' O ' ' HE1' ' A' ' 449' ' ' HIS . . . -83.49 -48.32 10.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.56 ' HA ' ' CE1' ' A' ' 449' ' ' HIS . 19.1 t -178.74 119.81 0.24 Allowed Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.02 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.31 -2.0 10.53 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.195 2.597 . . . . 0.0 113.76 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 79.7 mt -68.25 159.03 82.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 91.4 Cg_endo -83.36 18.23 21.95 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.786 -1.339 . . . . 0.0 114.17 5.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.94 133.8 36.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 36.0 mtt180 -98.72 112.28 24.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.505 -171.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.7 mp -85.75 117.89 24.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.793 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.449 ' C ' HD21 ' A' ' 462' ' ' ASN . 0.2 OUTLIER -81.52 -176.54 6.09 Favored 'General case' 1 C--O 1.314 4.485 0 CA-C-O 123.508 1.623 . . . . 0.0 110.635 176.344 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 8.8 p -53.27 -30.21 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.353 -1.467 . . . . 0.0 112.891 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.35 7.3 29.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.02 54.3 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.262 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -162.42 168.85 37.53 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.5 p -117.13 113.91 22.95 Favored 'General case' 1 N--CA 1.366 -4.631 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.074 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -47.23 -38.38 12.09 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.815 0.697 . . . . 0.0 111.697 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.5 p -59.61 -22.54 61.97 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 111.46 125.03 4.6 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.872 -171.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 29.4 tptp 149.11 -75.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.601 1.56 . . . . 0.0 109.084 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -87.15 123.49 69.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.93 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.21 175.09 11.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.779 2.319 . . . . 0.0 111.939 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -74.77 85.68 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 0.0 110.438 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.17 -40.0 39.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.932 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 61.92 24.58 14.65 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.339 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 10.6 ptpt -81.45 165.92 41.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 11.4 Cg_endo -55.14 101.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.536 2.157 . . . . 0.0 112.046 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 449' ' ' HIS . 0.0 OUTLIER -102.54 139.32 38.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.418 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.26 153.37 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.0 111.559 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -92.51 104.54 16.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.512 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -127.65 125.28 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.017 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 484' ' ' GLY . 4.3 ptp180 -110.05 -47.09 3.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.789 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 483' ' ' ARG . . . -91.14 139.17 14.67 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.846 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.102 174.604 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -99.07 145.04 27.54 Favored 'General case' 0 C--O 1.273 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.259 -174.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.637 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 22.7 mtp85 -87.18 157.85 19.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.645 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.637 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.0 OUTLIER -132.19 127.77 36.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.819 176.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.62 123.19 31.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -51.9 104.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.47 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 124.88 -17.02 7.25 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.5 140.3 29.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -76.02 -44.13 40.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.223 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 10.4 t -178.99 116.1 0.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.14 -10.8 28.58 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.023 2.482 . . . . 0.0 113.581 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.445 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 91.8 mt -59.39 153.16 50.45 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.695 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.36 19.15 13.98 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.851 5.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 96.8 m-70 -89.38 148.79 23.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.166 0.507 . . . . 0.0 110.112 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -121.29 121.31 37.42 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.021 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 8.5 mp -73.19 108.89 6.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.576 ' OD1' ' HA ' ' A' ' 467' ' ' CYS . 1.1 p-10 -75.01 68.73 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.464 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' SER . . . . . 0.623 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 92.0 p 64.15 -39.62 0.22 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.296 1.438 . . . . 0.0 114.103 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.469 HD21 ' HE2' ' A' ' 476' ' ' LYS . 39.7 mt -88.67 16.4 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.96 15.74 66.72 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.683 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -157.79 179.13 33.74 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.576 ' HA ' ' OD1' ' A' ' 462' ' ' ASN . 17.6 p -129.16 117.48 20.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.4 0.6 . . . . 0.0 110.026 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -68.84 97.19 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.208 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 470' ' ' GLY . 12.5 p -168.3 -41.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.886 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 469' ' ' CYS . . . 136.8 47.35 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.844 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 472' ' ' TYR . 16.9 tptm -140.13 -55.43 0.54 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.804 0.335 . . . . 0.0 110.55 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 75.2 m-85 -132.08 125.15 19.91 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.4 171.93 17.31 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.513 2.142 . . . . 0.0 111.909 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.82 87.41 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.353 . . . . 0.0 110.289 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 477' ' ' LYS . 91.7 mt -75.48 -26.61 58.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.865 -175.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.469 ' HE2' HD21 ' A' ' 464' ' ' LEU . 33.1 mmtp 66.11 26.21 10.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.08 0.552 . . . . 0.0 111.398 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.507 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 44.1 mtpt -100.62 158.63 31.53 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.306 -0.246 . . . . 0.0 110.982 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 10.1 Cg_endo -52.96 133.83 53.11 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.556 2.837 . . . . 0.0 112.558 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 0.1 OUTLIER -127.75 136.68 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.349 -176.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.637 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 10.5 t -82.29 152.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.61 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.564 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 55.1 m95 -109.12 107.36 17.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -124.54 125.19 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -62.36 -84.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.78 -63.05 1.11 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.49 168.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.243 0.544 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -100.5 133.7 44.54 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-O 122.448 1.118 . . . . 0.0 111.351 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 448' ' ' ARG . 51.7 mtt-85 -68.54 133.54 48.7 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.578 -2.555 . . . . 0.0 111.395 -172.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 449' ' ' HIS . . . . . 0.432 ' CB ' HG21 ' A' ' 480' ' ' VAL . 2.6 m170 -101.57 119.45 38.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.912 171.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.465 HG23 ' HD2' ' A' ' 477' ' ' LYS . 76.4 mt -66.85 125.66 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.494 ' HD3' ' HB2' ' A' ' 478' ' ' PRO . 20.8 mtp180 -58.69 105.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.409 0.623 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 129.53 -23.27 4.83 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.168 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -97.97 138.35 35.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.95 -38.44 72.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.504 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 36.9 t 178.95 114.07 0.19 Allowed Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 456' ' ' PRO . . . . . 0.4 ' HB2' HD11 ' A' ' 461' ' ' LEU . 56.7 Cg_endo -71.48 2.81 4.13 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.17 2.58 . . . . 0.0 113.922 -175.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 81.4 mt -69.22 156.99 90.5 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 76.5 Cg_endo -82.56 16.2 24.41 Favored 'Cis proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.51 -1.454 . . . . 0.0 113.771 5.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.404 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 45.6 m-70 -80.25 144.93 32.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 109.942 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.4 mmm180 -100.21 110.14 22.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.248 -174.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.2 mp -86.21 117.82 25.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.093 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.87 -167.31 1.22 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.377 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 3.2 p -65.1 -16.2 63.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.84 -0.08 57.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.629 0.252 . . . . 0.0 110.96 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.97 61.2 3.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.731 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -174.22 158.03 26.29 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 20.9 p -101.4 118.41 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.497 0.648 . . . . 0.0 109.91 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.55 -35.11 62.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.705 -175.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -22.27 60.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 108.11 132.34 6.73 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.062 -168.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.665 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 28.2 tptp 150.17 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 125.852 1.661 . . . . 0.0 108.101 171.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -132.42 117.69 15.64 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.877 176.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.7 160.43 49.75 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 111.601 177.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -65.88 95.55 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.163 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.478 HD11 ' HE3' ' A' ' 477' ' ' LYS . 95.1 mt -85.48 -28.71 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.627 -175.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 476' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 476' ' ' LYS . 20.7 ttmm 57.8 28.03 15.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.772 0.796 . . . . 0.0 110.509 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.565 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 16.0 ptpt -96.88 164.22 18.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 86.1 Cg_exo -38.88 115.51 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.742 2.961 . . . . 0.0 112.737 176.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 136.67 54.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.408 -176.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.432 HG21 ' CB ' ' A' ' 449' ' ' HIS . 0.1 OUTLIER -93.81 136.41 25.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -86.89 109.73 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -177.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -119.02 136.47 54.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.602 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 483' ' ' ARG . . . . . 0.413 ' HD3' ' N ' ' A' ' 483' ' ' ARG . 0.1 OUTLIER -95.66 -147.41 0.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.534 179.782 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -69.68 136.41 27.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.819 177.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.215 -177.456 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -93.31 175.86 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.848 2.365 . . . . 0.0 112.566 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 483' ' ' ARG . 20.2 p -81.79 134.46 35.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -95.76 142.74 27.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.597 ' CD ' ' HB ' ' A' ' 479' ' ' THR . 3.9 ttt180 -100.7 146.27 27.41 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.265 0.555 . . . . 0.0 111.632 -172.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -103.56 137.21 41.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.734 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 21.2 pt -87.54 13.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 109.802 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 451' ' ' ARG . 39.1 ttt85 69.4 88.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.531 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.08 60.22 1.14 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.259 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 456' ' ' PRO . 0.0 OUTLIER -136.91 1.74 2.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.807 0.337 . . . . 0.0 111.103 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 66.34 30.45 8.91 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.335 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 31.6 t 72.73 113.92 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.857 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.595 ' HG3' ' HG3' ' A' ' 453' ' ' GLU . 2.2 Cg_endo -82.51 21.41 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 113.683 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 53.8 mt -73.55 159.8 83.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.649 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 63.8 Cg_endo -88.14 21.5 26.63 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 113.455 2.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -83.02 143.43 30.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 110.067 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 117.81 32.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.912 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.3 mp -90.1 145.35 25.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.208 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -95.73 -167.25 1.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.281 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' SER . . . . . 0.45 ' HA ' HH11 ' A' ' 448' ' ' ARG . 3.3 p -68.92 -15.08 63.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.2 -3.77 57.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.264 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.74 4.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.58 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -166.96 166.49 39.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.814 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.817 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 25.6 p -114.1 124.07 51.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.195 0.497 . . . . 0.0 110.327 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 468' ' ' ARG . 6.4 mtp180 -52.09 -35.72 48.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.819 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.1 p -69.35 105.63 2.63 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -22.17 104.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.195 0 O-C-N 124.924 1.39 . . . . 0.0 115.355 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.817 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 56.5 tptt -172.85 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -0.807 . . . . 0.0 110.918 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -129.77 122.64 20.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.65 -167.83 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.125 2.55 . . . . 0.0 113.074 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 474' ' ' ASN . 0.9 OUTLIER -83.75 90.43 7.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.012 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.87 -30.05 18.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.52 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 21.1 tptm 53.2 77.99 0.16 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.756 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -123.72 165.01 25.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.816 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.46 86.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.242 1.961 . . . . 0.0 110.764 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.597 ' HB ' ' CD ' ' A' ' 448' ' ' ARG . 0.3 OUTLIER -87.98 132.3 34.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.654 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.48 132.52 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.048 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.484 ' CE3' ' HG3' ' A' ' 448' ' ' ARG . 54.0 m95 -76.4 109.96 10.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -118.21 125.74 50.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.394 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.592 ' HB2' HG23 ' A' ' 446' ' ' THR . 0.0 OUTLIER -153.15 13.47 0.5 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.252 0.548 . . . . 0.0 110.004 173.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -79.23 -1.57 85.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.212 177.788 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.37 -29.54 85.81 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.163 2.575 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.686 HG22 ' HB2' ' A' ' 483' ' ' ARG . 90.8 m -153.78 134.95 14.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -111.33 141.56 44.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.469 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 51.7 mtt180 -73.97 153.13 39.88 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 111.102 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 482' ' ' ARG . 1.7 m-70 -124.8 119.61 29.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.092 170.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.49 134.9 29.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.18 99.89 0.15 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.191 0.52 . . . . 0.0 110.607 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 128.97 -9.7 6.31 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.36 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.25 139.17 34.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 110.563 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -79.12 -40.81 30.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.742 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 25.3 t 173.35 117.59 0.08 OUTLIER Pre-proline 0 N--CA 1.462 0.165 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 459' ' ' HIS . 68.8 Cg_endo -72.83 -22.37 20.23 Favored 'Trans proline' 0 C--O 1.223 -0.23 0 C-N-CA 122.499 2.133 . . . . 0.0 114.748 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.0 mt -55.47 145.25 49.67 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.42 11.32 26.73 Favored 'Cis proline' 0 C--N 1.356 0.956 0 C-N-CA 123.819 -1.325 . . . . 0.0 113.718 4.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.489 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 2.6 m-70 -84.05 152.81 24.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -135.94 153.78 51.31 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.861 -0.524 . . . . 0.0 111.116 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.649 ' HB3' ' HA2' ' A' ' 465' ' ' GLY . 1.4 mm? -100.73 113.58 26.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.425 ' CG ' ' H ' ' A' ' 463' ' ' SER . 2.9 p30 -59.59 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.267 0.354 . . . . 0.0 110.715 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 462' ' ' ASN . 5.9 p -148.28 -30.58 0.29 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.044 0.45 . . . . 0.0 109.794 174.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.13 -1.65 55.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.716 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 461' ' ' LEU . . . 79.81 47.8 6.98 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.139 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -141.53 150.86 22.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.538 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.683 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -103.95 128.91 51.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 117.191 0.495 . . . . 0.0 109.703 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -44.62 -36.07 2.89 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.838 0.712 . . . . 0.0 110.616 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.04 82.03 7.87 Favored 'General case' 0 C--O 1.303 3.882 0 CA-C-O 117.932 -1.032 . . . . 0.0 108.458 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 29.48 69.99 0.07 OUTLIER Glycine 0 C--N 1.304 -1.229 0 C-N-CA 128.494 2.949 . . . . 0.0 117.584 158.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.683 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 87.8 tttt -150.38 -80.45 0.12 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.579 0.689 . . . . 0.0 110.886 164.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.631 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 92.2 m-85 -68.41 124.13 89.18 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.42 170.31 10.59 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.61 2.207 . . . . 0.0 112.262 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.12 87.63 3.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.096 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.41 ' HB3' ' HG2' ' A' ' 477' ' ' LYS . 95.3 mt -100.39 -29.15 12.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.9 tttm 59.09 49.17 9.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 475' ' ' LEU . 72.9 mmtt -90.85 157.98 42.77 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.81 109.62 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.243 2.629 . . . . 0.0 111.816 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.39 137.8 41.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.11 159.27 5.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.469 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 88.4 m95 -97.18 102.99 14.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.281 0.562 . . . . 0.0 111.352 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.474 ' HB2' ' CD2' ' A' ' 449' ' ' HIS . 33.6 mmt180 -112.38 120.24 40.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 122.209 1.004 . . . . 0.0 110.406 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.686 ' HB2' HG22 ' A' ' 446' ' ' THR . 10.5 tpt180 -145.17 -13.62 0.53 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.362 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -87.55 59.61 4.34 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.131 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.057 175.549 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.019 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.56 178.96 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.619 2.213 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 28.4 p -64.68 146.74 54.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 173.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -92.13 144.16 25.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.173 -171.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.872 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 57.4 mtt-85 -85.16 140.29 31.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.18 -172.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.4 m170 -107.41 122.35 46.44 Favored 'General case' 1 C--N 1.212 -5.371 0 C-N-CA 127.15 2.18 . . . . 0.0 111.576 173.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 450' ' ' ILE . 3.0 mp -82.76 122.13 36.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 451' ' ' ARG . 10.8 mmm180 -49.45 100.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.577 0.548 . . . . 0.0 111.126 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 137.02 -30.5 2.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.237 -0.983 . . . . 0.0 113.241 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -113.14 156.28 23.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.229 0.514 . . . . 0.0 110.669 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.82 -78.13 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.643 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 23.0 t -145.36 120.77 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.0 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.465 ' HB3' ' CE2' ' A' ' 472' ' ' TYR . 28.6 Cg_exo -65.66 -8.88 20.69 Favored 'Trans proline' 0 N--CA 1.477 0.503 0 C-N-CA 123.681 2.921 . . . . 0.0 114.411 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.73 150.28 87.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.478 0.18 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 20.55 23.32 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.811 -1.329 . . . . 0.0 113.818 4.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -84.44 157.4 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.8 mpt_? -127.39 134.64 49.91 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.097 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -100.06 106.87 18.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.538 HD21 ' N ' ' A' ' 463' ' ' SER . 0.4 OUTLIER -67.25 -23.06 65.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.814 -175.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' SER . . . . . 0.538 ' N ' HD21 ' A' ' 462' ' ' ASN . 17.5 p -174.87 -76.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' A' ' 476' ' ' LYS . 79.1 mt -70.46 4.53 2.29 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 94.74 16.06 43.66 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.486 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 472' ' ' TYR . . . -106.03 147.97 16.36 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.884 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 29.5 p -111.55 -10.9 14.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 71.93 -53.26 0.69 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.893 0.745 . . . . 0.0 111.915 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.7 -18.65 8.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 133.22 127.63 2.8 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.075 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.496 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 73.2 tttt 106.94 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 126.514 1.926 . . . . 0.0 109.777 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.535 ' HB3' ' HA2' ' A' ' 466' ' ' GLY . 78.3 m-85 -92.13 117.25 67.6 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.531 ' HD2' ' HG ' ' A' ' 475' ' ' LEU . 2.2 Cg_endo -83.03 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.984 2.456 . . . . 0.0 111.366 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . 0.418 ' H ' ' HB2' ' A' ' 473' ' ' PRO . 11.3 m120 -125.33 -69.6 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.531 ' HG ' ' HD2' ' A' ' 473' ' ' PRO . 97.9 mt 71.14 -51.36 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.647 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.53 ' HG3' HD21 ' A' ' 464' ' ' LEU . 88.2 tttt 68.73 61.63 0.34 Allowed 'General case' 0 N--CA 1.532 3.652 0 O-C-N 126.16 2.162 . . . . 0.0 108.096 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 475' ' ' LEU . 7.6 mptt -102.02 152.7 38.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.828 175.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 110.99 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.161 1.907 . . . . 0.0 111.288 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.872 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 19.4 p -94.28 132.1 39.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.529 . . . . 0.0 111.679 -174.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 2.7 t -96.74 133.44 38.17 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.238 0 CA-C-O 123.739 1.733 . . . . 0.0 110.558 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 33.2 m95 -78.62 109.96 13.31 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.811 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.429 ' HD2' ' C ' ' A' ' 481' ' ' TRP . 1.1 mpt_? -113.4 118.34 34.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.318 0.58 . . . . 0.0 111.587 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -130.59 2.97 4.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.76 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -72.67 -16.81 77.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.123 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.247 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.14 -169.51 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.402 2.068 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.635 HG22 ' HB2' ' A' ' 483' ' ' ARG . 12.8 p -66.26 127.69 33.21 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -83.12 142.83 30.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.54 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.536 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 44.7 mtt180 -75.92 128.57 35.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.378 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.533 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.2 m170 -104.14 119.51 39.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.433 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.586 HG13 HD21 ' A' ' 461' ' ' LEU . 47.5 mt -69.52 125.42 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.04 95.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.204 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 138.85 -18.18 3.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.766 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.89 156.08 40.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 0.0 109.854 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -68.68 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 13.0 t -137.73 115.39 9.62 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 36.6 Cg_exo -61.62 -25.45 79.19 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.286 2.657 . . . . 0.0 113.754 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.419 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 92.9 mt -51.14 144.79 14.11 Favored Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 123.07 0.231 . . . . 0.0 111.069 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.89 15.71 12.83 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.945 -1.273 . . . . 0.0 114.099 5.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.43 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 91.3 m-70 -83.26 132.05 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 109.867 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -107.36 125.3 51.02 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 7.8 mp -85.02 137.23 33.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.432 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.83 -174.42 4.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.835 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' SER . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 11.6 p -74.4 0.14 15.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 0.0 111.406 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 474' ' ' ASN . 91.8 mt -105.13 4.05 30.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.734 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.24 26.42 61.77 Favored Glycine 2 C--O 1.142 -5.603 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -133.01 -178.78 15.77 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 110.267 -2.967 . . . . 0.0 111.765 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 13.4 p -138.18 141.44 40.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 117.514 0.657 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 469' ' ' CYS . 71.8 ttt180 -55.75 147.85 17.86 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 1.6 p 108.31 -22.28 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.723 1.609 . . . . 0.0 109.542 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 85.9 36.81 9.82 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.115 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 1.1 tmtp? -95.11 -61.28 1.51 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.4 m-85 -99.71 118.79 61.34 Favored Pre-proline 0 C--O 1.167 -3.255 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.419 ' O ' HD11 ' A' ' 475' ' ' LEU . 59.6 Cg_endo -75.57 169.02 23.22 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.091 1.86 . . . . 0.0 111.04 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . 10.6 m120 -86.07 76.34 9.8 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.305 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 473' ' ' PRO . 4.0 mp -69.05 -25.36 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.676 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 65.7 28.54 11.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.78 150.99 46.93 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.23 130.44 34.15 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.432 2.088 . . . . 0.0 111.565 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.02 157.14 20.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.095 0.474 . . . . 0.0 111.739 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 28.1 t -84.93 140.28 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.22 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.536 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 8.3 m95 -92.51 106.86 18.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 0.0 112.012 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -135.56 118.17 15.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.635 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.4 ttt180 -100.3 -64.54 1.03 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.866 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -102.28 131.41 10.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.887 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.343 178.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -91.51 -173.25 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.77 2.313 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.918 HG21 ' HB2' ' A' ' 483' ' ' ARG . 2.1 p -70.94 129.33 38.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -97.3 148.76 22.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.182 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 448' ' ' ARG . 66.9 mtt-85 -83.67 142.55 30.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.624 0.726 . . . . 0.0 112.406 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.474 ' HB3' ' HA2' ' A' ' 452' ' ' GLY . 4.8 m-70 -118.28 116.98 27.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.968 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.45 HG22 HD22 ' A' ' 475' ' ' LEU . 2.8 mp -59.8 105.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 451' ' ' ARG . 1.5 tpm_? 56.42 17.73 3.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.664 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 449' ' ' HIS . . . 78.12 43.92 12.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.566 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 -163.76 0.47 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -52.87 -69.32 0.12 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-O 123.053 1.406 . . . . 0.0 112.172 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 35.0 t 170.32 106.58 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 120.643 -1.285 . . . . 0.0 109.239 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.538 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 52.8 Cg_exo -59.2 -18.6 45.35 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.377 2.718 . . . . 0.0 114.406 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 63.7 mt -65.63 154.11 89.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.586 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 5.4 Cg_exo -77.52 7.97 19.12 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 124.227 -1.156 . . . . 0.0 114.141 7.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 92.1 m-70 -78.94 107.16 11.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 0.0 110.385 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -86.67 127.29 34.94 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.821 -170.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 456' ' ' PRO . 1.1 mm? -87.03 150.87 23.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.083 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.3 -52.76 4.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.389 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.8 p -156.07 -66.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.09 33.41 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.399 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.53 2.96 82.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.11 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -98.13 157.56 20.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.325 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 30.7 p -121.42 110.46 16.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.01 -19.56 19.2 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.57 -6.7 27.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.648 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 91.07 123.61 2.86 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.3 tmtm? 156.13 -75.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.43 1.492 . . . . 0.0 108.629 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.538 ' HH ' ' HA ' ' A' ' 456' ' ' PRO . 65.1 m-85 -84.57 132.28 47.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.902 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.6 -164.64 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.18 2.587 . . . . 0.0 111.684 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.41 97.64 10.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 0.0 110.199 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.45 HD22 HG22 ' A' ' 450' ' ' ILE . 4.6 mp -103.17 83.6 2.22 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -72.68 78.36 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.368 0.604 . . . . 0.0 109.88 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -149.54 138.66 12.65 Favored Pre-proline 0 C--O 1.212 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.456 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.67 102.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.873 3.049 . . . . 0.0 114.426 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.09 135.95 33.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.146 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.5 t -98.59 140.3 18.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.194 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -89.5 106.93 18.78 Favored 'General case' 1 C--N 1.232 -4.539 0 O-C-N 124.938 1.399 . . . . 0.0 113.428 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -118.67 116.84 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.046 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.918 ' HB2' HG21 ' A' ' 446' ' ' THR . 45.6 ttt-85 -108.87 97.88 7.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.069 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 93.36 157.57 33.46 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.157 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -84.29 -172.06 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.608 2.205 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 131.64 47.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -96.5 123.89 40.31 Favored 'General case' 1 N--CA 1.551 4.583 0 CA-C-O 124.454 2.073 . . . . 0.0 107.969 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.494 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 9.3 ptm180 -72.83 132.79 44.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.442 -2.163 . . . . 0.0 111.678 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 479' ' ' THR . 2.5 m-70 -90.87 154.78 19.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.519 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.471 HG12 HD13 ' A' ' 475' ' ' LEU . 1.1 tp -90.52 -1.37 9.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.963 0.887 . . . . 0.0 108.974 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 73.38 92.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.392 -1.731 . . . . 0.0 111.772 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 101.4 42.79 2.29 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.206 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 455' ' ' CYS . 0.0 OUTLIER -127.95 -164.81 1.41 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 455' ' ' CYS . . . -98.48 27.94 4.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.704 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.54 ' H ' ' HG2' ' A' ' 453' ' ' GLU . 46.4 t 71.75 118.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.856 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.616 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 54.5 Cg_exo -53.78 -31.7 62.76 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.589 2.859 . . . . 0.0 114.665 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.24 142.84 47.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.17 23.9 20.76 Favored 'Cis proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.58 -1.425 . . . . 0.0 114.302 5.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.3 151.15 19.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 109.62 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -123.03 128.65 50.46 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.44 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -91.73 138.39 31.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.319 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.76 -177.87 5.1 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p -62.38 -15.2 47.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.7 3.36 52.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.486 0.184 . . . . 0.0 111.493 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 475' ' ' LEU . . . 87.29 9.86 72.19 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.25 171.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -109.28 171.55 15.37 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.803 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 12.2 p -126.85 148.24 49.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.684 0.742 . . . . 0.0 109.861 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -56.65 142.04 41.35 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 0.4 OUTLIER 84.22 141.92 0.06 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -170.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -72.56 59.35 1.62 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.102 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 469' ' ' CYS . 8.7 tmtm? -110.05 -62.02 1.57 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.616 ' HH ' ' HA ' ' A' ' 456' ' ' PRO . 49.6 m-85 -107.43 124.85 33.85 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-O 120.553 0.216 . . . . 0.0 110.95 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.2 177.55 8.5 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.733 2.288 . . . . 0.0 111.652 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.37 95.17 1.71 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.471 HD13 HG12 ' A' ' 450' ' ' ILE . 78.3 mt -109.42 93.77 4.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -82.22 16.63 1.92 Allowed 'General case' 1 CA--C 1.632 4.103 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.593 ' HG3' ' HD2' ' A' ' 478' ' ' PRO . 36.5 ttmt -68.4 142.47 94.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.155 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.593 ' HD2' ' HG3' ' A' ' 477' ' ' LYS . 2.7 Cg_exo -35.72 99.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.575 3.517 . . . . 0.0 113.244 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 448' ' ' ARG . 3.4 p -83.14 127.59 33.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -92.34 111.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.241 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.494 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 97.9 m95 -75.58 105.43 6.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.904 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -124.19 134.76 53.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -142.46 30.15 1.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.166 0.984 . . . . 0.0 108.794 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.76 69.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.553 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.019 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.3 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.61 -173.47 1.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.757 2.304 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 483' ' ' ARG . 18.8 m -65.74 126.75 29.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -96.2 158.0 15.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.35 0.595 . . . . 0.0 111.261 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -88.39 150.41 23.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.552 -175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -123.18 126.03 46.22 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.277 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.5 114.7 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -44.74 113.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.804 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.12 26.22 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.44 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -90.36 149.04 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.968 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -64.0 -62.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 42.0 t 179.6 106.96 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.593 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 20.5 Cg_endo -60.86 -2.27 2.05 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.048 3.165 . . . . 0.0 115.135 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.85 150.77 75.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.231 -0.293 . . . . 0.0 110.246 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.01 28.35 12.28 Favored 'Cis proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.919 -1.284 . . . . 0.0 113.418 4.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -95.46 167.35 11.37 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 460' ' ' ARG . 39.3 ttp180 -141.84 124.1 15.6 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.586 -171.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -83.72 111.74 19.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.116 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -59.42 -38.93 81.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.98 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -164.78 -71.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 111.858 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.5 37.98 0.71 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.44 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.19 29.15 68.97 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.352 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -129.8 163.8 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.928 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.1 p -135.1 140.15 45.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 469' ' ' CYS . 37.9 ttp-105 -62.5 88.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.603 0.564 . . . . 0.0 110.85 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER 160.28 157.01 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -74.28 56.88 2.39 Favored Glycine 0 C--N 1.308 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.154 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.537 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 1.8 tmtp? -123.39 -56.97 1.69 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.593 ' HH ' ' HA ' ' A' ' 456' ' ' PRO . 82.7 m-85 -118.54 112.1 37.49 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.391 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.53 -178.83 2.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.776 2.318 . . . . 0.0 111.279 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -74.64 80.22 2.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 110.316 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.88 75.59 9.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.785 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -75.62 79.2 2.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.247 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 0.0 OUTLIER -132.24 164.53 42.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 2.2 Cg_endo -41.93 103.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.244 2.629 . . . . 0.0 113.362 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 3.9 p -86.21 127.29 34.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.273 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.18 129.97 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.896 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -81.32 109.19 15.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.069 0.462 . . . . 0.0 110.897 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -132.63 123.55 26.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.077 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.554 ' HB2' HG21 ' A' ' 446' ' ' THR . 36.9 ttt180 -120.04 -38.2 2.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.099 0.476 . . . . 0.0 109.908 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -104.35 144.22 15.81 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.016 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.63 178.837 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -86.53 -163.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.411 2.074 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 9.5 m -100.08 126.38 46.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -93.89 139.68 30.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.291 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 448' ' ' ARG . 23.1 mtt180 -71.96 142.81 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.41 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -119.35 102.44 8.68 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.609 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.463 ' HA ' HG23 ' A' ' 479' ' ' THR . 56.9 mt -65.31 136.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -59.91 105.08 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 122.68 -21.13 7.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.839 -0.695 . . . . 0.0 111.557 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.58 142.17 27.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -80.06 -47.47 14.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.221 0.534 . . . . 0.0 110.154 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 20.5 t -178.35 112.25 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 -4.27 11.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.166 2.578 . . . . 0.0 114.238 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.575 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 48.8 mt -60.68 152.01 69.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.03 16.11 10.22 Favored 'Cis proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.042 -1.232 . . . . 0.0 114.278 8.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.575 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 52.8 m-70 -91.83 104.5 16.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -82.61 127.0 32.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.522 0.677 . . . . 0.0 110.192 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 467' ' ' CYS . 7.5 mp -87.63 141.13 28.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.994 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -82.89 -176.58 6.39 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -65.69 -13.41 59.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.12 7.01 36.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.45 15.16 54.2 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.448 -0.882 . . . . 0.0 114.452 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.15 141.5 15.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 29.0 p -84.35 114.17 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER -50.67 -32.8 20.26 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.584 0.552 . . . . 0.0 112.207 -174.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.13 -30.22 70.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 122.8 128.88 3.45 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.127 -171.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 77.2 tttt 148.59 -71.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.034 1.734 . . . . 0.0 108.942 169.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 67.0 m-85 -88.93 131.6 40.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.901 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 1.8 Cg_endo -82.71 175.53 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.997 2.465 . . . . 0.0 111.854 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -84.22 66.33 9.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 C-N-CA 127.305 2.242 . . . . 0.0 107.266 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.6 -5.95 57.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.987 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? 46.62 32.94 1.83 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.188 0.995 . . . . 0.0 112.964 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -70.43 156.45 91.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.364 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.14 126.68 21.04 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.997 2.464 . . . . 0.0 112.305 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 450' ' ' ILE . 16.7 p -140.65 140.61 35.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.034 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.7 142.21 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -90.33 108.13 19.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.146 0.498 . . . . 0.0 111.075 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -109.74 133.32 53.27 Favored 'General case' 1 N--CA 1.372 -4.348 0 CA-C-O 116.791 -1.576 . . . . 0.0 111.814 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -134.23 5.35 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.512 1.505 . . . . 0.0 111.785 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -162.09 119.47 0.88 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.433 175.267 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.252 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.06 52.76 3.55 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.079 2.52 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 483' ' ' ARG . 15.2 m 69.96 164.84 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -118.06 135.57 54.1 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.393 -0.817 . . . . 0.0 110.18 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.619 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 10.1 mtm180 -78.93 138.94 38.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.493 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.65 119.96 41.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.419 ' HA ' HG23 ' A' ' 479' ' ' THR . 49.0 mt -69.68 89.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.829 0.347 . . . . 0.0 110.212 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 58.4 -92.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.972 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -130.37 21.39 4.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.798 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.64 162.31 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.829 0.452 . . . . 0.0 110.114 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.01 163.64 5.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 18.5 t -65.02 131.66 95.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.063 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.588 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . 74.7 Cg_endo -85.14 17.84 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.899 2.399 . . . . 0.0 113.318 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.435 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 71.0 mt -87.13 155.35 54.98 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 51.0 Cg_endo -89.75 15.68 46.49 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.717 -1.368 . . . . 0.0 113.623 3.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.517 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 72.5 m-70 -68.94 -42.73 76.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 72.88 123.06 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.306 1.003 . . . . 0.0 111.138 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 41.2 mt -89.2 124.38 34.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -83.03 -171.58 3.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.8 p -50.63 -38.36 45.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.7 0.7 56.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.828 0.347 . . . . 0.0 111.918 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . 0.407 ' HA2' ' HE ' ' A' ' 448' ' ' ARG . . . 88.49 21.67 43.37 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.884 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -120.9 -172.31 14.51 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.1 p -126.05 121.34 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -52.63 -31.31 36.09 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.474 0.484 . . . . 0.0 111.828 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -24.78 67.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 109.39 134.26 6.95 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.101 -170.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 50.0 tttm 148.37 -65.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.82 1.648 . . . . 0.0 109.628 167.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -85.46 131.58 47.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.773 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.79 153.35 29.56 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.031 2.487 . . . . 0.0 112.865 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 474' ' ' ASN . 0.9 OUTLIER -71.04 99.13 1.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.04 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.78 -27.43 12.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.407 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.598 ' HZ3' ' HB3' ' A' ' 476' ' ' LYS . 9.9 mtpm? 63.21 6.81 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -65.91 150.34 96.6 Favored Pre-proline 0 C--O 1.236 0.349 0 O-C-N 122.472 -0.142 . . . . 0.0 110.943 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.73 145.72 22.58 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.466 2.777 . . . . 0.0 112.756 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 450' ' ' ILE . 1.1 p -145.21 154.42 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.957 -171.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.11 132.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.619 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 91.2 m95 -84.31 102.8 12.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.556 . . . . 0.0 111.712 -174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.78 118.51 36.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.636 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.419 ' HA ' HG22 ' A' ' 446' ' ' THR . 18.1 mtp180 -58.31 -79.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.919 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -159.55 141.76 7.76 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.956 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.849 0 CA-C-O 119.061 -0.495 . . . . 0.0 109.929 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.026 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.82 32.96 0.51 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.854 2.369 . . . . 0.0 112.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 483' ' ' ARG . 8.2 m 69.82 118.22 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.52 -171.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.64 141.05 29.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.414 0.626 . . . . 0.0 111.173 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.649 ' HD3' HG23 ' A' ' 479' ' ' THR . 69.2 mtt180 -77.52 123.14 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.255 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -89.04 109.38 20.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.006 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.63 107.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 15.2 ptm180 -55.1 110.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.341 0.591 . . . . 0.0 110.937 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 130.66 -27.14 3.96 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -103.6 178.73 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -93.78 -76.84 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.206 0.527 . . . . 0.0 111.405 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.5 118.06 4.83 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.441 ' HB2' HD13 ' A' ' 461' ' ' LEU . 11.7 Cg_endo -58.32 -23.55 63.47 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.739 2.293 . . . . 0.0 114.002 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.416 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 72.5 mt -59.07 149.61 65.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.539 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.21 18.88 14.04 Favored 'Cis proline' 0 C--N 1.351 0.674 0 C-N-CA 124.128 -1.197 . . . . 0.0 114.138 6.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 41.6 m-70 -101.82 106.37 17.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -78.86 135.42 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.175 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 466' ' ' GLY . 6.8 mp -95.32 142.98 27.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.901 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.76 -167.11 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.2 p -78.16 26.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 476' ' ' LYS . 95.4 mt -121.61 -71.74 0.72 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.67 66.27 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.609 ' N ' ' HG ' ' A' ' 461' ' ' LEU . . . 175.61 155.22 12.42 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 459' ' ' HIS . 6.1 p -99.53 6.6 45.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.754 0.777 . . . . 0.0 111.886 -174.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 56.06 33.46 21.94 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.086 0.469 . . . . 0.0 111.25 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.4 p -177.9 131.87 0.15 Allowed 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.858 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 21.01 100.87 0.01 OUTLIER Glycine 0 C--O 1.242 0.594 0 O-C-N 124.758 1.286 . . . . 0.0 115.655 164.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.508 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 44.8 tttm 126.83 -64.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.43 1.492 . . . . 0.0 111.5 164.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.508 ' CE2' ' HD3' ' A' ' 471' ' ' LYS . 83.5 m-85 -108.81 101.16 42.83 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -174.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.69 174.16 9.86 Favored 'Trans proline' 0 N--CA 1.466 -0.091 0 C-N-CA 122.572 2.181 . . . . 0.0 111.352 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . 0.436 HD21 ' HA3' ' A' ' 466' ' ' GLY . 13.7 m120 -83.58 97.32 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.573 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 79.9 mt -105.21 -24.38 12.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.14 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.736 ' HB3' ' HZ1' ' A' ' 476' ' ' LYS . 8.7 mtpm? 65.25 -103.88 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.997 0.811 . . . . 0.0 110.149 -175.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 75.9 mttt 62.28 169.72 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.174 0.59 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.9 Cg_endo -58.89 100.05 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.501 2.134 . . . . 0.0 112.067 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.649 HG23 ' HD3' ' A' ' 448' ' ' ARG . 16.7 p -92.64 135.96 33.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.036 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.99 141.75 14.2 Favored 'Isoleucine or valine' 1 C--O 1.132 -5.103 0 C-N-CA 116.647 -2.021 . . . . 0.0 108.406 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -91.82 110.92 22.27 Favored 'General case' 0 N--CA 1.387 -3.617 0 O-C-N 128.789 3.805 . . . . 0.0 111.246 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -133.15 131.88 40.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.979 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.617 ' HB2' HG22 ' A' ' 446' ' ' THR . 28.0 ttp180 -123.38 -88.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.447 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -76.44 107.45 2.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.814 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.608 175.929 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.12 -161.48 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.715 HG23 ' HB2' ' A' ' 483' ' ' ARG . 17.8 p -81.4 -178.9 7.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -97.97 146.88 25.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.21 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.42 ' HB3' HD13 ' A' ' 461' ' ' LEU . 89.0 mtt180 -72.35 142.23 48.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.898 -168.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.758 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 8.6 m170 -121.31 158.15 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.397 169.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.52 136.92 29.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -62.04 101.25 0.2 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.027 0.441 . . . . 0.0 110.774 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.53 6.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.904 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.97 159.22 15.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.836 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -82.79 -45.99 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.538 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.28 122.53 0.38 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.406 ' HA ' ' HH ' ' A' ' 472' ' ' TYR . 31.4 Cg_exo -62.4 -31.01 81.16 Favored 'Trans proline' 0 CA--C 1.525 0.06 0 C-N-CA 122.587 2.191 . . . . 0.0 113.175 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.466 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 66.6 mt -56.03 147.22 45.81 Favored Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 123.297 0.373 . . . . 0.0 111.203 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.73 16.76 10.87 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.906 -1.289 . . . . 0.0 114.081 4.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.466 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 48.0 m-70 -88.65 141.74 28.27 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -106.14 146.52 30.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 65.3 mt -102.58 127.73 49.55 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.99 0.181 . . . . 0.0 110.995 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -58.69 -56.81 17.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.625 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 45.9 p -178.97 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.046 0.538 . . . . 0.0 109.747 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.03 12.25 9.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.898 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.7 56.52 3.83 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.651 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -156.6 168.74 33.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.213 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 31.7 p -137.71 124.44 21.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 468' ' ' ARG . 4.3 mpt_? -55.62 -30.95 61.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.695 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 29.5 p -74.9 70.77 1.99 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.106 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.5 70.78 0.27 Allowed Glycine 0 N--CA 1.462 0.408 0 N-CA-C 115.199 0.84 . . . . 0.0 115.199 163.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.824 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 21.3 tptm -162.02 -72.97 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.073 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.563 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 46.8 m-85 -104.73 133.37 20.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.464 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.66 -177.37 2.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.842 2.362 . . . . 0.0 111.997 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -78.98 80.04 5.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.8 -15.2 59.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.742 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 58.36 68.82 0.79 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.975 0.416 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -132.4 143.33 48.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.663 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -59.2 126.0 19.67 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.007 2.472 . . . . 0.0 111.091 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 449' ' ' HIS . 20.3 p -79.5 134.75 36.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.994 0.426 . . . . 0.0 111.766 -176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 46.2 t -84.82 126.07 40.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.248 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.51 ' HB3' ' HG1' ' A' ' 446' ' ' THR . 88.6 m95 -89.7 105.82 18.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.829 0.347 . . . . 0.0 111.558 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -136.04 141.51 44.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.897 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.715 ' HB2' HG23 ' A' ' 446' ' ' THR . 47.0 ttt180 -139.23 134.02 32.13 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 81.58 138.84 2.63 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.849 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.659 178.716 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.212 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.509 ' HG2' HH22 ' A' ' 460' ' ' ARG . 60.3 Cg_endo -76.26 -170.46 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.341 2.028 . . . . 0.0 112.159 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 483' ' ' ARG . 43.1 p -73.48 175.95 6.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.052 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.9 138.6 50.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.983 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.433 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 3.7 mtm180 -83.12 144.49 29.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.652 -172.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -112.7 121.69 45.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.05 117.7 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -51.8 105.49 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.425 0.631 . . . . 0.0 111.967 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 120.4 -23.78 7.91 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.46 152.35 23.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -65.52 -69.65 0.28 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 43.7 t -173.37 121.88 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -17.34 50.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.275 . . . . 0.0 113.529 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.442 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 67.5 mt -54.54 143.16 49.21 Favored Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.089 0.243 . . . . 0.0 111.133 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.06 18.37 14.61 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.643 -1.399 . . . . 0.0 114.426 7.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.442 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 27.8 m-70 -97.76 165.72 11.82 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.509 HH22 ' HG2' ' A' ' 445' ' ' PRO . 5.3 ptm180 -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.67 141.36 28.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -172.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -80.65 -174.8 4.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 13.1 p -58.72 -28.42 65.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.73 8.4 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.146 -0.346 . . . . 0.0 111.627 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.62 20.12 64.57 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.164 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.09 156.36 15.72 Favored Glycine 1 C--O 1.315 5.187 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.964 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 6.2 p -110.95 149.06 31.2 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 120.552 -1.558 . . . . 0.0 109.819 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -58.85 156.74 10.82 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 87.49 -18.75 0.27 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.93 1.292 . . . . 0.0 111.294 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.78 72.9 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 8.9 tmtm? -124.29 -43.1 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.52 123.86 33.15 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.01 164.52 31.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.595 2.196 . . . . 0.0 111.897 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.37 91.07 3.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.901 0.382 . . . . 0.0 110.1 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.78 -6.52 26.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.661 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? 46.77 37.25 4.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.462 1.105 . . . . 0.0 112.589 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 35.1 mtpt -84.56 162.17 51.54 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 50.1 Cg_exo -51.95 122.81 11.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.47 2.78 . . . . 0.0 112.103 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.61 143.49 48.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.855 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.07 158.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.433 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 75.4 m95 -101.95 113.85 27.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 0.0 111.139 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 36.9 mmt180 -111.97 128.27 56.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.532 ' HB3' ' CG2' ' A' ' 446' ' ' THR . 10.0 ptm180 -140.21 5.07 2.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.923 -177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -90.11 -5.98 69.74 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.422 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.81 -179.397 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -86.79 169.2 7.94 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.186 2.591 . . . . 0.0 112.107 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 483' ' ' ARG . 0.2 OUTLIER -59.67 116.77 4.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . 0.401 ' HB2' ' NH1' ' A' ' 460' ' ' ARG . 36.0 p-80 -84.88 129.11 34.86 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.42 -171.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.642 ' NH1' ' HA ' ' A' ' 463' ' ' SER . 33.6 mtt85 -66.16 132.2 47.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.205 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.6 m170 -109.18 152.41 25.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.422 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 41.8 mt -91.74 146.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -68.76 80.34 0.29 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 0.0 110.718 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.12 49.81 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -162.55 136.28 6.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -70.32 -39.66 74.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.795 -178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 6.0 t 176.68 109.68 0.11 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.37 10.6 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.293 2.662 . . . . 0.0 113.939 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.648 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 68.1 mt -73.97 161.75 77.11 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.9 Cg_endo -84.38 19.97 21.08 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 124.151 -1.187 . . . . 0.0 113.915 6.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -84.38 131.71 34.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.7 tpm_? -99.65 105.58 17.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.053 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 465' ' ' GLY . 7.6 mp -70.15 133.54 47.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.97 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.59 -163.66 1.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' SER . . . . . 0.642 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 8.2 p -60.63 -33.83 73.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.6 mt -92.17 -3.97 54.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.673 0.273 . . . . 0.0 111.641 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . 0.442 ' O ' ' HG ' ' A' ' 461' ' ' LEU . . . 103.35 -16.49 52.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.319 -0.944 . . . . 0.0 113.187 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -73.62 152.76 46.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.609 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 14.2 p -111.24 25.06 12.12 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.088 -0.654 . . . . 0.0 111.129 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 74.44 -36.79 0.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 3.9 p -97.24 13.35 29.72 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 116.103 -2.239 . . . . 0.0 109.234 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 89.02 -28.88 6.27 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.852 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 7.4 tmtt? -47.29 -51.39 19.28 Favored 'General case' 0 N--CA 1.389 -3.501 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.53 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.3 m-85 -111.66 121.19 40.59 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 112.722 -2.035 . . . . 0.0 109.156 170.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.09 167.28 9.48 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 112.302 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -75.16 95.19 3.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.281 0.563 . . . . 0.0 109.997 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.99 -27.82 26.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.54 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 476' ' ' LYS . 27.7 tptp 62.53 28.77 16.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.711 0.767 . . . . 0.0 110.736 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 43.4 mtmt -98.65 163.07 19.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.8 Cg_endo -57.57 118.33 5.19 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.573 2.182 . . . . 0.0 112.221 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.49 HG22 ' HD3' ' A' ' 448' ' ' ARG . 11.8 p -97.99 146.38 25.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.966 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.4 t -92.32 134.91 28.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.967 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.33 108.27 20.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.74 0.305 . . . . 0.0 110.994 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.29 134.87 54.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 110.633 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.463 ' HB2' HG23 ' A' ' 446' ' ' THR . 42.2 ttt-85 -130.29 102.99 6.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 98.73 154.78 28.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.832 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.301 178.43 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.315 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -88.26 -164.21 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.94 2.427 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.434 HG21 ' HB2' ' A' ' 483' ' ' ARG . 2.2 p -69.12 165.39 20.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -132.4 146.12 51.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.973 0.416 . . . . 0.0 110.163 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 68.2 mtt180 -89.23 139.45 30.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.509 -176.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 25.9 m170 -98.62 133.6 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 461' ' ' LEU . 12.5 tt -80.54 14.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.117 0.484 . . . . 0.0 111.66 -173.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 69.28 16.39 8.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.419 0.628 . . . . 0.0 110.688 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -146.55 -52.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.04 132.81 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.38 69.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.724 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 11.8 t -171.7 102.19 0.38 Allowed Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.4 38.04 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.815 3.01 . . . . 0.0 113.984 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.497 ' HA ' ' H ' ' A' ' 459' ' ' HIS . 59.8 mt -104.3 157.71 33.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 29.3 Cg_endo -91.2 45.84 1.73 Allowed 'Cis proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.471 -1.054 . . . . 0.0 112.9 1.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 36.4 m-70 -94.38 -61.72 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.007 0.432 . . . . 0.0 109.923 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 81.78 126.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.028 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 55.5 mt -86.59 110.82 20.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.75 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -63.33 -62.95 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.521 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 7.6 p -152.89 -58.73 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.773 0.32 . . . . 0.0 111.403 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.44 19.02 0.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.42 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 74.89 36.16 48.07 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.694 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -119.74 176.54 16.17 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.269 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 22.1 p -142.23 126.37 17.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.697 0.249 . . . . 0.0 110.438 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -75.32 76.49 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.6 p 174.11 -2.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 95.57 123.5 4.17 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.761 -170.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 146.59 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.799 1.64 . . . . 0.0 109.414 164.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 465' ' ' GLY . 87.3 m-85 -101.9 123.37 44.02 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.353 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -90.24 -158.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.126 2.551 . . . . 0.0 111.23 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -86.76 83.77 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.127 0.489 . . . . 0.0 109.826 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.9 -39.39 12.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.371 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt 55.72 77.24 0.24 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.987 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.76 149.06 58.24 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.39 107.18 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.82 2.347 . . . . 0.0 111.824 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -105.12 140.93 37.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.235 0.541 . . . . 0.0 111.94 -172.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.8 t -93.31 131.98 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.515 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.58 110.82 20.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.016 0.436 . . . . 0.0 110.997 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -125.99 141.55 51.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.546 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.434 ' HB2' HG21 ' A' ' 446' ' ' THR . 48.1 ttp180 -121.4 -55.51 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.433 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.3 130.06 10.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.916 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.803 175.744 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.24 148.46 34.39 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.535 2.157 . . . . 0.0 113.266 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.847 HG23 ' HG2' ' A' ' 483' ' ' ARG . 10.1 p -116.41 114.88 24.89 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -112.88 176.71 4.9 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.93 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.936 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 49.3 mtt180 -117.86 143.32 46.4 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.49 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -110.05 138.14 46.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.504 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 11.2 tt -83.63 22.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.341 0.591 . . . . 0.0 111.055 -176.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 450' ' ' ILE . 8.8 ptm180 53.92 12.89 0.48 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.712 1.205 . . . . 0.0 112.889 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -149.45 31.44 1.14 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.55 152.04 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.47 -42.07 71.91 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 117.835 -1.546 . . . . 0.0 107.963 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 44.2 t -175.51 108.85 0.26 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 10.4 Cg_exo -73.79 29.9 0.32 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.549 2.832 . . . . 0.0 114.067 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.33 152.14 39.95 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.61 19.05 37.77 Favored 'Cis proline' 0 C--O 1.169 -2.93 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.956 2.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -65.67 -58.18 6.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 71.96 133.36 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.375 1.047 . . . . 0.0 111.27 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.9 mm? -86.18 130.74 34.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.222 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 464' ' ' LEU . 2.0 p-10 -80.66 47.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.672 0.272 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 89.8 p 59.88 -1.88 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.971 1.308 . . . . 0.0 113.431 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 462' ' ' ASN . 90.7 mt -107.29 4.93 27.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.21 67.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.446 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -125.1 177.38 16.92 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.413 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 29.9 p -125.79 121.77 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.48 -29.76 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 111.649 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.31 -9.14 57.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 96.12 124.87 4.64 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.147 -173.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.1 tmtp? 159.44 -48.01 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.83 1.652 . . . . 0.0 107.933 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.515 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 49.1 m-85 -123.26 128.43 25.28 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.703 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.75 157.57 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.329 2.019 . . . . 0.0 111.004 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.38 92.41 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 109.868 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.09 -6.34 45.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.274 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.4 mttm 64.3 28.65 13.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.861 0.362 . . . . 0.0 111.383 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 74.2 mmtt -89.5 140.99 28.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.4 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 477' ' ' LYS . 39.3 Cg_exo -61.77 115.19 2.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.063 2.509 . . . . 0.0 111.994 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.936 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 16.5 p -80.57 128.52 33.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.406 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.86 132.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.127 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -80.46 105.79 11.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.008 0.433 . . . . 0.0 111.807 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -126.02 139.15 53.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.469 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.847 ' HG2' HG23 ' A' ' 446' ' ' THR . 0.0 OUTLIER -166.27 164.33 17.69 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.117 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 103.94 8.37 39.49 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.817 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . 0.403 ' H3 ' ' HD3' ' A' ' 445' ' ' PRO . . . . . . . . 0 C--O 1.231 0.103 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.403 ' HD3' ' H3 ' ' A' ' 444' ' ' ACE . 2.5 Cg_endo -86.21 165.74 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.242 2.628 . . . . 0.0 112.508 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.5 m -58.8 140.57 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -95.23 131.47 41.24 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.553 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.678 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 67.9 mtt180 -71.9 132.76 44.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.475 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.868 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.9 m170 -97.8 111.94 24.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.384 170.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.97 109.02 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -43.59 106.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.746 0.654 . . . . 0.0 111.687 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.45 -19.92 6.63 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.321 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -106.64 153.91 21.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.601 0.36 . . . . 0.0 110.169 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -81.15 -49.21 11.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.706 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 34.1 t -174.09 102.29 0.29 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.35 33.49 0.36 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.409 2.74 . . . . 0.0 114.22 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 33.2 mt -75.22 158.86 83.5 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 4.1 Cg_endo -86.77 33.66 5.57 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.255 -1.144 . . . . 0.0 113.206 3.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.435 ' H ' ' HA ' ' A' ' 457' ' ' LEU . 87.8 m-70 -103.4 116.21 31.99 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.282 0.563 . . . . 0.0 110.205 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -95.96 121.4 37.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.132 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 2.5 mm? -82.54 135.62 35.05 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.902 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -77.18 -168.6 1.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.42 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.2 p -77.83 11.67 2.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.883 0.373 . . . . 0.0 111.665 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.8 mt -120.5 1.29 10.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.0 110.209 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 75.86 35.88 43.74 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.446 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -133.76 164.98 24.34 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -129.57 120.67 25.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.74 0.77 . . . . 0.0 110.882 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -46.88 -40.98 15.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 124.2 0.937 . . . . 0.0 110.806 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 26.0 p -69.04 74.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 32.45 75.89 0.04 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 124.151 0.907 . . . . 0.0 115.127 166.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 16.6 tppt? -167.92 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.994 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -76.16 119.94 79.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 111.394 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.52 43.74 1.1 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.672 2.915 . . . . 0.0 113.11 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 63.08 94.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 111.311 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.0 mt -117.78 84.49 2.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.572 ' HB3' ' HZ2' ' A' ' 476' ' ' LYS . 6.8 mtpm? -62.07 95.01 0.06 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.45 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -144.08 155.66 58.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.274 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -50.48 124.35 13.07 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 111.58 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.501 HG23 ' HD3' ' A' ' 448' ' ' ARG . 0.9 OUTLIER -132.21 159.94 37.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.838 -171.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.868 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 49.0 t -96.09 141.28 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.846 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -100.51 106.8 18.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.111 0.482 . . . . 0.0 111.803 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -132.23 131.43 42.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.47 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 484' ' ' GLY . 2.7 ptp85 -96.42 -52.66 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.243 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 483' ' ' ARG . . . -133.22 155.18 21.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.449 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.032 -179.729 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 154.16 68.18 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.638 2.225 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 6.4 m -54.31 123.92 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -91.68 138.12 31.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.771 -168.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 39.7 mtt180 -71.24 130.08 40.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.686 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.621 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m170 -98.31 105.73 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.935 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.1 115.47 5.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -47.51 107.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.4 14.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.594 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.11 -5.15 58.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 110.967 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 62.6 -98.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.426 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 456' ' ' PRO . 35.7 t -127.04 97.08 32.93 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 455' ' ' CYS . 13.3 Cg_endo -57.48 -1.95 0.57 Allowed 'Trans proline' 0 N--CA 1.477 0.526 0 C-N-CA 124.255 3.304 . . . . 0.0 114.869 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.572 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 54.1 mt -61.62 152.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.317 0 O-C-N 122.159 -0.338 . . . . 0.0 110.09 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.47 25.94 4.83 Favored 'Cis proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.063 -1.224 . . . . 0.0 114.494 6.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.572 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 71.8 m-70 -96.56 134.81 39.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 45.3 ttp180 -118.86 124.93 48.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.106 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 1.8 mm? -91.38 138.36 31.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.933 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.414 ' O ' ' HD2' ' A' ' 448' ' ' ARG . 10.1 p30 -86.97 -171.78 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.8 p -68.14 -7.56 30.93 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.8 mt -95.2 -4.82 45.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 110.492 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.42 45.24 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.868 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -123.39 152.05 17.0 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.16 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 28.0 p -101.52 116.12 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.37 0.585 . . . . 0.0 110.582 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -49.04 -33.57 11.65 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.823 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.91 -13.01 61.26 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 98.13 124.66 5.04 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.837 -173.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 1.2 tmtp? 156.03 -55.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.256 1.422 . . . . 0.0 109.457 166.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.504 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 97.9 m-85 -97.92 125.62 43.53 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.98 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.11 167.39 27.47 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.824 2.349 . . . . 0.0 111.865 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.49 97.31 3.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -98.41 -20.13 17.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 39.1 mttm 67.95 -1.92 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.814 0.446 . . . . 0.0 112.053 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.69 152.17 96.53 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -170.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.96 125.43 18.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.494 2.796 . . . . 0.0 112.173 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 448' ' ' ARG . 5.2 p -123.23 157.03 33.99 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 36.6 t -89.9 141.82 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.75 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.454 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 36.0 m95 -94.45 105.37 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.554 ' HG3' ' CE1' ' A' ' 449' ' ' HIS . 39.7 mmt180 -123.39 118.16 26.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -87.82 -48.86 7.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -140.17 171.94 23.69 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.023 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.177 -2.713 0 CA-C-O 122.309 1.052 . . . . 0.0 109.918 -179.657 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.66 23.53 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.62 2.213 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 483' ' ' ARG . 33.7 m 67.32 110.0 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -170.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -92.38 144.15 25.67 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.08 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.495 ' HB3' ' CG2' ' A' ' 479' ' ' THR . 68.2 mtt180 -76.77 125.49 29.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.312 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.733 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 6.2 m170 -91.71 117.88 30.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.867 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 59.7 mt -72.78 115.94 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.664 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 13.3 ptm180 -57.33 101.86 0.08 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.609 0.718 . . . . 0.0 110.185 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.68 4.62 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.155 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.95 136.11 54.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.03 -60.54 3.62 Favored 'General case' 1 N--CA 1.349 -5.483 0 O-C-N 119.242 -2.162 . . . . 0.0 111.125 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.436 ' SG ' ' HG ' ' A' ' 457' ' ' LEU . 34.4 t -155.8 107.17 2.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.27 29.56 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.873 2.382 . . . . 0.0 113.877 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 42.0 mt -83.46 162.85 52.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.668 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.1 Cg_endo -84.94 18.38 27.02 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 124.32 -1.117 . . . . 0.0 113.346 3.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.462 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 76.3 m-70 -77.81 132.47 38.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.353 0.596 . . . . 0.0 110.267 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -94.42 108.58 20.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.098 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.8 mp -76.23 110.83 11.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.466 ' C ' HD21 ' A' ' 462' ' ' ASN . 0.2 OUTLIER -69.31 -178.55 1.37 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.075 175.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.3 p -68.92 -1.45 7.36 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.406 ' CB ' HD21 ' A' ' 474' ' ' ASN . 5.5 mp -98.23 5.8 48.05 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.205 -0.31 . . . . 0.0 111.034 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.81 49.57 22.7 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.853 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . 177.94 -165.51 35.1 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 19.0 p -145.69 128.36 16.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.16 0.48 . . . . 0.0 110.192 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.02 -22.75 61.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.163 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.07 -24.32 64.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.79 84.3 1.79 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.122 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -168.42 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.462 ' HE2' ' HB2' ' A' ' 459' ' ' HIS . 73.8 m-85 -124.74 117.37 26.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.42 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 2.9 Cg_exo -73.13 166.32 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.613 2.209 . . . . 0.0 111.883 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . 0.406 HD21 ' CB ' ' A' ' 464' ' ' LEU . 14.7 m120 -77.23 81.86 3.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.2 mt -106.87 -1.57 22.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.989 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 65.19 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.622 0.576 . . . . 0.0 110.485 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 63.04 152.36 0.11 Allowed Pre-proline 0 N--CA 1.466 0.332 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.664 ' HG2' ' HD3' ' A' ' 451' ' ' ARG . 28.0 Cg_endo -65.48 105.24 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.299 1.999 . . . . 0.0 111.208 171.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -113.79 144.27 43.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.43 -174.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 9.0 t -94.52 140.08 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.459 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -96.45 109.44 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.888 0.375 . . . . 0.0 111.888 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -132.3 127.39 35.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.506 ' HB3' ' HA ' ' A' ' 446' ' ' THR . 11.2 ptm180 -131.66 -1.32 3.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.575 0.226 . . . . 0.0 110.906 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -59.69 -26.94 63.23 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.492 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.343 175.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -92.89 -158.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.059 2.506 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.443 HG21 ' HB3' ' A' ' 483' ' ' ARG . 7.8 p -61.95 120.19 10.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.069 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -97.94 143.99 27.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.362 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -73.99 137.64 43.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.523 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 455' ' ' CYS . 1.5 m-70 -110.99 148.46 32.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.692 171.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 477' ' ' LYS . 22.3 mt -77.17 1.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.808 0.813 . . . . 0.0 109.597 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 57.71 78.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.319 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 154.46 -7.37 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.159 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -178.75 3.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.927 0.394 . . . . 0.0 110.466 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . 0.434 ' O ' ' HE1' ' A' ' 449' ' ' HIS . . . -83.49 -48.32 10.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.56 ' HA ' ' CE1' ' A' ' 449' ' ' HIS . 19.1 t -178.74 119.81 0.24 Allowed Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.02 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.31 -2.0 10.53 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.195 2.597 . . . . 0.0 113.76 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 79.7 mt -68.25 159.03 82.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 91.4 Cg_endo -83.36 18.23 21.95 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.786 -1.339 . . . . 0.0 114.17 5.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.94 133.8 36.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 36.0 mtt180 -98.72 112.28 24.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.505 -171.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.7 mp -85.75 117.89 24.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.793 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.449 ' C ' HD21 ' A' ' 462' ' ' ASN . 0.2 OUTLIER -81.52 -176.54 6.09 Favored 'General case' 1 C--O 1.314 4.485 0 CA-C-O 123.508 1.623 . . . . 0.0 110.635 176.344 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 8.8 p -53.27 -30.21 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.353 -1.467 . . . . 0.0 112.891 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.35 7.3 29.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.02 54.3 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.262 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -162.42 168.85 37.53 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.5 p -117.13 113.91 22.95 Favored 'General case' 1 N--CA 1.366 -4.631 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.074 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -47.23 -38.38 12.09 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.815 0.697 . . . . 0.0 111.697 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.5 p -59.61 -22.54 61.97 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 111.46 125.03 4.6 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.872 -171.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 29.4 tptp 149.11 -75.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.601 1.56 . . . . 0.0 109.084 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -87.15 123.49 69.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.93 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.21 175.09 11.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.779 2.319 . . . . 0.0 111.939 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -74.77 85.68 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 0.0 110.438 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.17 -40.0 39.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.932 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 61.92 24.58 14.65 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.339 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 10.6 ptpt -81.45 165.92 41.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 11.4 Cg_endo -55.14 101.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.536 2.157 . . . . 0.0 112.046 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 449' ' ' HIS . 0.0 OUTLIER -102.54 139.32 38.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.418 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.26 153.37 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.0 111.559 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -92.51 104.54 16.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.512 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -127.65 125.28 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.017 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 484' ' ' GLY . 4.3 ptp180 -110.05 -47.09 3.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.789 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 483' ' ' ARG . . . -91.14 139.17 14.67 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.846 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.102 174.604 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' A' ' 446' ' ' THR . 74.4 Cg_endo -89.78 34.04 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.99 2.46 . . . . 0.0 112.255 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 445' ' ' PRO . 25.1 m 75.83 128.52 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.78 0.675 . . . . 0.0 110.148 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -99.07 145.04 27.54 Favored 'General case' 0 C--O 1.273 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.259 -174.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.637 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 22.7 mtp85 -87.18 157.85 19.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.645 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.637 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.0 OUTLIER -132.19 127.77 36.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.819 176.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.62 123.19 31.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -51.9 104.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.47 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 124.88 -17.02 7.25 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.5 140.3 29.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -76.02 -44.13 40.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.223 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 10.4 t -178.99 116.1 0.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.14 -10.8 28.58 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.023 2.482 . . . . 0.0 113.581 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.445 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 91.8 mt -59.39 153.16 50.45 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.695 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.36 19.15 13.98 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.851 5.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 96.8 m-70 -89.38 148.79 23.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.166 0.507 . . . . 0.0 110.112 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -121.29 121.31 37.42 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.021 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 8.5 mp -73.19 108.89 6.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.576 ' OD1' ' HA ' ' A' ' 467' ' ' CYS . 1.1 p-10 -75.01 68.73 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.464 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' SER . . . . . 0.623 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 92.0 p 64.15 -39.62 0.22 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.296 1.438 . . . . 0.0 114.103 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.469 HD21 ' HE2' ' A' ' 476' ' ' LYS . 39.7 mt -88.67 16.4 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.96 15.74 66.72 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.683 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -157.79 179.13 33.74 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.576 ' HA ' ' OD1' ' A' ' 462' ' ' ASN . 17.6 p -129.16 117.48 20.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.4 0.6 . . . . 0.0 110.026 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -68.84 97.19 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.208 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 470' ' ' GLY . 12.5 p -168.3 -41.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.886 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 469' ' ' CYS . . . 136.8 47.35 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.844 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 472' ' ' TYR . 16.9 tptm -140.13 -55.43 0.54 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.804 0.335 . . . . 0.0 110.55 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 75.2 m-85 -132.08 125.15 19.91 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.4 171.93 17.31 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.513 2.142 . . . . 0.0 111.909 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.82 87.41 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.353 . . . . 0.0 110.289 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 477' ' ' LYS . 91.7 mt -75.48 -26.61 58.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.865 -175.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.469 ' HE2' HD21 ' A' ' 464' ' ' LEU . 33.1 mmtp 66.11 26.21 10.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.08 0.552 . . . . 0.0 111.398 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.507 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 44.1 mtpt -100.62 158.63 31.53 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.306 -0.246 . . . . 0.0 110.982 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 10.1 Cg_endo -52.96 133.83 53.11 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.556 2.837 . . . . 0.0 112.558 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 0.1 OUTLIER -127.75 136.68 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.349 -176.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.637 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 10.5 t -82.29 152.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.61 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.564 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 55.1 m95 -109.12 107.36 17.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -124.54 125.19 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -62.36 -84.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.78 -63.05 1.11 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.49 168.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.52 56.07 4.98 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.135 2.556 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.3 p 50.96 99.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.573 0.749 . . . . 0.0 112.05 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -100.5 133.7 44.54 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-O 122.448 1.118 . . . . 0.0 111.351 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 448' ' ' ARG . 51.7 mtt-85 -68.54 133.54 48.7 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.578 -2.555 . . . . 0.0 111.395 -172.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 449' ' ' HIS . . . . . 0.432 ' CB ' HG21 ' A' ' 480' ' ' VAL . 2.6 m170 -101.57 119.45 38.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.912 171.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.465 HG23 ' HD2' ' A' ' 477' ' ' LYS . 76.4 mt -66.85 125.66 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.494 ' HD3' ' HB2' ' A' ' 478' ' ' PRO . 20.8 mtp180 -58.69 105.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.409 0.623 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 129.53 -23.27 4.83 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.168 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -97.97 138.35 35.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.95 -38.44 72.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.504 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 36.9 t 178.95 114.07 0.19 Allowed Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 456' ' ' PRO . . . . . 0.4 ' HB2' HD11 ' A' ' 461' ' ' LEU . 56.7 Cg_endo -71.48 2.81 4.13 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.17 2.58 . . . . 0.0 113.922 -175.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 81.4 mt -69.22 156.99 90.5 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 76.5 Cg_endo -82.56 16.2 24.41 Favored 'Cis proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.51 -1.454 . . . . 0.0 113.771 5.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.404 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 45.6 m-70 -80.25 144.93 32.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 109.942 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.4 mmm180 -100.21 110.14 22.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.248 -174.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.2 mp -86.21 117.82 25.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.093 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.87 -167.31 1.22 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.377 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 3.2 p -65.1 -16.2 63.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.84 -0.08 57.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.629 0.252 . . . . 0.0 110.96 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.97 61.2 3.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.731 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -174.22 158.03 26.29 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 20.9 p -101.4 118.41 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.497 0.648 . . . . 0.0 109.91 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.55 -35.11 62.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.705 -175.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -22.27 60.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 108.11 132.34 6.73 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.062 -168.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.665 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 28.2 tptp 150.17 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 125.852 1.661 . . . . 0.0 108.101 171.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -132.42 117.69 15.64 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.877 176.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.7 160.43 49.75 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 111.601 177.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -65.88 95.55 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.163 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.478 HD11 ' HE3' ' A' ' 477' ' ' LYS . 95.1 mt -85.48 -28.71 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.627 -175.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 476' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 476' ' ' LYS . 20.7 ttmm 57.8 28.03 15.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.772 0.796 . . . . 0.0 110.509 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.565 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 16.0 ptpt -96.88 164.22 18.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 86.1 Cg_exo -38.88 115.51 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.742 2.961 . . . . 0.0 112.737 176.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 136.67 54.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.408 -176.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.432 HG21 ' CB ' ' A' ' 449' ' ' HIS . 0.1 OUTLIER -93.81 136.41 25.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -86.89 109.73 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -177.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -119.02 136.47 54.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.602 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 483' ' ' ARG . . . . . 0.413 ' HD3' ' N ' ' A' ' 483' ' ' ARG . 0.1 OUTLIER -95.66 -147.41 0.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.534 179.782 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -69.68 136.41 27.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.819 177.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.215 -177.456 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 483' ' ' ARG . 20.2 p . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -95.76 142.74 27.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.589 ' CD ' ' HB ' ' A' ' 479' ' ' THR . 3.9 ttt180 -100.7 146.27 27.41 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.265 0.555 . . . . 0.0 111.632 -172.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -103.56 137.21 41.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.734 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 21.2 pt -87.54 13.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 109.802 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 451' ' ' ARG . 39.1 ttt85 69.4 88.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.531 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.08 60.22 1.14 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.259 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' GLU . . . . . 0.614 ' HG3' ' HG3' ' A' ' 456' ' ' PRO . 0.0 OUTLIER -136.91 1.74 2.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.807 0.337 . . . . 0.0 111.103 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 66.34 30.45 8.91 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.335 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 31.6 t 72.73 113.92 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.857 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.614 ' HG3' ' HG3' ' A' ' 453' ' ' GLU . 2.2 Cg_endo -82.51 21.41 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 113.683 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 53.8 mt -73.55 159.8 83.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.649 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 63.8 Cg_endo -88.14 21.5 26.63 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 113.455 2.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -83.02 143.43 30.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 110.067 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 117.81 32.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.912 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.3 mp -90.1 145.35 25.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.208 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -95.73 -167.25 1.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.281 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' SER . . . . . 0.518 ' HA ' HH11 ' A' ' 448' ' ' ARG . 3.3 p -68.92 -15.08 63.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.2 -3.77 57.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.264 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.74 4.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.58 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -166.96 166.49 39.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.814 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 25.6 p -114.1 124.07 51.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.195 0.497 . . . . 0.0 110.327 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 468' ' ' ARG . 6.4 mtp180 -52.09 -35.72 48.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.819 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.1 p -69.35 105.63 2.63 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -22.17 104.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.195 0 O-C-N 124.924 1.39 . . . . 0.0 115.355 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 56.5 tptt -172.85 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -0.807 . . . . 0.0 110.918 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -129.77 122.64 20.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.65 -167.83 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.125 2.55 . . . . 0.0 113.074 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -83.75 90.43 7.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.012 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.87 -30.05 18.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.52 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 21.1 tptm 53.2 77.99 0.16 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.756 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -123.72 165.01 25.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.816 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.46 86.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.242 1.961 . . . . 0.0 110.764 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.589 ' HB ' ' CD ' ' A' ' 448' ' ' ARG . 0.3 OUTLIER -87.98 132.3 34.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.654 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.48 132.52 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.048 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.482 ' CE3' ' HG3' ' A' ' 448' ' ' ARG . 54.0 m95 -76.4 109.96 10.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -118.21 125.74 50.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.394 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.625 ' HB2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -153.15 13.47 0.5 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.252 0.548 . . . . 0.0 110.004 173.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -79.23 -1.57 85.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.212 177.788 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 483' ' ' ARG . 90.8 m . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -111.33 141.56 44.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 51.7 mtt180 -73.97 153.13 39.88 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 111.102 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -124.8 119.61 29.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.092 170.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.49 134.9 29.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.18 99.89 0.15 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.191 0.52 . . . . 0.0 110.607 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 128.97 -9.7 6.31 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.36 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.25 139.17 34.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 110.563 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -79.12 -40.81 30.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.742 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 25.3 t 173.35 117.59 0.08 OUTLIER Pre-proline 0 N--CA 1.462 0.165 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.83 -22.37 20.23 Favored 'Trans proline' 0 C--O 1.223 -0.23 0 C-N-CA 122.499 2.133 . . . . 0.0 114.748 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.0 mt -55.47 145.25 49.67 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.42 11.32 26.73 Favored 'Cis proline' 0 C--N 1.356 0.956 0 C-N-CA 123.819 -1.325 . . . . 0.0 113.718 4.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 2.4 m80 -84.05 152.81 24.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -135.94 153.78 51.31 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.861 -0.524 . . . . 0.0 111.116 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.652 ' HB3' ' HA2' ' A' ' 465' ' ' GLY . 1.4 mm? -100.73 113.58 26.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -59.59 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.267 0.354 . . . . 0.0 110.715 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 5.9 p -148.28 -30.58 0.29 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.044 0.45 . . . . 0.0 109.794 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.13 -1.65 55.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.716 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 461' ' ' LEU . . . 79.81 47.8 6.98 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.139 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -141.53 150.86 22.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.538 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -103.95 128.91 51.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 117.191 0.495 . . . . 0.0 109.703 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -44.62 -36.07 2.89 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.838 0.712 . . . . 0.0 110.616 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.04 82.03 7.87 Favored 'General case' 0 C--O 1.303 3.882 0 CA-C-O 117.932 -1.032 . . . . 0.0 108.458 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 29.48 69.99 0.07 OUTLIER Glycine 0 C--N 1.304 -1.229 0 C-N-CA 128.494 2.949 . . . . 0.0 117.584 158.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 87.8 tttt -150.38 -80.45 0.12 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.579 0.689 . . . . 0.0 110.886 164.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.656 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 92.2 m-85 -68.41 124.13 89.18 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.42 170.31 10.59 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.61 2.207 . . . . 0.0 112.262 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.12 87.63 3.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.096 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 477' ' ' LYS . 95.3 mt -100.39 -29.15 12.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.9 tttm 59.09 49.17 9.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 475' ' ' LEU . 72.9 mmtt -90.85 157.98 42.77 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.81 109.62 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.243 2.629 . . . . 0.0 111.816 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.39 137.8 41.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.11 159.27 5.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.492 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 88.4 m95 -97.18 102.99 14.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.281 0.562 . . . . 0.0 111.352 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -112.38 120.24 40.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 122.209 1.004 . . . . 0.0 110.406 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.719 ' HB2' HG23 ' A' ' 446' ' ' THR . 10.5 tpt180 -145.17 -13.62 0.53 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.362 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -87.55 59.61 4.34 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.131 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.057 175.549 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 483' ' ' ARG . 28.4 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -92.13 144.16 25.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.173 -171.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.86 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 57.4 mtt-85 -85.16 140.29 31.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.18 -172.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.4 m170 -107.41 122.35 46.44 Favored 'General case' 1 C--N 1.212 -5.371 0 C-N-CA 127.15 2.18 . . . . 0.0 111.576 173.253 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 450' ' ' ILE . 3.0 mp -82.76 122.13 36.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 451' ' ' ARG . 10.8 mmm180 -49.45 100.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.577 0.548 . . . . 0.0 111.126 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 137.02 -30.5 2.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.237 -0.983 . . . . 0.0 113.241 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -113.14 156.28 23.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.229 0.514 . . . . 0.0 110.669 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.82 -78.13 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.643 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 23.0 t -145.36 120.77 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.0 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.472 ' CB ' HD21 ' A' ' 461' ' ' LEU . 28.6 Cg_exo -65.66 -8.88 20.69 Favored 'Trans proline' 0 N--CA 1.477 0.503 0 C-N-CA 123.681 2.921 . . . . 0.0 114.411 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.73 150.28 87.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.478 0.18 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 20.55 23.32 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.811 -1.329 . . . . 0.0 113.818 4.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -84.44 157.4 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.8 mpt_? -127.39 134.64 49.91 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.097 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -100.06 106.87 18.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.623 ' ND2' HH21 ' A' ' 468' ' ' ARG . 20.3 p30 -67.25 -23.06 65.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.814 -175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 17.5 p -174.87 -76.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 476' ' ' LYS . 79.1 mt -70.46 4.53 2.29 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 94.74 16.06 43.66 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.486 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 472' ' ' TYR . . . -106.03 147.97 16.36 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.884 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 29.5 p -111.55 -10.9 14.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.623 HH21 ' ND2' ' A' ' 462' ' ' ASN . 10.0 ttm180 71.93 -53.26 0.69 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.893 0.745 . . . . 0.0 111.915 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.7 -18.65 8.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 467' ' ' CYS . . . 133.22 127.63 2.8 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.075 -164.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 73.2 tttt 106.94 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 126.514 1.926 . . . . 0.0 109.777 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.552 ' HB3' ' HA2' ' A' ' 466' ' ' GLY . 78.3 m-85 -92.13 117.25 67.6 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.648 ' HD2' ' HG ' ' A' ' 475' ' ' LEU . 2.2 Cg_endo -83.03 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.984 2.456 . . . . 0.0 111.366 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 473' ' ' PRO . 11.3 m120 -125.33 -69.6 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.648 ' HG ' ' HD2' ' A' ' 473' ' ' PRO . 97.9 mt 71.14 -51.36 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.647 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' LYS . . . . . 0.53 ' HG3' HD22 ' A' ' 464' ' ' LEU . 88.2 tttt 68.73 61.63 0.34 Allowed 'General case' 0 N--CA 1.532 3.652 0 O-C-N 126.16 2.162 . . . . 0.0 108.096 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 475' ' ' LEU . 7.6 mptt -102.02 152.7 38.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.828 175.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 110.99 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.161 1.907 . . . . 0.0 111.288 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.86 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 19.4 p -94.28 132.1 39.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.529 . . . . 0.0 111.679 -174.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 2.7 t -96.74 133.44 38.17 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.238 0 CA-C-O 123.739 1.733 . . . . 0.0 110.558 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 33.2 m95 -78.62 109.96 13.31 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.811 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.446 ' HD2' ' C ' ' A' ' 481' ' ' TRP . 1.1 mpt_? -113.4 118.34 34.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.318 0.58 . . . . 0.0 111.587 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.422 ' HB3' HG22 ' A' ' 446' ' ' THR . 36.1 ptt180 -130.59 2.97 4.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.76 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -72.67 -16.81 77.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.123 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.247 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 483' ' ' ARG . 12.8 p . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -83.12 142.83 30.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.54 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.615 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 44.7 mtt180 -75.92 128.57 35.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.378 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.567 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.2 m170 -104.14 119.51 39.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.433 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.605 HG13 HD21 ' A' ' 461' ' ' LEU . 47.5 mt -69.52 125.42 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.04 95.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.204 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 138.85 -18.18 3.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.766 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.89 156.08 40.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 0.0 109.854 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -68.68 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 13.0 t -137.73 115.39 9.62 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 36.6 Cg_exo -61.62 -25.45 79.19 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.286 2.657 . . . . 0.0 113.754 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.432 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 92.9 mt -51.14 144.79 14.11 Favored Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 123.07 0.231 . . . . 0.0 111.069 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.89 15.71 12.83 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.945 -1.273 . . . . 0.0 114.099 5.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 91.3 m-70 -83.26 132.05 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 109.867 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -107.36 125.3 51.02 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 7.8 mp -85.02 137.23 33.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.432 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.83 -174.42 4.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.835 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' SER . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 11.6 p -74.4 0.14 15.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 0.0 111.406 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 474' ' ' ASN . 91.8 mt -105.13 4.05 30.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.734 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.24 26.42 61.77 Favored Glycine 2 C--O 1.142 -5.603 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -133.01 -178.78 15.77 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 110.267 -2.967 . . . . 0.0 111.765 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 13.4 p -138.18 141.44 40.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 117.514 0.657 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 469' ' ' CYS . 71.8 ttt180 -55.75 147.85 17.86 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 1.6 p 108.31 -22.28 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.723 1.609 . . . . 0.0 109.542 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 85.9 36.81 9.82 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.115 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.632 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 1.1 tmtp? -95.11 -61.28 1.51 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.4 m-85 -99.71 118.79 61.34 Favored Pre-proline 0 C--O 1.167 -3.255 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.422 ' O ' HD12 ' A' ' 475' ' ' LEU . 59.6 Cg_endo -75.57 169.02 23.22 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.091 1.86 . . . . 0.0 111.04 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . 62.1 m-20 -86.07 76.34 9.8 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.305 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 473' ' ' PRO . 4.0 mp -69.05 -25.36 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.676 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 65.7 28.54 11.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.78 150.99 46.93 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.23 130.44 34.15 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.432 2.088 . . . . 0.0 111.565 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.02 157.14 20.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.095 0.474 . . . . 0.0 111.739 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 28.1 t -84.93 140.28 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.22 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.615 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 8.3 m95 -92.51 106.86 18.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 0.0 112.012 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -135.56 118.17 15.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.67 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.4 ttt180 -100.3 -64.54 1.03 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.866 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -102.28 131.41 10.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.887 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.343 178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.93 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.1 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -97.3 148.76 22.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.182 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 448' ' ' ARG . 66.9 mtt-85 -83.67 142.55 30.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.624 0.726 . . . . 0.0 112.406 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.481 ' HB3' ' HA2' ' A' ' 452' ' ' GLY . 4.8 m-70 -118.28 116.98 27.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.968 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 475' ' ' LEU . 2.8 mp -59.8 105.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 451' ' ' ARG . 1.5 tpm_? 56.42 17.73 3.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.664 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 449' ' ' HIS . . . 78.12 43.92 12.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.566 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 -163.76 0.47 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -52.87 -69.32 0.12 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-O 123.053 1.406 . . . . 0.0 112.172 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 35.0 t 170.32 106.58 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 120.643 -1.285 . . . . 0.0 109.239 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.657 ' HB2' HD21 ' A' ' 461' ' ' LEU . 52.8 Cg_exo -59.2 -18.6 45.35 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.377 2.718 . . . . 0.0 114.406 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 63.7 mt -65.63 154.11 89.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.586 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 5.4 Cg_exo -77.52 7.97 19.12 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 124.227 -1.156 . . . . 0.0 114.141 7.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.502 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 92.1 m-70 -78.94 107.16 11.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 0.0 110.385 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -86.67 127.29 34.94 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.821 -170.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 456' ' ' PRO . 1.1 mm? -87.03 150.87 23.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.083 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.3 -52.76 4.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.389 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.8 p -156.07 -66.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.09 33.41 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.399 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.53 2.96 82.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.11 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -98.13 157.56 20.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.325 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 30.7 p -121.42 110.46 16.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.01 -19.56 19.2 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.57 -6.7 27.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 91.07 123.61 2.86 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.3 tmtm? 156.13 -75.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.43 1.492 . . . . 0.0 108.629 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -84.57 132.28 47.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.902 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.6 -164.64 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.18 2.587 . . . . 0.0 111.684 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.41 97.64 10.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 0.0 110.199 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 450' ' ' ILE . 4.6 mp -103.17 83.6 2.22 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -72.68 78.36 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.368 0.604 . . . . 0.0 109.88 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -149.54 138.66 12.65 Favored Pre-proline 0 C--O 1.212 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.456 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.67 102.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.873 3.049 . . . . 0.0 114.426 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.09 135.95 33.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.146 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.5 t -98.59 140.3 18.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.194 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -89.5 106.93 18.78 Favored 'General case' 1 C--N 1.232 -4.539 0 O-C-N 124.938 1.399 . . . . 0.0 113.428 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -118.67 116.84 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.046 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.93 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.6 ttt-85 -108.87 97.88 7.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.069 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 93.36 157.57 33.46 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.157 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -96.5 123.89 40.31 Favored 'General case' 1 N--CA 1.551 4.583 0 CA-C-O 124.454 2.073 . . . . 0.0 107.969 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.503 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 9.3 ptm180 -72.83 132.79 44.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.442 -2.163 . . . . 0.0 111.678 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 479' ' ' THR . 2.5 m-70 -90.87 154.78 19.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.519 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 475' ' ' LEU . 1.1 tp -90.52 -1.37 9.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.963 0.887 . . . . 0.0 108.974 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 73.38 92.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.392 -1.731 . . . . 0.0 111.772 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 101.4 42.79 2.29 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.206 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' A' ' 455' ' ' CYS . 0.0 OUTLIER -127.95 -164.81 1.41 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 454' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 455' ' ' CYS . . . -98.48 27.94 4.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.704 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.56 ' H ' ' HG2' ' A' ' 453' ' ' GLU . 46.4 t 71.75 118.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.856 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.703 ' HB3' HD21 ' A' ' 461' ' ' LEU . 54.5 Cg_exo -53.78 -31.7 62.76 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.589 2.859 . . . . 0.0 114.665 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.24 142.84 47.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.17 23.9 20.76 Favored 'Cis proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.58 -1.425 . . . . 0.0 114.302 5.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.3 151.15 19.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 109.62 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -123.03 128.65 50.46 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.44 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 456' ' ' PRO . 1.2 mm? -91.73 138.39 31.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.319 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.76 -177.87 5.1 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p -62.38 -15.2 47.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.7 3.36 52.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.486 0.184 . . . . 0.0 111.493 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 475' ' ' LEU . . . 87.29 9.86 72.19 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.25 171.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -109.28 171.55 15.37 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.803 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 12.2 p -126.85 148.24 49.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.684 0.742 . . . . 0.0 109.861 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -56.65 142.04 41.35 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 0.4 OUTLIER 84.22 141.92 0.06 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -170.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -72.56 59.35 1.62 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.102 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 469' ' ' CYS . 8.7 tmtm? -110.05 -62.02 1.57 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -107.43 124.85 33.85 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-O 120.553 0.216 . . . . 0.0 110.95 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.2 177.55 8.5 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.733 2.288 . . . . 0.0 111.652 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -72.37 95.17 1.71 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 450' ' ' ILE . 78.3 mt -109.42 93.77 4.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -82.22 16.63 1.92 Allowed 'General case' 1 CA--C 1.632 4.103 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.587 ' HG3' ' HD2' ' A' ' 478' ' ' PRO . 36.5 ttmt -68.4 142.47 94.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.155 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 477' ' ' LYS . 2.7 Cg_exo -35.72 99.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.575 3.517 . . . . 0.0 113.244 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 448' ' ' ARG . 3.4 p -83.14 127.59 33.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -92.34 111.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.241 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 97.9 m95 -75.58 105.43 6.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.904 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -124.19 134.76 53.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -142.46 30.15 1.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.166 0.984 . . . . 0.0 108.794 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.76 69.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.553 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.019 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.578 HG23 ' HB2' ' A' ' 483' ' ' ARG . 18.8 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -96.2 158.0 15.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.35 0.595 . . . . 0.0 111.261 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -88.39 150.41 23.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.552 -175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m80 -123.18 126.03 46.22 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.277 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.5 114.7 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -44.74 113.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.804 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.12 26.22 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.44 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -90.36 149.04 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.968 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -64.0 -62.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 42.0 t 179.6 106.96 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.86 -2.27 2.05 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.048 3.165 . . . . 0.0 115.135 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.85 150.77 75.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.231 -0.293 . . . . 0.0 110.246 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.01 28.35 12.28 Favored 'Cis proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.919 -1.284 . . . . 0.0 113.418 4.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -95.46 167.35 11.37 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 460' ' ' ARG . 39.3 ttp180 -141.84 124.1 15.6 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.586 -171.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -83.72 111.74 19.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.116 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -59.42 -38.93 81.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.98 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -164.78 -71.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 111.858 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.5 37.98 0.71 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.44 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.19 29.15 68.97 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.352 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -129.8 163.8 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.928 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.1 p -135.1 140.15 45.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 469' ' ' CYS . 37.9 ttp-105 -62.5 88.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.603 0.564 . . . . 0.0 110.85 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' CYS . . . . . 0.654 ' HB3' ' O ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER 160.28 157.01 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -74.28 56.88 2.39 Favored Glycine 0 C--N 1.308 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.154 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 1.8 tmtp? -123.39 -56.97 1.69 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.54 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 82.7 m-85 -118.54 112.1 37.49 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.391 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.53 -178.83 2.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.776 2.318 . . . . 0.0 111.279 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -74.64 80.22 2.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 110.316 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.88 75.59 9.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.785 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -75.62 79.2 2.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.247 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 0.0 OUTLIER -132.24 164.53 42.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 2.2 Cg_endo -41.93 103.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.244 2.629 . . . . 0.0 113.362 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 3.9 p -86.21 127.29 34.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.273 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 40.8 t -91.18 129.97 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.896 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -81.32 109.19 15.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.069 0.462 . . . . 0.0 110.897 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -132.63 123.55 26.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.077 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 446' ' ' THR . 36.9 ttt180 -120.04 -38.2 2.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.099 0.476 . . . . 0.0 109.908 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -104.35 144.22 15.81 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.016 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.63 178.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.441 HG21 ' HB3' ' A' ' 481' ' ' TRP . 9.5 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -93.89 139.68 30.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.291 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 448' ' ' ARG . 23.1 mtt180 -71.96 142.81 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.41 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -119.35 102.44 8.68 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.609 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 479' ' ' THR . 56.9 mt -65.31 136.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -59.91 105.08 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 122.68 -21.13 7.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.839 -0.695 . . . . 0.0 111.557 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.58 142.17 27.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -80.06 -47.47 14.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.221 0.534 . . . . 0.0 110.154 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 20.5 t -178.35 112.25 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 -4.27 11.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.166 2.578 . . . . 0.0 114.238 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.579 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 48.8 mt -60.68 152.01 69.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 83.4 Cg_endo -78.03 16.11 10.22 Favored 'Cis proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.042 -1.232 . . . . 0.0 114.278 8.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.579 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 52.8 m-70 -91.83 104.5 16.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -82.61 127.0 32.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.522 0.677 . . . . 0.0 110.192 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.432 HD12 ' HB3' ' A' ' 467' ' ' CYS . 7.5 mp -87.63 141.13 28.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.994 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -82.89 -176.58 6.39 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -65.69 -13.41 59.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.12 7.01 36.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.45 15.16 54.2 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.448 -0.882 . . . . 0.0 114.452 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.15 141.5 15.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 29.0 p -84.35 114.17 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.544 ' HE ' ' HA ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER -50.67 -32.8 20.26 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.584 0.552 . . . . 0.0 112.207 -174.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.13 -30.22 70.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 122.8 128.88 3.45 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.127 -171.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 77.2 tttt 148.59 -71.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.034 1.734 . . . . 0.0 108.942 169.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 67.0 m-85 -88.93 131.6 40.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.901 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 1.8 Cg_endo -82.71 175.53 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.997 2.465 . . . . 0.0 111.854 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -84.22 66.33 9.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 C-N-CA 127.305 2.242 . . . . 0.0 107.266 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.6 -5.95 57.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.987 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? 46.62 32.94 1.83 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.188 0.995 . . . . 0.0 112.964 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -70.43 156.45 91.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.364 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.14 126.68 21.04 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.997 2.464 . . . . 0.0 112.305 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 450' ' ' ILE . 16.7 p -140.65 140.61 35.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.034 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.7 142.21 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.441 ' HB3' HG21 ' A' ' 446' ' ' THR . 91.9 m95 -90.33 108.13 19.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.146 0.498 . . . . 0.0 111.075 -175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -109.74 133.32 53.27 Favored 'General case' 1 N--CA 1.372 -4.348 0 CA-C-O 116.791 -1.576 . . . . 0.0 111.814 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -134.23 5.35 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.512 1.505 . . . . 0.0 111.785 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -162.09 119.47 0.88 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.433 175.267 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 483' ' ' ARG . 15.2 m . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -118.06 135.57 54.1 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.393 -0.817 . . . . 0.0 110.18 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.619 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 10.1 mtm180 -78.93 138.94 38.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.493 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.65 119.96 41.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 479' ' ' THR . 49.0 mt -69.68 89.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.829 0.347 . . . . 0.0 110.212 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 58.4 -92.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.972 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -130.37 21.39 4.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.798 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.64 162.31 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.829 0.452 . . . . 0.0 110.114 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.01 163.64 5.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 18.5 t -65.02 131.66 95.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.063 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.589 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . 74.7 Cg_endo -85.14 17.84 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.899 2.399 . . . . 0.0 113.318 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 71.0 mt -87.13 155.35 54.98 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 51.0 Cg_endo -89.75 15.68 46.49 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.717 -1.368 . . . . 0.0 113.623 3.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.532 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 72.5 m-70 -68.94 -42.73 76.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 72.88 123.06 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.306 1.003 . . . . 0.0 111.138 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 41.2 mt -89.2 124.38 34.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -83.03 -171.58 3.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.8 p -50.63 -38.36 45.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.7 0.7 56.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.828 0.347 . . . . 0.0 111.918 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . 0.474 ' HA2' ' HE ' ' A' ' 448' ' ' ARG . . . 88.49 21.67 43.37 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.884 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -120.9 -172.31 14.51 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.1 p -126.05 121.34 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -52.63 -31.31 36.09 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.474 0.484 . . . . 0.0 111.828 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -24.78 67.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 109.39 134.26 6.95 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.101 -170.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 50.0 tttm 148.37 -65.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.82 1.648 . . . . 0.0 109.628 167.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -85.46 131.58 47.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.773 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.79 153.35 29.56 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.031 2.487 . . . . 0.0 112.865 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.04 99.13 1.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.04 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.418 HD13 ' HE2' ' A' ' 477' ' ' LYS . 89.5 mt -103.78 -27.43 12.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.407 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? 63.21 6.81 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 475' ' ' LEU . 53.4 mtmt -65.91 150.34 96.6 Favored Pre-proline 0 C--O 1.236 0.349 0 O-C-N 122.472 -0.142 . . . . 0.0 110.943 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.73 145.72 22.58 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.466 2.777 . . . . 0.0 112.756 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 450' ' ' ILE . 1.1 p -145.21 154.42 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.957 -171.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.11 132.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.619 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 91.2 m95 -84.31 102.8 12.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.556 . . . . 0.0 111.712 -174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.78 118.51 36.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.636 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.445 ' HA ' HG23 ' A' ' 446' ' ' THR . 18.1 mtp180 -58.31 -79.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.919 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -159.55 141.76 7.76 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.956 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.849 0 CA-C-O 119.061 -0.495 . . . . 0.0 109.929 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.633 HG23 ' HB2' ' A' ' 483' ' ' ARG . 8.2 m . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.64 141.05 29.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.414 0.626 . . . . 0.0 111.173 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 479' ' ' THR . 69.2 mtt180 -77.52 123.14 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.255 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -89.04 109.38 20.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.006 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.63 107.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.5 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 15.2 ptm180 -55.1 110.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.341 0.591 . . . . 0.0 110.937 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 130.66 -27.14 3.96 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -103.6 178.73 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -93.78 -76.84 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.206 0.527 . . . . 0.0 111.405 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.5 118.06 4.83 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.519 ' HB2' HD13 ' A' ' 461' ' ' LEU . 11.7 Cg_endo -58.32 -23.55 63.47 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.739 2.293 . . . . 0.0 114.002 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.424 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 72.5 mt -59.07 149.61 65.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.539 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.21 18.88 14.04 Favored 'Cis proline' 0 C--N 1.351 0.674 0 C-N-CA 124.128 -1.197 . . . . 0.0 114.138 6.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 41.6 m-70 -101.82 106.37 17.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -78.86 135.42 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.175 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.624 ' HG ' ' N ' ' A' ' 466' ' ' GLY . 6.8 mp -95.32 142.98 27.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.901 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.76 -167.11 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.2 p -78.16 26.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 476' ' ' LYS . 95.4 mt -121.61 -71.74 0.72 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.67 66.27 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 461' ' ' LEU . . . 175.61 155.22 12.42 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 459' ' ' HIS . 6.1 p -99.53 6.6 45.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.754 0.777 . . . . 0.0 111.886 -174.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 56.06 33.46 21.94 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.086 0.469 . . . . 0.0 111.25 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.4 p -177.9 131.87 0.15 Allowed 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.858 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 21.01 100.87 0.01 OUTLIER Glycine 0 C--O 1.242 0.594 0 O-C-N 124.758 1.286 . . . . 0.0 115.655 164.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 44.8 tttm 126.83 -64.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.43 1.492 . . . . 0.0 111.5 164.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 471' ' ' LYS . 83.5 m-85 -108.81 101.16 42.83 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -174.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.69 174.16 9.86 Favored 'Trans proline' 0 N--CA 1.466 -0.091 0 C-N-CA 122.572 2.181 . . . . 0.0 111.352 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -83.58 97.32 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.596 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 79.9 mt -105.21 -24.38 12.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.14 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.7 mtpm? 65.25 -103.88 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.997 0.811 . . . . 0.0 110.149 -175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 75.9 mttt 62.28 169.72 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.174 0.59 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.9 Cg_endo -58.89 100.05 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.501 2.134 . . . . 0.0 112.067 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 448' ' ' ARG . 16.7 p -92.64 135.96 33.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.036 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.99 141.75 14.2 Favored 'Isoleucine or valine' 1 C--O 1.132 -5.103 0 C-N-CA 116.647 -2.021 . . . . 0.0 108.406 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -91.82 110.92 22.27 Favored 'General case' 0 N--CA 1.387 -3.617 0 O-C-N 128.789 3.805 . . . . 0.0 111.246 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -133.15 131.88 40.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.979 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.633 ' HB2' HG23 ' A' ' 446' ' ' THR . 28.0 ttp180 -123.38 -88.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.447 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -76.44 107.45 2.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.814 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.608 175.929 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 483' ' ' ARG . 17.8 p . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -97.97 146.88 25.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.21 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 461' ' ' LEU . 89.0 mtt180 -72.35 142.23 48.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.898 -168.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.793 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 8.6 m170 -121.31 158.15 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.397 169.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 453' ' ' GLU . 55.0 mt -100.52 136.92 29.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 478' ' ' PRO . 33.9 mtp180 -62.04 101.25 0.2 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.027 0.441 . . . . 0.0 110.774 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.53 6.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.904 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 450' ' ' ILE . 5.1 mm-40 -100.97 159.22 15.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.836 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -82.79 -45.99 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.538 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 49.1 t -174.28 122.53 0.38 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 31.4 Cg_exo -62.4 -31.01 81.16 Favored 'Trans proline' 0 CA--C 1.525 0.06 0 C-N-CA 122.587 2.191 . . . . 0.0 113.175 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.475 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 66.6 mt -56.03 147.22 45.81 Favored Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 123.297 0.373 . . . . 0.0 111.203 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.73 16.76 10.87 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.906 -1.289 . . . . 0.0 114.081 4.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.475 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 48.0 m-70 -88.65 141.74 28.27 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -106.14 146.52 30.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 65.3 mt -102.58 127.73 49.55 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.99 0.181 . . . . 0.0 110.995 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -58.69 -56.81 17.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.625 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 45.9 p -178.97 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.046 0.538 . . . . 0.0 109.747 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.03 12.25 9.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.898 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.7 56.52 3.83 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.651 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -156.6 168.74 33.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.213 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 31.7 p -137.71 124.44 21.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.442 ' H ' ' HD2' ' A' ' 468' ' ' ARG . 4.3 mpt_? -55.62 -30.95 61.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.695 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 29.5 p -74.9 70.77 1.99 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.106 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.5 70.78 0.27 Allowed Glycine 0 N--CA 1.462 0.408 0 N-CA-C 115.199 0.84 . . . . 0.0 115.199 163.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.834 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 21.3 tptm -162.02 -72.97 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.073 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.588 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 46.8 m-85 -104.73 133.37 20.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.464 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.66 -177.37 2.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.842 2.362 . . . . 0.0 111.997 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -78.98 80.04 5.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.8 -15.2 59.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.742 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 58.36 68.82 0.79 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.975 0.416 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -132.4 143.33 48.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.663 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.409 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 30.9 Cg_exo -59.2 126.0 19.67 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.007 2.472 . . . . 0.0 111.091 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 20.3 p -79.5 134.75 36.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.994 0.426 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.793 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 46.2 t -84.82 126.07 40.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.248 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.507 ' HB3' ' OG1' ' A' ' 446' ' ' THR . 88.6 m95 -89.7 105.82 18.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.829 0.347 . . . . 0.0 111.558 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 482' ' ' ARG . 9.0 mmt180 -136.04 141.51 44.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.897 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.756 ' HB2' HG22 ' A' ' 446' ' ' THR . 47.0 ttt180 -139.23 134.02 32.13 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 81.58 138.84 2.63 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.849 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.659 178.716 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 483' ' ' ARG . 43.1 p . . . . . 0 C--O 1.238 0.449 0 CA-C-O 120.675 0.274 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -113.9 138.6 50.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.983 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.45 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 3.7 mtm180 -83.12 144.49 29.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.652 -172.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -112.7 121.69 45.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.05 117.7 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -51.8 105.49 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.425 0.631 . . . . 0.0 111.967 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 120.4 -23.78 7.91 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.46 152.35 23.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -65.52 -69.65 0.28 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 43.7 t -173.37 121.88 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -17.34 50.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.275 . . . . 0.0 113.529 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.447 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 67.5 mt -54.54 143.16 49.21 Favored Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.089 0.243 . . . . 0.0 111.133 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.06 18.37 14.61 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.643 -1.399 . . . . 0.0 114.426 7.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.447 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 27.8 m-70 -97.76 165.72 11.82 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.67 141.36 28.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -172.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -80.65 -174.8 4.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 13.1 p -58.72 -28.42 65.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.73 8.4 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.146 -0.346 . . . . 0.0 111.627 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.62 20.12 64.57 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.164 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.09 156.36 15.72 Favored Glycine 1 C--O 1.315 5.187 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.964 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 6.2 p -110.95 149.06 31.2 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 120.552 -1.558 . . . . 0.0 109.819 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.467 ' O ' ' SG ' ' A' ' 469' ' ' CYS . 90.2 mtt180 -58.85 156.74 10.82 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 469' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 468' ' ' ARG . 0.8 OUTLIER 87.49 -18.75 0.27 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.93 1.292 . . . . 0.0 111.294 -174.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.78 72.9 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 8.9 tmtm? -124.29 -43.1 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.52 123.86 33.15 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.01 164.52 31.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.595 2.196 . . . . 0.0 111.897 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.37 91.07 3.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.901 0.382 . . . . 0.0 110.1 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.78 -6.52 26.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.661 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? 46.77 37.25 4.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.462 1.105 . . . . 0.0 112.589 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 35.1 mtpt -84.56 162.17 51.54 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 50.1 Cg_exo -51.95 122.81 11.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.47 2.78 . . . . 0.0 112.103 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.61 143.49 48.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.855 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.07 158.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.45 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 75.4 m95 -101.95 113.85 27.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 0.0 111.139 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 36.9 mmt180 -111.97 128.27 56.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.55 ' HB3' ' CG2' ' A' ' 446' ' ' THR . 10.0 ptm180 -140.21 5.07 2.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.923 -177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -90.11 -5.98 69.74 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.422 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.81 -179.397 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 483' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' HIS . . . . . 0.423 ' HB2' ' NH1' ' A' ' 460' ' ' ARG . 36.0 p-80 -84.88 129.11 34.86 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.42 -171.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.653 ' NH1' ' HA ' ' A' ' 463' ' ' SER . 33.6 mtt85 -66.16 132.2 47.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.205 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 0.1 OUTLIER -109.18 152.41 25.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.422 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 41.8 mt -91.74 146.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -68.76 80.34 0.29 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 0.0 110.718 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.12 49.81 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -162.55 136.28 6.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -70.32 -39.66 74.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.795 -178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 6.0 t 176.68 109.68 0.11 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 4.0 Cg_exo -75.37 10.6 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.293 2.662 . . . . 0.0 113.939 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.653 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 68.1 mt -73.97 161.75 77.11 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.9 Cg_endo -84.38 19.97 21.08 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 124.151 -1.187 . . . . 0.0 113.915 6.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -84.38 131.71 34.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.7 tpm_? -99.65 105.58 17.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.053 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 465' ' ' GLY . 7.6 mp -70.15 133.54 47.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.97 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.59 -163.66 1.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' SER . . . . . 0.653 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 8.2 p -60.63 -33.83 73.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.6 mt -92.17 -3.97 54.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.673 0.273 . . . . 0.0 111.641 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 461' ' ' LEU . . . 103.35 -16.49 52.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.319 -0.944 . . . . 0.0 113.187 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -73.62 152.76 46.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.609 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 14.2 p -111.24 25.06 12.12 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.088 -0.654 . . . . 0.0 111.129 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 74.44 -36.79 0.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 3.9 p -97.24 13.35 29.72 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 116.103 -2.239 . . . . 0.0 109.234 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 89.02 -28.88 6.27 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.852 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.543 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 7.4 tmtt? -47.29 -51.39 19.28 Favored 'General case' 0 N--CA 1.389 -3.501 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.543 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.3 m-85 -111.66 121.19 40.59 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 112.722 -2.035 . . . . 0.0 109.156 170.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.433 ' HG2' HD21 ' A' ' 475' ' ' LEU . 83.1 Cg_endo -86.09 167.28 9.48 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 112.302 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -75.16 95.19 3.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.281 0.563 . . . . 0.0 109.997 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.433 HD21 ' HG2' ' A' ' 473' ' ' PRO . 95.2 mt -84.99 -27.82 26.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.54 -175.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 476' ' ' LYS . 27.7 tptp 62.53 28.77 16.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.711 0.767 . . . . 0.0 110.736 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 43.4 mtmt -98.65 163.07 19.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.8 Cg_endo -57.57 118.33 5.19 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.573 2.182 . . . . 0.0 112.221 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 448' ' ' ARG . 11.8 p -97.99 146.38 25.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.966 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.4 t -92.32 134.91 28.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.967 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 448' ' ' ARG . 76.2 m95 -95.33 108.27 20.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.74 0.305 . . . . 0.0 110.994 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.29 134.87 54.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 110.633 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.485 ' HB2' HG23 ' A' ' 446' ' ' THR . 42.2 ttt-85 -130.29 102.99 6.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 98.73 154.78 28.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.832 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.301 178.43 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.2 p . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.861 0.363 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -132.4 146.12 51.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.973 0.416 . . . . 0.0 110.163 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.848 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 68.2 mtt180 -89.23 139.45 30.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.509 -176.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 25.9 m170 -98.62 133.6 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' A' ' 461' ' ' LEU . 12.5 tt -80.54 14.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.117 0.484 . . . . 0.0 111.66 -173.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 69.28 16.39 8.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.419 0.628 . . . . 0.0 110.688 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -146.55 -52.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.04 132.81 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.38 69.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.724 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 11.8 t -171.7 102.19 0.38 Allowed Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.4 38.04 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.815 3.01 . . . . 0.0 113.984 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 459' ' ' HIS . 59.8 mt -104.3 157.71 33.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.2 45.84 1.73 Allowed 'Cis proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.471 -1.054 . . . . 0.0 112.9 1.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 36.4 m-70 -94.38 -61.72 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.007 0.432 . . . . 0.0 109.923 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 81.78 126.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.028 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.848 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 55.5 mt -86.59 110.82 20.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.75 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -63.33 -62.95 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.521 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' SER . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 7.6 p -152.89 -58.73 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.773 0.32 . . . . 0.0 111.403 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.44 19.02 0.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.42 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 74.89 36.16 48.07 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.694 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -119.74 176.54 16.17 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.269 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 22.1 p -142.23 126.37 17.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.697 0.249 . . . . 0.0 110.438 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -75.32 76.49 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.6 p 174.11 -2.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 95.57 123.5 4.17 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.761 -170.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 146.59 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.799 1.64 . . . . 0.0 109.414 164.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 465' ' ' GLY . 87.3 m-85 -101.9 123.37 44.02 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.353 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -90.24 -158.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.126 2.551 . . . . 0.0 111.23 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -86.76 83.77 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.127 0.489 . . . . 0.0 109.826 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.9 -39.39 12.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.371 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt 55.72 77.24 0.24 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.987 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.76 149.06 58.24 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.39 107.18 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.82 2.347 . . . . 0.0 111.824 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -105.12 140.93 37.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.235 0.541 . . . . 0.0 111.94 -172.202 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.8 t -93.31 131.98 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.515 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.58 110.82 20.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.016 0.436 . . . . 0.0 110.997 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -125.99 141.55 51.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.546 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 446' ' ' THR . 48.1 ttp180 -121.4 -55.51 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.433 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.3 130.06 10.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.916 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.803 175.744 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.874 HG22 ' HG2' ' A' ' 483' ' ' ARG . 10.1 p . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -112.88 176.71 4.9 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.93 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.942 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 49.3 mtt180 -117.86 143.32 46.4 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.49 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -110.05 138.14 46.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 11.2 tt -83.63 22.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.341 0.591 . . . . 0.0 111.055 -176.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 450' ' ' ILE . 8.8 ptm180 53.92 12.89 0.48 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.712 1.205 . . . . 0.0 112.889 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -149.45 31.44 1.14 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.55 152.04 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.47 -42.07 71.91 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 117.835 -1.546 . . . . 0.0 107.963 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 44.2 t -175.51 108.85 0.26 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 10.4 Cg_exo -73.79 29.9 0.32 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.549 2.832 . . . . 0.0 114.067 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.33 152.14 39.95 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.61 19.05 37.77 Favored 'Cis proline' 0 C--O 1.169 -2.93 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.956 2.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -65.67 -58.18 6.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 71.96 133.36 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.375 1.047 . . . . 0.0 111.27 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.9 mm? -86.18 130.74 34.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.222 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.66 47.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.672 0.272 . . . . 0.0 110.871 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 89.8 p 59.88 -1.88 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.971 1.308 . . . . 0.0 113.431 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.7 mt -107.29 4.93 27.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.21 67.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.446 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -125.1 177.38 16.92 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.413 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 29.9 p -125.79 121.77 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.48 -29.76 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 111.649 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.31 -9.14 57.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 96.12 124.87 4.64 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.147 -173.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.1 tmtp? 159.44 -48.01 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.83 1.652 . . . . 0.0 107.933 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.537 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 49.1 m-85 -123.26 128.43 25.28 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.703 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.75 157.57 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.329 2.019 . . . . 0.0 111.004 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.38 92.41 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 109.868 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.09 -6.34 45.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.274 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.4 mttm 64.3 28.65 13.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.861 0.362 . . . . 0.0 111.383 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 74.2 mmtt -89.5 140.99 28.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.4 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 477' ' ' LYS . 39.3 Cg_exo -61.77 115.19 2.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.063 2.509 . . . . 0.0 111.994 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 16.5 p -80.57 128.52 33.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.406 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.86 132.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.127 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -80.46 105.79 11.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.008 0.433 . . . . 0.0 111.807 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 19.0 mmt180 -126.02 139.15 53.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.469 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.874 ' HG2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -166.27 164.33 17.69 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.117 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 103.94 8.37 39.49 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.817 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -95.23 131.47 41.24 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.553 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.695 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 67.9 mtt180 -71.9 132.76 44.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.475 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.893 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.9 m170 -97.8 111.94 24.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.384 170.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.97 109.02 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -43.59 106.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.746 0.654 . . . . 0.0 111.687 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.45 -19.92 6.63 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.321 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -106.64 153.91 21.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.601 0.36 . . . . 0.0 110.169 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -81.15 -49.21 11.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.706 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 34.1 t -174.09 102.29 0.29 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.35 33.49 0.36 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.409 2.74 . . . . 0.0 114.22 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 33.2 mt -75.22 158.86 83.5 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 4.1 Cg_endo -86.77 33.66 5.57 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.255 -1.144 . . . . 0.0 113.206 3.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.432 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 87.8 m-70 -103.4 116.21 31.99 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.282 0.563 . . . . 0.0 110.205 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -95.96 121.4 37.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.132 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 2.5 mm? -82.54 135.62 35.05 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.902 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -77.18 -168.6 1.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.42 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.2 p -77.83 11.67 2.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.883 0.373 . . . . 0.0 111.665 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.425 HD22 ' HE2' ' A' ' 476' ' ' LYS . 84.8 mt -120.5 1.29 10.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.0 110.209 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 75.86 35.88 43.74 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.446 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -133.76 164.98 24.34 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -129.57 120.67 25.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.74 0.77 . . . . 0.0 110.882 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -46.88 -40.98 15.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 124.2 0.937 . . . . 0.0 110.806 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 26.0 p -69.04 74.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 32.45 75.89 0.04 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 124.151 0.907 . . . . 0.0 115.127 166.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.83 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 16.6 tppt? -167.92 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.994 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 82.1 m-85 -76.16 119.94 79.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 111.394 -172.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 97.9 Cg_endo -86.52 43.74 1.1 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.672 2.915 . . . . 0.0 113.11 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 63.08 94.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 111.311 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.0 mt -117.78 84.49 2.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' LYS . . . . . 0.425 ' HE2' HD22 ' A' ' 464' ' ' LEU . 6.8 mtpm? -62.07 95.01 0.06 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.45 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -144.08 155.66 58.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.274 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -50.48 124.35 13.07 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 111.58 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.507 HG21 ' HD3' ' A' ' 448' ' ' ARG . 0.9 OUTLIER -132.21 159.94 37.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.838 -171.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.893 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 49.0 t -96.09 141.28 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.846 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -100.51 106.8 18.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.111 0.482 . . . . 0.0 111.803 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -132.23 131.43 42.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.47 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 484' ' ' GLY . 2.7 ptp85 -96.42 -52.66 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.243 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 483' ' ' ARG . . . -133.22 155.18 21.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.449 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.032 -179.729 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.234 0.289 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -91.68 138.12 31.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.771 -168.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 39.7 mtt180 -71.24 130.08 40.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.686 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m170 -98.31 105.73 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.935 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.1 115.47 5.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -47.51 107.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.4 14.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.594 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.11 -5.15 58.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 110.967 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 62.6 -98.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.426 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 456' ' ' PRO . 35.7 t -127.04 97.08 32.93 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 455' ' ' CYS . 13.3 Cg_endo -57.48 -1.95 0.57 Allowed 'Trans proline' 0 N--CA 1.477 0.526 0 C-N-CA 124.255 3.304 . . . . 0.0 114.869 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.57 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 54.1 mt -61.62 152.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.317 0 O-C-N 122.159 -0.338 . . . . 0.0 110.09 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.47 25.94 4.83 Favored 'Cis proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.063 -1.224 . . . . 0.0 114.494 6.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.57 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 71.8 m-70 -96.56 134.81 39.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 45.3 ttp180 -118.86 124.93 48.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.106 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 1.8 mm? -91.38 138.36 31.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.933 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.415 ' O ' ' HD2' ' A' ' 448' ' ' ARG . 10.1 p30 -86.97 -171.78 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.8 p -68.14 -7.56 30.93 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.8 mt -95.2 -4.82 45.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 110.492 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.42 45.24 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.868 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -123.39 152.05 17.0 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.16 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 28.0 p -101.52 116.12 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.37 0.585 . . . . 0.0 110.582 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -49.04 -33.57 11.65 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.823 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.91 -13.01 61.26 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 98.13 124.66 5.04 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.837 -173.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 1.2 tmtp? 156.03 -55.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.256 1.422 . . . . 0.0 109.457 166.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 97.9 m-85 -97.92 125.62 43.53 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.98 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.11 167.39 27.47 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.824 2.349 . . . . 0.0 111.865 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -74.49 97.31 3.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -98.41 -20.13 17.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 39.1 mttm 67.95 -1.92 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.814 0.446 . . . . 0.0 112.053 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.69 152.17 96.53 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -170.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.96 125.43 18.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.494 2.796 . . . . 0.0 112.173 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.41 HG21 ' HB3' ' A' ' 448' ' ' ARG . 5.2 p -123.23 157.03 33.99 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 36.6 t -89.9 141.82 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.75 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.476 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 36.0 m95 -94.45 105.37 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.557 ' HG3' ' CE1' ' A' ' 449' ' ' HIS . 39.7 mmt180 -123.39 118.16 26.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -87.82 -48.86 7.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -140.17 171.94 23.69 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.023 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.177 -2.713 0 CA-C-O 122.309 1.052 . . . . 0.0 109.918 -179.657 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 483' ' ' ARG . 33.7 m . . . . . 0 C--O 1.231 0.097 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -92.38 144.15 25.67 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.08 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.51 ' HB3' ' CG2' ' A' ' 479' ' ' THR . 68.2 mtt180 -76.77 125.49 29.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.312 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.76 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 6.2 m170 -91.71 117.88 30.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.867 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 59.7 mt -72.78 115.94 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.695 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 13.3 ptm180 -57.33 101.86 0.08 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.609 0.718 . . . . 0.0 110.185 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.68 4.62 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.155 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.95 136.11 54.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.03 -60.54 3.62 Favored 'General case' 1 N--CA 1.349 -5.483 0 O-C-N 119.242 -2.162 . . . . 0.0 111.125 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.441 ' SG ' ' HG ' ' A' ' 457' ' ' LEU . 34.4 t -155.8 107.17 2.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.27 29.56 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.873 2.382 . . . . 0.0 113.877 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.679 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 42.0 mt -83.46 162.85 52.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.1 Cg_endo -84.94 18.38 27.02 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 124.32 -1.117 . . . . 0.0 113.346 3.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 76.3 m-70 -77.81 132.47 38.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.353 0.596 . . . . 0.0 110.267 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -94.42 108.58 20.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.098 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.8 mp -76.23 110.83 11.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -69.31 -178.55 1.37 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.075 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.3 p -68.92 -1.45 7.36 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.23 5.8 48.05 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.205 -0.31 . . . . 0.0 111.034 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.81 49.57 22.7 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.853 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . 177.94 -165.51 35.1 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 19.0 p -145.69 128.36 16.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.16 0.48 . . . . 0.0 110.192 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.02 -22.75 61.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.163 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.07 -24.32 64.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.79 84.3 1.79 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.122 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -168.42 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.473 ' HE2' ' HB2' ' A' ' 459' ' ' HIS . 73.8 m-85 -124.74 117.37 26.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.42 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 2.9 Cg_exo -73.13 166.32 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.613 2.209 . . . . 0.0 111.883 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.23 81.86 3.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.2 mt -106.87 -1.57 22.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.989 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 65.19 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.622 0.576 . . . . 0.0 110.485 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 63.04 152.36 0.11 Allowed Pre-proline 0 N--CA 1.466 0.332 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.695 ' HG2' ' HD3' ' A' ' 451' ' ' ARG . 28.0 Cg_endo -65.48 105.24 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.299 1.999 . . . . 0.0 111.208 171.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -113.79 144.27 43.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.43 -174.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 9.0 t -94.52 140.08 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.459 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -96.45 109.44 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.888 0.375 . . . . 0.0 111.888 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 482' ' ' ARG . 31.0 mmt180 -132.3 127.39 35.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 446' ' ' THR . 11.2 ptm180 -131.66 -1.32 3.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.575 0.226 . . . . 0.0 110.906 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -59.69 -26.94 63.23 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.492 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.343 175.905 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 483' ' ' ARG . 7.8 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -97.94 143.99 27.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.362 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -73.99 137.64 43.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.523 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 455' ' ' CYS . 1.5 m-70 -110.99 148.46 32.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.692 171.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 477' ' ' LYS . 22.3 mt -77.17 1.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.808 0.813 . . . . 0.0 109.597 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 57.71 78.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.319 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 154.46 -7.37 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.159 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -178.75 3.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.927 0.394 . . . . 0.0 110.466 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' ALA . . . . . 0.431 ' O ' ' HE1' ' A' ' 449' ' ' HIS . . . -83.49 -48.32 10.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 449' ' ' HIS . 19.1 t -178.74 119.81 0.24 Allowed Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.02 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.31 -2.0 10.53 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.195 2.597 . . . . 0.0 113.76 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 79.7 mt -68.25 159.03 82.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 91.4 Cg_endo -83.36 18.23 21.95 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.786 -1.339 . . . . 0.0 114.17 5.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.94 133.8 36.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 36.0 mtt180 -98.72 112.28 24.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.505 -171.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.7 mp -85.75 117.89 24.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.793 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -81.52 -176.54 6.09 Favored 'General case' 1 C--O 1.314 4.485 0 CA-C-O 123.508 1.623 . . . . 0.0 110.635 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 8.8 p -53.27 -30.21 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.353 -1.467 . . . . 0.0 112.891 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.35 7.3 29.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.02 54.3 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.262 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -162.42 168.85 37.53 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.5 p -117.13 113.91 22.95 Favored 'General case' 1 N--CA 1.366 -4.631 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.074 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -47.23 -38.38 12.09 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.815 0.697 . . . . 0.0 111.697 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.5 p -59.61 -22.54 61.97 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 111.46 125.03 4.6 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.872 -171.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 29.4 tptp 149.11 -75.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.601 1.56 . . . . 0.0 109.084 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -87.15 123.49 69.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.93 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.21 175.09 11.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.779 2.319 . . . . 0.0 111.939 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -74.77 85.68 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 0.0 110.438 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.17 -40.0 39.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.932 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 61.92 24.58 14.65 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.339 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 10.6 ptpt -81.45 165.92 41.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 11.4 Cg_endo -55.14 101.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.536 2.157 . . . . 0.0 112.046 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 449' ' ' HIS . 0.0 OUTLIER -102.54 139.32 38.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.418 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.26 153.37 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.0 111.559 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -92.51 104.54 16.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.512 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -127.65 125.28 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.017 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' A' ' 484' ' ' GLY . 4.3 ptp180 -110.05 -47.09 3.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.789 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 483' ' ' ARG . . . -91.14 139.17 14.67 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.846 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.102 174.604 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -99.07 145.04 27.54 Favored 'General case' 0 C--O 1.273 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.259 -174.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 22.7 mtp85 -87.18 157.85 19.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.645 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.654 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.0 OUTLIER -132.19 127.77 36.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.819 176.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.62 123.19 31.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -51.9 104.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.47 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 124.88 -17.02 7.25 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.5 140.3 29.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -76.02 -44.13 40.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.223 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 10.4 t -178.99 116.1 0.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.14 -10.8 28.58 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.023 2.482 . . . . 0.0 113.581 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.453 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 91.8 mt -59.39 153.16 50.45 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.695 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.36 19.15 13.98 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.851 5.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 96.8 m-70 -89.38 148.79 23.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.166 0.507 . . . . 0.0 110.112 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -121.29 121.31 37.42 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.021 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 8.5 mp -73.19 108.89 6.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 467' ' ' CYS . 1.1 p-10 -75.01 68.73 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.464 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' SER . . . . . 0.623 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 92.0 p 64.15 -39.62 0.22 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.296 1.438 . . . . 0.0 114.103 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 476' ' ' LYS . 39.7 mt -88.67 16.4 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.96 15.74 66.72 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.683 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -157.79 179.13 33.74 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.574 ' HA ' ' OD1' ' A' ' 462' ' ' ASN . 17.6 p -129.16 117.48 20.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.4 0.6 . . . . 0.0 110.026 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -68.84 97.19 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.208 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 470' ' ' GLY . 12.5 p -168.3 -41.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.886 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 469' ' ' CYS . . . 136.8 47.35 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.844 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 472' ' ' TYR . 16.9 tptm -140.13 -55.43 0.54 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.804 0.335 . . . . 0.0 110.55 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' TYR . . . . . 0.441 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 75.2 m-85 -132.08 125.15 19.91 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.411 ' O ' ' HA3' ' A' ' 466' ' ' GLY . 67.4 Cg_endo -75.4 171.93 17.31 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.513 2.142 . . . . 0.0 111.909 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.82 87.41 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.353 . . . . 0.0 110.289 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.423 ' HB3' ' HG3' ' A' ' 477' ' ' LYS . 91.7 mt -75.48 -26.61 58.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.865 -175.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' LYS . . . . . 0.452 ' HE2' HD22 ' A' ' 464' ' ' LEU . 33.1 mmtp 66.11 26.21 10.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.08 0.552 . . . . 0.0 111.398 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 44.1 mtpt -100.62 158.63 31.53 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.306 -0.246 . . . . 0.0 110.982 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 10.1 Cg_endo -52.96 133.83 53.11 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.556 2.837 . . . . 0.0 112.558 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 479' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 0.1 OUTLIER -127.75 136.68 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.349 -176.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 10.5 t -82.29 152.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.61 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.586 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 55.1 m95 -109.12 107.36 17.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -124.54 125.19 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -62.36 -84.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.78 -63.05 1.11 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.49 168.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.243 0.544 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -100.5 133.7 44.54 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-O 122.448 1.118 . . . . 0.0 111.351 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 448' ' ' ARG . 51.7 mtt-85 -68.54 133.54 48.7 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.578 -2.555 . . . . 0.0 111.395 -172.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 449' ' ' HIS . . . . . 0.423 ' CB ' HG23 ' A' ' 480' ' ' VAL . 0.5 OUTLIER -101.57 119.45 38.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.912 171.715 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 477' ' ' LYS . 76.4 mt -66.85 125.66 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 478' ' ' PRO . 20.8 mtp180 -58.69 105.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.409 0.623 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 129.53 -23.27 4.83 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.168 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -97.97 138.35 35.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.95 -38.44 72.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.504 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 36.9 t 178.95 114.07 0.19 Allowed Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 456' ' ' PRO . . . . . 0.445 ' HG3' HD22 ' A' ' 461' ' ' LEU . 56.7 Cg_endo -71.48 2.81 4.13 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.17 2.58 . . . . 0.0 113.922 -175.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 81.4 mt -69.22 156.99 90.5 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 76.5 Cg_endo -82.56 16.2 24.41 Favored 'Cis proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.51 -1.454 . . . . 0.0 113.771 5.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 45.6 m-70 -80.25 144.93 32.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 109.942 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.4 mmm180 -100.21 110.14 22.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.248 -174.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.2 mp -86.21 117.82 25.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.093 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.87 -167.31 1.22 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.377 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 463' ' ' SER . . . . . 0.408 ' HA ' ' HE ' ' A' ' 448' ' ' ARG . 3.2 p -65.1 -16.2 63.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.84 -0.08 57.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.629 0.252 . . . . 0.0 110.96 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.97 61.2 3.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.731 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -174.22 158.03 26.29 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 20.9 p -101.4 118.41 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.497 0.648 . . . . 0.0 109.91 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.55 -35.11 62.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.705 -175.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -22.27 60.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 108.11 132.34 6.73 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.062 -168.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.672 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 28.2 tptp 150.17 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 125.852 1.661 . . . . 0.0 108.101 171.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -132.42 117.69 15.64 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.877 176.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.7 160.43 49.75 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 111.601 177.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -65.88 95.55 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.163 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.488 HD13 ' HE3' ' A' ' 477' ' ' LYS . 95.1 mt -85.48 -28.71 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.627 -175.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 476' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 476' ' ' LYS . 20.7 ttmm 57.8 28.03 15.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.772 0.796 . . . . 0.0 110.509 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.583 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 16.0 ptpt -96.88 164.22 18.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 86.1 Cg_exo -38.88 115.51 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.742 2.961 . . . . 0.0 112.737 176.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 136.67 54.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.408 -176.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 449' ' ' HIS . 0.1 OUTLIER -93.81 136.41 25.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.853 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -86.89 109.73 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -177.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -119.02 136.47 54.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.602 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 483' ' ' ARG . . . . . 0.414 ' HB3' ' H ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -95.66 -147.41 0.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.534 179.782 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 483' ' ' ARG . . . -69.68 136.41 27.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.819 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.215 -177.456 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -93.31 175.86 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.848 2.365 . . . . 0.0 112.566 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 483' ' ' ARG . 20.2 p -81.79 134.46 35.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -95.76 142.74 27.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.589 ' CD ' ' HB ' ' A' ' 479' ' ' THR . 3.9 ttt180 -100.7 146.27 27.41 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.265 0.555 . . . . 0.0 111.632 -172.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -103.56 137.21 41.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.734 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 21.2 pt -87.54 13.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 109.802 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 451' ' ' ARG . 39.1 ttt85 69.4 88.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.531 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.08 60.22 1.14 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.259 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' GLU . . . . . 0.614 ' HG3' ' HG3' ' A' ' 456' ' ' PRO . 0.0 OUTLIER -136.91 1.74 2.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.807 0.337 . . . . 0.0 111.103 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 66.34 30.45 8.91 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.335 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 31.6 t 72.73 113.92 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.857 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.614 ' HG3' ' HG3' ' A' ' 453' ' ' GLU . 2.2 Cg_endo -82.51 21.41 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 113.683 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 53.8 mt -73.55 159.8 83.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.649 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 63.8 Cg_endo -88.14 21.5 26.63 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 113.455 2.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -83.02 143.43 30.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 110.067 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 117.81 32.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.912 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.3 mp -90.1 145.35 25.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.208 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -95.73 -167.25 1.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.281 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' SER . . . . . 0.518 ' HA ' HH11 ' A' ' 448' ' ' ARG . 3.3 p -68.92 -15.08 63.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.2 -3.77 57.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.264 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.74 4.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.58 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -166.96 166.49 39.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.814 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 25.6 p -114.1 124.07 51.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.195 0.497 . . . . 0.0 110.327 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 468' ' ' ARG . 6.4 mtp180 -52.09 -35.72 48.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.819 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.1 p -69.35 105.63 2.63 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -22.17 104.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.195 0 O-C-N 124.924 1.39 . . . . 0.0 115.355 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 56.5 tptt -172.85 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -0.807 . . . . 0.0 110.918 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -129.77 122.64 20.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.65 -167.83 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.125 2.55 . . . . 0.0 113.074 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -83.75 90.43 7.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.012 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.87 -30.05 18.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.52 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 21.1 tptm 53.2 77.99 0.16 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.756 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -123.72 165.01 25.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.816 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.46 86.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.242 1.961 . . . . 0.0 110.764 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.589 ' HB ' ' CD ' ' A' ' 448' ' ' ARG . 0.3 OUTLIER -87.98 132.3 34.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.654 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.48 132.52 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.048 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.482 ' CE3' ' HG3' ' A' ' 448' ' ' ARG . 54.0 m95 -76.4 109.96 10.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -118.21 125.74 50.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.394 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.625 ' HB2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -153.15 13.47 0.5 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.252 0.548 . . . . 0.0 110.004 173.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -79.23 -1.57 85.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.212 177.788 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.37 -29.54 85.81 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.163 2.575 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 483' ' ' ARG . 90.8 m -153.78 134.95 14.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -111.33 141.56 44.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 51.7 mtt180 -73.97 153.13 39.88 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 111.102 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 482' ' ' ARG . 1.7 m-70 -124.8 119.61 29.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.092 170.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.49 134.9 29.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.18 99.89 0.15 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.191 0.52 . . . . 0.0 110.607 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 128.97 -9.7 6.31 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.36 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.25 139.17 34.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 110.563 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -79.12 -40.81 30.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.742 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 25.3 t 173.35 117.59 0.08 OUTLIER Pre-proline 0 N--CA 1.462 0.165 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' A' ' 459' ' ' HIS . 68.8 Cg_endo -72.83 -22.37 20.23 Favored 'Trans proline' 0 C--O 1.223 -0.23 0 C-N-CA 122.499 2.133 . . . . 0.0 114.748 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.0 mt -55.47 145.25 49.67 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.42 11.32 26.73 Favored 'Cis proline' 0 C--N 1.356 0.956 0 C-N-CA 123.819 -1.325 . . . . 0.0 113.718 4.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 2.6 m-70 -84.05 152.81 24.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -135.94 153.78 51.31 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.861 -0.524 . . . . 0.0 111.116 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.652 ' HB3' ' HA2' ' A' ' 465' ' ' GLY . 1.4 mm? -100.73 113.58 26.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -59.59 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.267 0.354 . . . . 0.0 110.715 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 5.9 p -148.28 -30.58 0.29 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.044 0.45 . . . . 0.0 109.794 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.13 -1.65 55.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.716 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 461' ' ' LEU . . . 79.81 47.8 6.98 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.139 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -141.53 150.86 22.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.538 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -103.95 128.91 51.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 117.191 0.495 . . . . 0.0 109.703 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -44.62 -36.07 2.89 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.838 0.712 . . . . 0.0 110.616 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.04 82.03 7.87 Favored 'General case' 0 C--O 1.303 3.882 0 CA-C-O 117.932 -1.032 . . . . 0.0 108.458 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 29.48 69.99 0.07 OUTLIER Glycine 0 C--N 1.304 -1.229 0 C-N-CA 128.494 2.949 . . . . 0.0 117.584 158.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 87.8 tttt -150.38 -80.45 0.12 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.579 0.689 . . . . 0.0 110.886 164.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.656 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 92.2 m-85 -68.41 124.13 89.18 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.42 170.31 10.59 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.61 2.207 . . . . 0.0 112.262 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.12 87.63 3.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.096 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 477' ' ' LYS . 95.3 mt -100.39 -29.15 12.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.9 tttm 59.09 49.17 9.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 475' ' ' LEU . 72.9 mmtt -90.85 157.98 42.77 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.81 109.62 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.243 2.629 . . . . 0.0 111.816 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.39 137.8 41.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.11 159.27 5.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.492 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 88.4 m95 -97.18 102.99 14.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.281 0.562 . . . . 0.0 111.352 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.48 ' HB2' ' CD2' ' A' ' 449' ' ' HIS . 33.6 mmt180 -112.38 120.24 40.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 122.209 1.004 . . . . 0.0 110.406 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.719 ' HB2' HG23 ' A' ' 446' ' ' THR . 10.5 tpt180 -145.17 -13.62 0.53 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.362 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -87.55 59.61 4.34 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.131 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.057 175.549 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.019 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.56 178.96 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.619 2.213 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 483' ' ' ARG . 28.4 p -64.68 146.74 54.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 173.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -92.13 144.16 25.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.173 -171.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.86 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 57.4 mtt-85 -85.16 140.29 31.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.18 -172.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.4 m170 -107.41 122.35 46.44 Favored 'General case' 1 C--N 1.212 -5.371 0 C-N-CA 127.15 2.18 . . . . 0.0 111.576 173.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 450' ' ' ILE . 3.0 mp -82.76 122.13 36.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 451' ' ' ARG . 10.8 mmm180 -49.45 100.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.577 0.548 . . . . 0.0 111.126 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 137.02 -30.5 2.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.237 -0.983 . . . . 0.0 113.241 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -113.14 156.28 23.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.229 0.514 . . . . 0.0 110.669 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.82 -78.13 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.643 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 23.0 t -145.36 120.77 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.0 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.472 ' CB ' HD21 ' A' ' 461' ' ' LEU . 28.6 Cg_exo -65.66 -8.88 20.69 Favored 'Trans proline' 0 N--CA 1.477 0.503 0 C-N-CA 123.681 2.921 . . . . 0.0 114.411 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.73 150.28 87.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.478 0.18 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 20.55 23.32 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.811 -1.329 . . . . 0.0 113.818 4.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -84.44 157.4 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.8 mpt_? -127.39 134.64 49.91 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.097 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -100.06 106.87 18.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.623 ' ND2' HH21 ' A' ' 468' ' ' ARG . 20.3 p30 -67.25 -23.06 65.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.814 -175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 17.5 p -174.87 -76.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 476' ' ' LYS . 79.1 mt -70.46 4.53 2.29 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 94.74 16.06 43.66 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.486 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 472' ' ' TYR . . . -106.03 147.97 16.36 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.884 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 29.5 p -111.55 -10.9 14.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.623 HH21 ' ND2' ' A' ' 462' ' ' ASN . 10.0 ttm180 71.93 -53.26 0.69 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.893 0.745 . . . . 0.0 111.915 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.7 -18.65 8.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 133.22 127.63 2.8 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.075 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 73.2 tttt 106.94 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 126.514 1.926 . . . . 0.0 109.777 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.552 ' HB3' ' HA2' ' A' ' 466' ' ' GLY . 78.3 m-85 -92.13 117.25 67.6 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.648 ' HD2' ' HG ' ' A' ' 475' ' ' LEU . 2.2 Cg_endo -83.03 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.984 2.456 . . . . 0.0 111.366 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 473' ' ' PRO . 11.3 m120 -125.33 -69.6 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.648 ' HG ' ' HD2' ' A' ' 473' ' ' PRO . 97.9 mt 71.14 -51.36 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.647 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' LYS . . . . . 0.53 ' HG3' HD22 ' A' ' 464' ' ' LEU . 88.2 tttt 68.73 61.63 0.34 Allowed 'General case' 0 N--CA 1.532 3.652 0 O-C-N 126.16 2.162 . . . . 0.0 108.096 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 475' ' ' LEU . 7.6 mptt -102.02 152.7 38.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.828 175.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 110.99 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.161 1.907 . . . . 0.0 111.288 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.86 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 19.4 p -94.28 132.1 39.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.529 . . . . 0.0 111.679 -174.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 2.7 t -96.74 133.44 38.17 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.238 0 CA-C-O 123.739 1.733 . . . . 0.0 110.558 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 33.2 m95 -78.62 109.96 13.31 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.811 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.446 ' HD2' ' C ' ' A' ' 481' ' ' TRP . 1.1 mpt_? -113.4 118.34 34.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.318 0.58 . . . . 0.0 111.587 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.422 ' HB3' HG22 ' A' ' 446' ' ' THR . 36.1 ptt180 -130.59 2.97 4.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.76 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -72.67 -16.81 77.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.123 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.247 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.14 -169.51 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.402 2.068 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 483' ' ' ARG . 12.8 p -66.26 127.69 33.21 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -83.12 142.83 30.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.54 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.615 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 44.7 mtt180 -75.92 128.57 35.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.378 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.567 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.2 m170 -104.14 119.51 39.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.433 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.605 HG13 HD21 ' A' ' 461' ' ' LEU . 47.5 mt -69.52 125.42 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.04 95.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.204 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 138.85 -18.18 3.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.766 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.89 156.08 40.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 0.0 109.854 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -68.68 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 13.0 t -137.73 115.39 9.62 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 36.6 Cg_exo -61.62 -25.45 79.19 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.286 2.657 . . . . 0.0 113.754 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.432 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 92.9 mt -51.14 144.79 14.11 Favored Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 123.07 0.231 . . . . 0.0 111.069 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.89 15.71 12.83 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.945 -1.273 . . . . 0.0 114.099 5.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 91.3 m-70 -83.26 132.05 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 109.867 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -107.36 125.3 51.02 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 7.8 mp -85.02 137.23 33.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.432 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.83 -174.42 4.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.835 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' SER . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 11.6 p -74.4 0.14 15.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 0.0 111.406 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 474' ' ' ASN . 91.8 mt -105.13 4.05 30.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.734 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.24 26.42 61.77 Favored Glycine 2 C--O 1.142 -5.603 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -133.01 -178.78 15.77 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 110.267 -2.967 . . . . 0.0 111.765 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 13.4 p -138.18 141.44 40.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 117.514 0.657 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 469' ' ' CYS . 71.8 ttt180 -55.75 147.85 17.86 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 1.6 p 108.31 -22.28 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.723 1.609 . . . . 0.0 109.542 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 85.9 36.81 9.82 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.115 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.632 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 1.1 tmtp? -95.11 -61.28 1.51 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.4 m-85 -99.71 118.79 61.34 Favored Pre-proline 0 C--O 1.167 -3.255 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.422 ' O ' HD12 ' A' ' 475' ' ' LEU . 59.6 Cg_endo -75.57 169.02 23.22 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.091 1.86 . . . . 0.0 111.04 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . 62.1 m-20 -86.07 76.34 9.8 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.305 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 473' ' ' PRO . 4.0 mp -69.05 -25.36 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.676 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 65.7 28.54 11.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.78 150.99 46.93 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.23 130.44 34.15 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.432 2.088 . . . . 0.0 111.565 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.02 157.14 20.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.095 0.474 . . . . 0.0 111.739 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 28.1 t -84.93 140.28 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.22 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.615 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 8.3 m95 -92.51 106.86 18.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 0.0 112.012 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -135.56 118.17 15.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.67 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.4 ttt180 -100.3 -64.54 1.03 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.866 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -102.28 131.41 10.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.887 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.343 178.893 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -91.51 -173.25 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.77 2.313 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.93 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.1 p -70.94 129.33 38.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -97.3 148.76 22.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.182 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 448' ' ' ARG . 66.9 mtt-85 -83.67 142.55 30.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.624 0.726 . . . . 0.0 112.406 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.481 ' HB3' ' HA2' ' A' ' 452' ' ' GLY . 4.8 m-70 -118.28 116.98 27.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.968 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 475' ' ' LEU . 2.8 mp -59.8 105.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 451' ' ' ARG . 1.5 tpm_? 56.42 17.73 3.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.664 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 449' ' ' HIS . . . 78.12 43.92 12.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.566 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 -163.76 0.47 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -52.87 -69.32 0.12 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-O 123.053 1.406 . . . . 0.0 112.172 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 35.0 t 170.32 106.58 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 120.643 -1.285 . . . . 0.0 109.239 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.657 ' HB2' HD21 ' A' ' 461' ' ' LEU . 52.8 Cg_exo -59.2 -18.6 45.35 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.377 2.718 . . . . 0.0 114.406 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 63.7 mt -65.63 154.11 89.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.586 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 5.4 Cg_exo -77.52 7.97 19.12 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 124.227 -1.156 . . . . 0.0 114.141 7.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.502 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 92.1 m-70 -78.94 107.16 11.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 0.0 110.385 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -86.67 127.29 34.94 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.821 -170.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 456' ' ' PRO . 1.1 mm? -87.03 150.87 23.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.083 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.3 -52.76 4.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.389 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.8 p -156.07 -66.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.09 33.41 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.399 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.53 2.96 82.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.11 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -98.13 157.56 20.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.325 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 30.7 p -121.42 110.46 16.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.01 -19.56 19.2 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.57 -6.7 27.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 91.07 123.61 2.86 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.3 tmtm? 156.13 -75.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.43 1.492 . . . . 0.0 108.629 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -84.57 132.28 47.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.902 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.6 -164.64 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.18 2.587 . . . . 0.0 111.684 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.41 97.64 10.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 0.0 110.199 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 450' ' ' ILE . 4.6 mp -103.17 83.6 2.22 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -72.68 78.36 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.368 0.604 . . . . 0.0 109.88 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -149.54 138.66 12.65 Favored Pre-proline 0 C--O 1.212 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.456 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.67 102.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.873 3.049 . . . . 0.0 114.426 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.09 135.95 33.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.146 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.5 t -98.59 140.3 18.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.194 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -89.5 106.93 18.78 Favored 'General case' 1 C--N 1.232 -4.539 0 O-C-N 124.938 1.399 . . . . 0.0 113.428 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -118.67 116.84 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.046 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.93 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.6 ttt-85 -108.87 97.88 7.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.069 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 93.36 157.57 33.46 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.157 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.96 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -84.29 -172.06 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.608 2.205 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 131.64 47.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -96.5 123.89 40.31 Favored 'General case' 1 N--CA 1.551 4.583 0 CA-C-O 124.454 2.073 . . . . 0.0 107.969 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.503 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 9.3 ptm180 -72.83 132.79 44.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.442 -2.163 . . . . 0.0 111.678 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 479' ' ' THR . 2.5 m-70 -90.87 154.78 19.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.519 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 475' ' ' LEU . 1.1 tp -90.52 -1.37 9.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.963 0.887 . . . . 0.0 108.974 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 73.38 92.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.392 -1.731 . . . . 0.0 111.772 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 101.4 42.79 2.29 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.206 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' A' ' 455' ' ' CYS . 0.0 OUTLIER -127.95 -164.81 1.41 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 454' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 455' ' ' CYS . . . -98.48 27.94 4.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.704 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.56 ' H ' ' HG2' ' A' ' 453' ' ' GLU . 46.4 t 71.75 118.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.856 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.703 ' HB3' HD21 ' A' ' 461' ' ' LEU . 54.5 Cg_exo -53.78 -31.7 62.76 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.589 2.859 . . . . 0.0 114.665 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.24 142.84 47.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.17 23.9 20.76 Favored 'Cis proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.58 -1.425 . . . . 0.0 114.302 5.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.3 151.15 19.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 109.62 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -123.03 128.65 50.46 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.44 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 456' ' ' PRO . 1.2 mm? -91.73 138.39 31.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.319 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.76 -177.87 5.1 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p -62.38 -15.2 47.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.7 3.36 52.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.486 0.184 . . . . 0.0 111.493 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 475' ' ' LEU . . . 87.29 9.86 72.19 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.25 171.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -109.28 171.55 15.37 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.803 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 12.2 p -126.85 148.24 49.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.684 0.742 . . . . 0.0 109.861 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -56.65 142.04 41.35 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 0.4 OUTLIER 84.22 141.92 0.06 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -170.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -72.56 59.35 1.62 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.102 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 469' ' ' CYS . 8.7 tmtm? -110.05 -62.02 1.57 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -107.43 124.85 33.85 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-O 120.553 0.216 . . . . 0.0 110.95 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.2 177.55 8.5 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.733 2.288 . . . . 0.0 111.652 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -72.37 95.17 1.71 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 450' ' ' ILE . 78.3 mt -109.42 93.77 4.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -82.22 16.63 1.92 Allowed 'General case' 1 CA--C 1.632 4.103 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.587 ' HG3' ' HD2' ' A' ' 478' ' ' PRO . 36.5 ttmt -68.4 142.47 94.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.155 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 477' ' ' LYS . 2.7 Cg_exo -35.72 99.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.575 3.517 . . . . 0.0 113.244 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 448' ' ' ARG . 3.4 p -83.14 127.59 33.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -92.34 111.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.241 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 97.9 m95 -75.58 105.43 6.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.904 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -124.19 134.76 53.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -142.46 30.15 1.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.166 0.984 . . . . 0.0 108.794 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.76 69.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.553 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.019 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.3 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.61 -173.47 1.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.757 2.304 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.578 HG23 ' HB2' ' A' ' 483' ' ' ARG . 18.8 m -65.74 126.75 29.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -96.2 158.0 15.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.35 0.595 . . . . 0.0 111.261 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -88.39 150.41 23.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.552 -175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.1 m-70 -123.18 126.03 46.22 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.277 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.5 114.7 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -44.74 113.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.804 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.12 26.22 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.44 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -90.36 149.04 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.968 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -64.0 -62.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 42.0 t 179.6 106.96 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.86 -2.27 2.05 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.048 3.165 . . . . 0.0 115.135 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.85 150.77 75.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.231 -0.293 . . . . 0.0 110.246 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.01 28.35 12.28 Favored 'Cis proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.919 -1.284 . . . . 0.0 113.418 4.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -95.46 167.35 11.37 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 460' ' ' ARG . 39.3 ttp180 -141.84 124.1 15.6 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.586 -171.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -83.72 111.74 19.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.116 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -59.42 -38.93 81.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.98 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -164.78 -71.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 111.858 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.5 37.98 0.71 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.44 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.19 29.15 68.97 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.352 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -129.8 163.8 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.928 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.1 p -135.1 140.15 45.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 469' ' ' CYS . 37.9 ttp-105 -62.5 88.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.603 0.564 . . . . 0.0 110.85 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' CYS . . . . . 0.654 ' HB3' ' O ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER 160.28 157.01 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -74.28 56.88 2.39 Favored Glycine 0 C--N 1.308 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.154 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 1.8 tmtp? -123.39 -56.97 1.69 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.54 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 82.7 m-85 -118.54 112.1 37.49 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.391 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.53 -178.83 2.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.776 2.318 . . . . 0.0 111.279 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -74.64 80.22 2.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 110.316 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.88 75.59 9.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.785 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -75.62 79.2 2.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.247 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 0.0 OUTLIER -132.24 164.53 42.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 2.2 Cg_endo -41.93 103.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.244 2.629 . . . . 0.0 113.362 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 3.9 p -86.21 127.29 34.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.273 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 40.8 t -91.18 129.97 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.896 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -81.32 109.19 15.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.069 0.462 . . . . 0.0 110.897 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -132.63 123.55 26.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.077 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 446' ' ' THR . 36.9 ttt180 -120.04 -38.2 2.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.099 0.476 . . . . 0.0 109.908 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -104.35 144.22 15.81 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.016 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.63 178.837 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -86.53 -163.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.411 2.074 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.441 HG21 ' HB3' ' A' ' 481' ' ' TRP . 9.5 m -100.08 126.38 46.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -93.89 139.68 30.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.291 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 448' ' ' ARG . 23.1 mtt180 -71.96 142.81 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.41 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -119.35 102.44 8.68 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.609 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 479' ' ' THR . 56.9 mt -65.31 136.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -59.91 105.08 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 122.68 -21.13 7.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.839 -0.695 . . . . 0.0 111.557 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.58 142.17 27.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -80.06 -47.47 14.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.221 0.534 . . . . 0.0 110.154 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 20.5 t -178.35 112.25 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 -4.27 11.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.166 2.578 . . . . 0.0 114.238 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.579 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 48.8 mt -60.68 152.01 69.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 83.4 Cg_endo -78.03 16.11 10.22 Favored 'Cis proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.042 -1.232 . . . . 0.0 114.278 8.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.579 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 52.8 m-70 -91.83 104.5 16.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -82.61 127.0 32.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.522 0.677 . . . . 0.0 110.192 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.432 HD12 ' HB3' ' A' ' 467' ' ' CYS . 7.5 mp -87.63 141.13 28.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.994 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -82.89 -176.58 6.39 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -65.69 -13.41 59.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.12 7.01 36.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.45 15.16 54.2 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.448 -0.882 . . . . 0.0 114.452 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.15 141.5 15.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 29.0 p -84.35 114.17 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.544 ' HE ' ' HA ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER -50.67 -32.8 20.26 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.584 0.552 . . . . 0.0 112.207 -174.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.13 -30.22 70.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 122.8 128.88 3.45 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.127 -171.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 77.2 tttt 148.59 -71.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.034 1.734 . . . . 0.0 108.942 169.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 67.0 m-85 -88.93 131.6 40.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.901 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 1.8 Cg_endo -82.71 175.53 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.997 2.465 . . . . 0.0 111.854 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -84.22 66.33 9.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 C-N-CA 127.305 2.242 . . . . 0.0 107.266 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.6 -5.95 57.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.987 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? 46.62 32.94 1.83 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.188 0.995 . . . . 0.0 112.964 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -70.43 156.45 91.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.364 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.14 126.68 21.04 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.997 2.464 . . . . 0.0 112.305 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 450' ' ' ILE . 16.7 p -140.65 140.61 35.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.034 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.7 142.21 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.441 ' HB3' HG21 ' A' ' 446' ' ' THR . 91.9 m95 -90.33 108.13 19.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.146 0.498 . . . . 0.0 111.075 -175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -109.74 133.32 53.27 Favored 'General case' 1 N--CA 1.372 -4.348 0 CA-C-O 116.791 -1.576 . . . . 0.0 111.814 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -134.23 5.35 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.512 1.505 . . . . 0.0 111.785 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -162.09 119.47 0.88 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.433 175.267 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.252 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.06 52.76 3.55 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.079 2.52 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 483' ' ' ARG . 15.2 m 69.96 164.84 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -118.06 135.57 54.1 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.393 -0.817 . . . . 0.0 110.18 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.619 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 10.1 mtm180 -78.93 138.94 38.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.493 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.65 119.96 41.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 479' ' ' THR . 49.0 mt -69.68 89.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.829 0.347 . . . . 0.0 110.212 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 58.4 -92.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.972 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -130.37 21.39 4.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.798 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.64 162.31 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.829 0.452 . . . . 0.0 110.114 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.01 163.64 5.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 18.5 t -65.02 131.66 95.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.063 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.589 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . 74.7 Cg_endo -85.14 17.84 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.899 2.399 . . . . 0.0 113.318 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 71.0 mt -87.13 155.35 54.98 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 51.0 Cg_endo -89.75 15.68 46.49 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.717 -1.368 . . . . 0.0 113.623 3.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.532 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 72.5 m-70 -68.94 -42.73 76.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 72.88 123.06 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.306 1.003 . . . . 0.0 111.138 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 41.2 mt -89.2 124.38 34.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -83.03 -171.58 3.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.8 p -50.63 -38.36 45.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.7 0.7 56.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.828 0.347 . . . . 0.0 111.918 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . 0.474 ' HA2' ' HE ' ' A' ' 448' ' ' ARG . . . 88.49 21.67 43.37 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.884 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -120.9 -172.31 14.51 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.1 p -126.05 121.34 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -52.63 -31.31 36.09 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.474 0.484 . . . . 0.0 111.828 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -24.78 67.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 109.39 134.26 6.95 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.101 -170.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 50.0 tttm 148.37 -65.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.82 1.648 . . . . 0.0 109.628 167.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -85.46 131.58 47.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.773 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.79 153.35 29.56 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.031 2.487 . . . . 0.0 112.865 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.04 99.13 1.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.04 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.418 HD13 ' HE2' ' A' ' 477' ' ' LYS . 89.5 mt -103.78 -27.43 12.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.407 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? 63.21 6.81 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 475' ' ' LEU . 53.4 mtmt -65.91 150.34 96.6 Favored Pre-proline 0 C--O 1.236 0.349 0 O-C-N 122.472 -0.142 . . . . 0.0 110.943 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.73 145.72 22.58 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.466 2.777 . . . . 0.0 112.756 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 450' ' ' ILE . 1.1 p -145.21 154.42 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.957 -171.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.11 132.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.619 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 91.2 m95 -84.31 102.8 12.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.556 . . . . 0.0 111.712 -174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.78 118.51 36.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.636 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.445 ' HA ' HG23 ' A' ' 446' ' ' THR . 18.1 mtp180 -58.31 -79.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.919 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -159.55 141.76 7.76 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.956 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.849 0 CA-C-O 119.061 -0.495 . . . . 0.0 109.929 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.026 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.82 32.96 0.51 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.854 2.369 . . . . 0.0 112.425 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.633 HG23 ' HB2' ' A' ' 483' ' ' ARG . 8.2 m 69.82 118.22 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.52 -171.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.64 141.05 29.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.414 0.626 . . . . 0.0 111.173 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 479' ' ' THR . 69.2 mtt180 -77.52 123.14 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.255 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -89.04 109.38 20.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.006 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.63 107.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.5 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 15.2 ptm180 -55.1 110.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.341 0.591 . . . . 0.0 110.937 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 130.66 -27.14 3.96 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -103.6 178.73 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -93.78 -76.84 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.206 0.527 . . . . 0.0 111.405 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.5 118.06 4.83 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.519 ' HB2' HD13 ' A' ' 461' ' ' LEU . 11.7 Cg_endo -58.32 -23.55 63.47 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.739 2.293 . . . . 0.0 114.002 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.424 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 72.5 mt -59.07 149.61 65.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.539 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.21 18.88 14.04 Favored 'Cis proline' 0 C--N 1.351 0.674 0 C-N-CA 124.128 -1.197 . . . . 0.0 114.138 6.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 41.6 m-70 -101.82 106.37 17.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -78.86 135.42 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.175 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.624 ' HG ' ' N ' ' A' ' 466' ' ' GLY . 6.8 mp -95.32 142.98 27.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.901 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.76 -167.11 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.2 p -78.16 26.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 476' ' ' LYS . 95.4 mt -121.61 -71.74 0.72 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.67 66.27 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 461' ' ' LEU . . . 175.61 155.22 12.42 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 459' ' ' HIS . 6.1 p -99.53 6.6 45.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.754 0.777 . . . . 0.0 111.886 -174.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 56.06 33.46 21.94 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.086 0.469 . . . . 0.0 111.25 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.4 p -177.9 131.87 0.15 Allowed 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.858 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 21.01 100.87 0.01 OUTLIER Glycine 0 C--O 1.242 0.594 0 O-C-N 124.758 1.286 . . . . 0.0 115.655 164.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 44.8 tttm 126.83 -64.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.43 1.492 . . . . 0.0 111.5 164.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 471' ' ' LYS . 83.5 m-85 -108.81 101.16 42.83 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -174.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.69 174.16 9.86 Favored 'Trans proline' 0 N--CA 1.466 -0.091 0 C-N-CA 122.572 2.181 . . . . 0.0 111.352 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -83.58 97.32 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.596 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 79.9 mt -105.21 -24.38 12.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.14 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.7 mtpm? 65.25 -103.88 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.997 0.811 . . . . 0.0 110.149 -175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 75.9 mttt 62.28 169.72 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.174 0.59 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.9 Cg_endo -58.89 100.05 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.501 2.134 . . . . 0.0 112.067 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 448' ' ' ARG . 16.7 p -92.64 135.96 33.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.036 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.99 141.75 14.2 Favored 'Isoleucine or valine' 1 C--O 1.132 -5.103 0 C-N-CA 116.647 -2.021 . . . . 0.0 108.406 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -91.82 110.92 22.27 Favored 'General case' 0 N--CA 1.387 -3.617 0 O-C-N 128.789 3.805 . . . . 0.0 111.246 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -133.15 131.88 40.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.979 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.633 ' HB2' HG23 ' A' ' 446' ' ' THR . 28.0 ttp180 -123.38 -88.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.447 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -76.44 107.45 2.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.814 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.608 175.929 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.12 -161.48 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 483' ' ' ARG . 17.8 p -81.4 -178.9 7.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -97.97 146.88 25.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.21 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 461' ' ' LEU . 89.0 mtt180 -72.35 142.23 48.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.898 -168.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.793 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 8.6 m170 -121.31 158.15 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.397 169.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 453' ' ' GLU . 55.0 mt -100.52 136.92 29.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 478' ' ' PRO . 33.9 mtp180 -62.04 101.25 0.2 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.027 0.441 . . . . 0.0 110.774 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.53 6.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.904 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 450' ' ' ILE . 5.1 mm-40 -100.97 159.22 15.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.836 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -82.79 -45.99 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.538 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 49.1 t -174.28 122.53 0.38 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 31.4 Cg_exo -62.4 -31.01 81.16 Favored 'Trans proline' 0 CA--C 1.525 0.06 0 C-N-CA 122.587 2.191 . . . . 0.0 113.175 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.475 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 66.6 mt -56.03 147.22 45.81 Favored Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 123.297 0.373 . . . . 0.0 111.203 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.73 16.76 10.87 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.906 -1.289 . . . . 0.0 114.081 4.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.475 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 48.0 m-70 -88.65 141.74 28.27 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -106.14 146.52 30.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 65.3 mt -102.58 127.73 49.55 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.99 0.181 . . . . 0.0 110.995 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -58.69 -56.81 17.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.625 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 45.9 p -178.97 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.046 0.538 . . . . 0.0 109.747 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.03 12.25 9.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.898 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.7 56.52 3.83 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.651 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -156.6 168.74 33.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.213 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 31.7 p -137.71 124.44 21.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.442 ' H ' ' HD2' ' A' ' 468' ' ' ARG . 4.3 mpt_? -55.62 -30.95 61.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.695 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 29.5 p -74.9 70.77 1.99 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.106 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.5 70.78 0.27 Allowed Glycine 0 N--CA 1.462 0.408 0 N-CA-C 115.199 0.84 . . . . 0.0 115.199 163.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.834 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 21.3 tptm -162.02 -72.97 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.073 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.588 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 46.8 m-85 -104.73 133.37 20.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.464 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.66 -177.37 2.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.842 2.362 . . . . 0.0 111.997 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -78.98 80.04 5.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.8 -15.2 59.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.742 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 58.36 68.82 0.79 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.975 0.416 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -132.4 143.33 48.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.663 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.409 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 30.9 Cg_exo -59.2 126.0 19.67 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.007 2.472 . . . . 0.0 111.091 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 20.3 p -79.5 134.75 36.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.994 0.426 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.793 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 46.2 t -84.82 126.07 40.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.248 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.507 ' HB3' ' OG1' ' A' ' 446' ' ' THR . 88.6 m95 -89.7 105.82 18.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.829 0.347 . . . . 0.0 111.558 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 482' ' ' ARG . 9.0 mmt180 -136.04 141.51 44.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.897 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.756 ' HB2' HG22 ' A' ' 446' ' ' THR . 47.0 ttt180 -139.23 134.02 32.13 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 81.58 138.84 2.63 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.849 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.659 178.716 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.212 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.533 ' HG2' HH22 ' A' ' 460' ' ' ARG . 60.3 Cg_endo -76.26 -170.46 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.341 2.028 . . . . 0.0 112.159 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 483' ' ' ARG . 43.1 p -73.48 175.95 6.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.052 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.9 138.6 50.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.983 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.45 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 3.7 mtm180 -83.12 144.49 29.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.652 -172.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -112.7 121.69 45.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.05 117.7 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -51.8 105.49 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.425 0.631 . . . . 0.0 111.967 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 120.4 -23.78 7.91 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.46 152.35 23.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -65.52 -69.65 0.28 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 43.7 t -173.37 121.88 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -17.34 50.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.275 . . . . 0.0 113.529 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.447 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 67.5 mt -54.54 143.16 49.21 Favored Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.089 0.243 . . . . 0.0 111.133 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.06 18.37 14.61 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.643 -1.399 . . . . 0.0 114.426 7.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.447 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 27.8 m-70 -97.76 165.72 11.82 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.533 HH22 ' HG2' ' A' ' 445' ' ' PRO . 5.3 ptm180 -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.67 141.36 28.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -172.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -80.65 -174.8 4.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 13.1 p -58.72 -28.42 65.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.73 8.4 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.146 -0.346 . . . . 0.0 111.627 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.62 20.12 64.57 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.164 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.09 156.36 15.72 Favored Glycine 1 C--O 1.315 5.187 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.964 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 6.2 p -110.95 149.06 31.2 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 120.552 -1.558 . . . . 0.0 109.819 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -58.85 156.74 10.82 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 87.49 -18.75 0.27 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.93 1.292 . . . . 0.0 111.294 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.78 72.9 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 8.9 tmtm? -124.29 -43.1 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.52 123.86 33.15 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.01 164.52 31.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.595 2.196 . . . . 0.0 111.897 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.37 91.07 3.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.901 0.382 . . . . 0.0 110.1 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.78 -6.52 26.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.661 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? 46.77 37.25 4.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.462 1.105 . . . . 0.0 112.589 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 35.1 mtpt -84.56 162.17 51.54 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 50.1 Cg_exo -51.95 122.81 11.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.47 2.78 . . . . 0.0 112.103 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.61 143.49 48.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.855 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.07 158.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.45 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 75.4 m95 -101.95 113.85 27.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 0.0 111.139 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 36.9 mmt180 -111.97 128.27 56.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.55 ' HB3' ' CG2' ' A' ' 446' ' ' THR . 10.0 ptm180 -140.21 5.07 2.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.923 -177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -90.11 -5.98 69.74 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.422 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.81 -179.397 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -86.79 169.2 7.94 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.186 2.591 . . . . 0.0 112.107 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 483' ' ' ARG . 0.2 OUTLIER -59.67 116.77 4.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 447' ' ' HIS . . . . . 0.423 ' HB2' ' NH1' ' A' ' 460' ' ' ARG . 36.0 p-80 -84.88 129.11 34.86 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.42 -171.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.653 ' NH1' ' HA ' ' A' ' 463' ' ' SER . 33.6 mtt85 -66.16 132.2 47.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.205 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.6 m170 -109.18 152.41 25.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.422 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 41.8 mt -91.74 146.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -68.76 80.34 0.29 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 0.0 110.718 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.12 49.81 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -162.55 136.28 6.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -70.32 -39.66 74.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.795 -178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 6.0 t 176.68 109.68 0.11 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 4.0 Cg_exo -75.37 10.6 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.293 2.662 . . . . 0.0 113.939 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.653 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 68.1 mt -73.97 161.75 77.11 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.9 Cg_endo -84.38 19.97 21.08 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 124.151 -1.187 . . . . 0.0 113.915 6.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -84.38 131.71 34.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.7 tpm_? -99.65 105.58 17.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.053 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 465' ' ' GLY . 7.6 mp -70.15 133.54 47.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.97 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.59 -163.66 1.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' SER . . . . . 0.653 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 8.2 p -60.63 -33.83 73.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.6 mt -92.17 -3.97 54.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.673 0.273 . . . . 0.0 111.641 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 461' ' ' LEU . . . 103.35 -16.49 52.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.319 -0.944 . . . . 0.0 113.187 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -73.62 152.76 46.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.609 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 14.2 p -111.24 25.06 12.12 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.088 -0.654 . . . . 0.0 111.129 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 74.44 -36.79 0.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 3.9 p -97.24 13.35 29.72 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 116.103 -2.239 . . . . 0.0 109.234 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 89.02 -28.88 6.27 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.852 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.543 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 7.4 tmtt? -47.29 -51.39 19.28 Favored 'General case' 0 N--CA 1.389 -3.501 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.543 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.3 m-85 -111.66 121.19 40.59 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 112.722 -2.035 . . . . 0.0 109.156 170.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.433 ' HG2' HD21 ' A' ' 475' ' ' LEU . 83.1 Cg_endo -86.09 167.28 9.48 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 112.302 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -75.16 95.19 3.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.281 0.563 . . . . 0.0 109.997 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.433 HD21 ' HG2' ' A' ' 473' ' ' PRO . 95.2 mt -84.99 -27.82 26.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.54 -175.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 476' ' ' LYS . 27.7 tptp 62.53 28.77 16.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.711 0.767 . . . . 0.0 110.736 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 43.4 mtmt -98.65 163.07 19.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.8 Cg_endo -57.57 118.33 5.19 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.573 2.182 . . . . 0.0 112.221 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 448' ' ' ARG . 11.8 p -97.99 146.38 25.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.966 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.4 t -92.32 134.91 28.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.967 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 448' ' ' ARG . 76.2 m95 -95.33 108.27 20.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.74 0.305 . . . . 0.0 110.994 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.29 134.87 54.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 110.633 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.485 ' HB2' HG23 ' A' ' 446' ' ' THR . 42.2 ttt-85 -130.29 102.99 6.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 98.73 154.78 28.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.832 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.301 178.43 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.315 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -88.26 -164.21 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.94 2.427 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.2 p -69.12 165.39 20.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -132.4 146.12 51.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.973 0.416 . . . . 0.0 110.163 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.848 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 68.2 mtt180 -89.23 139.45 30.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.509 -176.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 25.9 m170 -98.62 133.6 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' A' ' 461' ' ' LEU . 12.5 tt -80.54 14.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.117 0.484 . . . . 0.0 111.66 -173.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 69.28 16.39 8.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.419 0.628 . . . . 0.0 110.688 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -146.55 -52.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.04 132.81 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.38 69.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.724 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 11.8 t -171.7 102.19 0.38 Allowed Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.4 38.04 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.815 3.01 . . . . 0.0 113.984 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 459' ' ' HIS . 59.8 mt -104.3 157.71 33.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.2 45.84 1.73 Allowed 'Cis proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.471 -1.054 . . . . 0.0 112.9 1.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 36.4 m-70 -94.38 -61.72 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.007 0.432 . . . . 0.0 109.923 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 81.78 126.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.028 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.848 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 55.5 mt -86.59 110.82 20.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.75 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -63.33 -62.95 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.521 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' SER . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 7.6 p -152.89 -58.73 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.773 0.32 . . . . 0.0 111.403 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.44 19.02 0.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.42 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 74.89 36.16 48.07 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.694 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -119.74 176.54 16.17 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.269 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 22.1 p -142.23 126.37 17.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.697 0.249 . . . . 0.0 110.438 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -75.32 76.49 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.6 p 174.11 -2.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 95.57 123.5 4.17 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.761 -170.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 146.59 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.799 1.64 . . . . 0.0 109.414 164.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 465' ' ' GLY . 87.3 m-85 -101.9 123.37 44.02 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.353 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -90.24 -158.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.126 2.551 . . . . 0.0 111.23 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -86.76 83.77 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.127 0.489 . . . . 0.0 109.826 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.9 -39.39 12.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.371 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt 55.72 77.24 0.24 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.987 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.76 149.06 58.24 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.39 107.18 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.82 2.347 . . . . 0.0 111.824 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -105.12 140.93 37.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.235 0.541 . . . . 0.0 111.94 -172.202 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.8 t -93.31 131.98 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.515 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.58 110.82 20.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.016 0.436 . . . . 0.0 110.997 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -125.99 141.55 51.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.546 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 446' ' ' THR . 48.1 ttp180 -121.4 -55.51 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.433 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.3 130.06 10.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.916 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.803 175.744 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.24 148.46 34.39 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.535 2.157 . . . . 0.0 113.266 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.874 HG22 ' HG2' ' A' ' 483' ' ' ARG . 10.1 p -116.41 114.88 24.89 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -112.88 176.71 4.9 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.93 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.942 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 49.3 mtt180 -117.86 143.32 46.4 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.49 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -110.05 138.14 46.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 11.2 tt -83.63 22.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.341 0.591 . . . . 0.0 111.055 -176.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 450' ' ' ILE . 8.8 ptm180 53.92 12.89 0.48 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.712 1.205 . . . . 0.0 112.889 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -149.45 31.44 1.14 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.55 152.04 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.47 -42.07 71.91 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 117.835 -1.546 . . . . 0.0 107.963 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 44.2 t -175.51 108.85 0.26 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 10.4 Cg_exo -73.79 29.9 0.32 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.549 2.832 . . . . 0.0 114.067 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.33 152.14 39.95 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.61 19.05 37.77 Favored 'Cis proline' 0 C--O 1.169 -2.93 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.956 2.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -65.67 -58.18 6.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 71.96 133.36 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.375 1.047 . . . . 0.0 111.27 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.9 mm? -86.18 130.74 34.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.222 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.66 47.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.672 0.272 . . . . 0.0 110.871 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 89.8 p 59.88 -1.88 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.971 1.308 . . . . 0.0 113.431 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.7 mt -107.29 4.93 27.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.21 67.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.446 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -125.1 177.38 16.92 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.413 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 29.9 p -125.79 121.77 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.48 -29.76 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 111.649 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.31 -9.14 57.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 96.12 124.87 4.64 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.147 -173.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.1 tmtp? 159.44 -48.01 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.83 1.652 . . . . 0.0 107.933 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.537 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 49.1 m-85 -123.26 128.43 25.28 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.703 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.75 157.57 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.329 2.019 . . . . 0.0 111.004 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.38 92.41 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 109.868 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.09 -6.34 45.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.274 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.4 mttm 64.3 28.65 13.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.861 0.362 . . . . 0.0 111.383 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 74.2 mmtt -89.5 140.99 28.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.4 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 477' ' ' LYS . 39.3 Cg_exo -61.77 115.19 2.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.063 2.509 . . . . 0.0 111.994 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 16.5 p -80.57 128.52 33.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.406 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.86 132.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.127 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -80.46 105.79 11.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.008 0.433 . . . . 0.0 111.807 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 19.0 mmt180 -126.02 139.15 53.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.469 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.874 ' HG2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -166.27 164.33 17.69 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.117 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 103.94 8.37 39.49 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.817 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.21 165.74 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.242 2.628 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.5 m -58.8 140.57 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -95.23 131.47 41.24 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.553 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.695 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 67.9 mtt180 -71.9 132.76 44.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.475 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.893 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.9 m170 -97.8 111.94 24.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.384 170.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.97 109.02 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -43.59 106.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.746 0.654 . . . . 0.0 111.687 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.45 -19.92 6.63 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.321 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -106.64 153.91 21.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.601 0.36 . . . . 0.0 110.169 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -81.15 -49.21 11.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.706 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 34.1 t -174.09 102.29 0.29 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.35 33.49 0.36 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.409 2.74 . . . . 0.0 114.22 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 33.2 mt -75.22 158.86 83.5 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 4.1 Cg_endo -86.77 33.66 5.57 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.255 -1.144 . . . . 0.0 113.206 3.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.432 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 87.8 m-70 -103.4 116.21 31.99 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.282 0.563 . . . . 0.0 110.205 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -95.96 121.4 37.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.132 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 2.5 mm? -82.54 135.62 35.05 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.902 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -77.18 -168.6 1.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.42 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.2 p -77.83 11.67 2.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.883 0.373 . . . . 0.0 111.665 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.425 HD22 ' HE2' ' A' ' 476' ' ' LYS . 84.8 mt -120.5 1.29 10.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.0 110.209 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 75.86 35.88 43.74 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.446 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -133.76 164.98 24.34 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -129.57 120.67 25.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.74 0.77 . . . . 0.0 110.882 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -46.88 -40.98 15.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 124.2 0.937 . . . . 0.0 110.806 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 26.0 p -69.04 74.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 32.45 75.89 0.04 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 124.151 0.907 . . . . 0.0 115.127 166.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.83 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 16.6 tppt? -167.92 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.994 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 82.1 m-85 -76.16 119.94 79.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 111.394 -172.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 97.9 Cg_endo -86.52 43.74 1.1 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.672 2.915 . . . . 0.0 113.11 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 63.08 94.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 111.311 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.0 mt -117.78 84.49 2.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' LYS . . . . . 0.425 ' HE2' HD22 ' A' ' 464' ' ' LEU . 6.8 mtpm? -62.07 95.01 0.06 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.45 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -144.08 155.66 58.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.274 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -50.48 124.35 13.07 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 111.58 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.507 HG21 ' HD3' ' A' ' 448' ' ' ARG . 0.9 OUTLIER -132.21 159.94 37.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.838 -171.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.893 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 49.0 t -96.09 141.28 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.846 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -100.51 106.8 18.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.111 0.482 . . . . 0.0 111.803 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -132.23 131.43 42.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.47 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 484' ' ' GLY . 2.7 ptp85 -96.42 -52.66 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.243 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 483' ' ' ARG . . . -133.22 155.18 21.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.449 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.032 -179.729 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 154.16 68.18 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.638 2.225 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 6.4 m -54.31 123.92 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -91.68 138.12 31.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.771 -168.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 39.7 mtt180 -71.24 130.08 40.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.686 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m170 -98.31 105.73 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.935 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.1 115.47 5.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -47.51 107.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.4 14.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.594 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.11 -5.15 58.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 110.967 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 62.6 -98.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.426 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 456' ' ' PRO . 35.7 t -127.04 97.08 32.93 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 455' ' ' CYS . 13.3 Cg_endo -57.48 -1.95 0.57 Allowed 'Trans proline' 0 N--CA 1.477 0.526 0 C-N-CA 124.255 3.304 . . . . 0.0 114.869 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.57 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 54.1 mt -61.62 152.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.317 0 O-C-N 122.159 -0.338 . . . . 0.0 110.09 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.47 25.94 4.83 Favored 'Cis proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.063 -1.224 . . . . 0.0 114.494 6.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.57 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 71.8 m-70 -96.56 134.81 39.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 45.3 ttp180 -118.86 124.93 48.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.106 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 1.8 mm? -91.38 138.36 31.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.933 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.415 ' O ' ' HD2' ' A' ' 448' ' ' ARG . 10.1 p30 -86.97 -171.78 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.8 p -68.14 -7.56 30.93 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.8 mt -95.2 -4.82 45.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 110.492 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.42 45.24 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.868 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -123.39 152.05 17.0 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.16 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 28.0 p -101.52 116.12 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.37 0.585 . . . . 0.0 110.582 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -49.04 -33.57 11.65 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.823 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.91 -13.01 61.26 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 98.13 124.66 5.04 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.837 -173.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 1.2 tmtp? 156.03 -55.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.256 1.422 . . . . 0.0 109.457 166.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 97.9 m-85 -97.92 125.62 43.53 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.98 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.11 167.39 27.47 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.824 2.349 . . . . 0.0 111.865 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -74.49 97.31 3.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -98.41 -20.13 17.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 39.1 mttm 67.95 -1.92 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.814 0.446 . . . . 0.0 112.053 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.69 152.17 96.53 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -170.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.96 125.43 18.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.494 2.796 . . . . 0.0 112.173 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.41 HG21 ' HB3' ' A' ' 448' ' ' ARG . 5.2 p -123.23 157.03 33.99 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 36.6 t -89.9 141.82 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.75 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.476 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 36.0 m95 -94.45 105.37 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.557 ' HG3' ' CE1' ' A' ' 449' ' ' HIS . 39.7 mmt180 -123.39 118.16 26.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -87.82 -48.86 7.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -140.17 171.94 23.69 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.023 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.177 -2.713 0 CA-C-O 122.309 1.052 . . . . 0.0 109.918 -179.657 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.66 23.53 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.62 2.213 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 483' ' ' ARG . 33.7 m 67.32 110.0 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -170.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -92.38 144.15 25.67 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.08 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.51 ' HB3' ' CG2' ' A' ' 479' ' ' THR . 68.2 mtt180 -76.77 125.49 29.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.312 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.76 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 6.2 m170 -91.71 117.88 30.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.867 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 59.7 mt -72.78 115.94 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.695 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 13.3 ptm180 -57.33 101.86 0.08 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.609 0.718 . . . . 0.0 110.185 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.68 4.62 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.155 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.95 136.11 54.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.03 -60.54 3.62 Favored 'General case' 1 N--CA 1.349 -5.483 0 O-C-N 119.242 -2.162 . . . . 0.0 111.125 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.441 ' SG ' ' HG ' ' A' ' 457' ' ' LEU . 34.4 t -155.8 107.17 2.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.27 29.56 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.873 2.382 . . . . 0.0 113.877 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.679 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 42.0 mt -83.46 162.85 52.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.1 Cg_endo -84.94 18.38 27.02 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 124.32 -1.117 . . . . 0.0 113.346 3.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 76.3 m-70 -77.81 132.47 38.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.353 0.596 . . . . 0.0 110.267 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -94.42 108.58 20.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.098 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.8 mp -76.23 110.83 11.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -69.31 -178.55 1.37 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.075 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.3 p -68.92 -1.45 7.36 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.23 5.8 48.05 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.205 -0.31 . . . . 0.0 111.034 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.81 49.57 22.7 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.853 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . 177.94 -165.51 35.1 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 19.0 p -145.69 128.36 16.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.16 0.48 . . . . 0.0 110.192 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.02 -22.75 61.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.163 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.07 -24.32 64.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.79 84.3 1.79 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.122 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -168.42 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.473 ' HE2' ' HB2' ' A' ' 459' ' ' HIS . 73.8 m-85 -124.74 117.37 26.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.42 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 2.9 Cg_exo -73.13 166.32 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.613 2.209 . . . . 0.0 111.883 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.23 81.86 3.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.2 mt -106.87 -1.57 22.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.989 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 65.19 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.622 0.576 . . . . 0.0 110.485 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 63.04 152.36 0.11 Allowed Pre-proline 0 N--CA 1.466 0.332 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.695 ' HG2' ' HD3' ' A' ' 451' ' ' ARG . 28.0 Cg_endo -65.48 105.24 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.299 1.999 . . . . 0.0 111.208 171.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -113.79 144.27 43.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.43 -174.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 9.0 t -94.52 140.08 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.459 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -96.45 109.44 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.888 0.375 . . . . 0.0 111.888 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 482' ' ' ARG . 31.0 mmt180 -132.3 127.39 35.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 446' ' ' THR . 11.2 ptm180 -131.66 -1.32 3.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.575 0.226 . . . . 0.0 110.906 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -59.69 -26.94 63.23 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.492 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.343 175.905 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -92.89 -158.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.059 2.506 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 483' ' ' ARG . 7.8 p -61.95 120.19 10.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.069 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -97.94 143.99 27.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.362 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -73.99 137.64 43.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.523 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 455' ' ' CYS . 1.5 m-70 -110.99 148.46 32.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.692 171.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 477' ' ' LYS . 22.3 mt -77.17 1.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.808 0.813 . . . . 0.0 109.597 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 57.71 78.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.319 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 154.46 -7.37 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.159 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -178.75 3.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.927 0.394 . . . . 0.0 110.466 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' ALA . . . . . 0.431 ' O ' ' HE1' ' A' ' 449' ' ' HIS . . . -83.49 -48.32 10.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 449' ' ' HIS . 19.1 t -178.74 119.81 0.24 Allowed Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.02 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.31 -2.0 10.53 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.195 2.597 . . . . 0.0 113.76 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 79.7 mt -68.25 159.03 82.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 91.4 Cg_endo -83.36 18.23 21.95 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.786 -1.339 . . . . 0.0 114.17 5.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.94 133.8 36.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 36.0 mtt180 -98.72 112.28 24.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.505 -171.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.7 mp -85.75 117.89 24.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.793 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -81.52 -176.54 6.09 Favored 'General case' 1 C--O 1.314 4.485 0 CA-C-O 123.508 1.623 . . . . 0.0 110.635 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 8.8 p -53.27 -30.21 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.353 -1.467 . . . . 0.0 112.891 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.35 7.3 29.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.02 54.3 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.262 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -162.42 168.85 37.53 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.5 p -117.13 113.91 22.95 Favored 'General case' 1 N--CA 1.366 -4.631 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.074 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -47.23 -38.38 12.09 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.815 0.697 . . . . 0.0 111.697 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.5 p -59.61 -22.54 61.97 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 111.46 125.03 4.6 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.872 -171.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 29.4 tptp 149.11 -75.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.601 1.56 . . . . 0.0 109.084 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -87.15 123.49 69.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.93 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.21 175.09 11.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.779 2.319 . . . . 0.0 111.939 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -74.77 85.68 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 0.0 110.438 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.17 -40.0 39.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.932 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 61.92 24.58 14.65 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.339 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 10.6 ptpt -81.45 165.92 41.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 11.4 Cg_endo -55.14 101.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.536 2.157 . . . . 0.0 112.046 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 449' ' ' HIS . 0.0 OUTLIER -102.54 139.32 38.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.418 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.26 153.37 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.0 111.559 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -92.51 104.54 16.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.512 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -127.65 125.28 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.017 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' A' ' 484' ' ' GLY . 4.3 ptp180 -110.05 -47.09 3.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.789 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 483' ' ' ARG . . . -91.14 139.17 14.67 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.846 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.102 174.604 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' A' ' 446' ' ' THR . 74.4 Cg_endo -89.78 34.04 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.99 2.46 . . . . 0.0 112.255 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 445' ' ' PRO . 25.1 m 75.83 128.52 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.78 0.675 . . . . 0.0 110.148 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -99.07 145.04 27.54 Favored 'General case' 0 C--O 1.273 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.259 -174.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 22.7 mtp85 -87.18 157.85 19.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.645 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.654 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.0 OUTLIER -132.19 127.77 36.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.819 176.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.62 123.19 31.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -51.9 104.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.47 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 124.88 -17.02 7.25 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.5 140.3 29.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -76.02 -44.13 40.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.223 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 10.4 t -178.99 116.1 0.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.14 -10.8 28.58 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.023 2.482 . . . . 0.0 113.581 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.453 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 91.8 mt -59.39 153.16 50.45 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.695 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.36 19.15 13.98 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.851 5.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 96.8 m-70 -89.38 148.79 23.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.166 0.507 . . . . 0.0 110.112 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -121.29 121.31 37.42 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.021 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 8.5 mp -73.19 108.89 6.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 467' ' ' CYS . 1.1 p-10 -75.01 68.73 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.464 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' SER . . . . . 0.623 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 92.0 p 64.15 -39.62 0.22 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.296 1.438 . . . . 0.0 114.103 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 476' ' ' LYS . 39.7 mt -88.67 16.4 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.96 15.74 66.72 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.683 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -157.79 179.13 33.74 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.574 ' HA ' ' OD1' ' A' ' 462' ' ' ASN . 17.6 p -129.16 117.48 20.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.4 0.6 . . . . 0.0 110.026 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -68.84 97.19 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.208 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 470' ' ' GLY . 12.5 p -168.3 -41.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.886 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 469' ' ' CYS . . . 136.8 47.35 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.844 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 472' ' ' TYR . 16.9 tptm -140.13 -55.43 0.54 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.804 0.335 . . . . 0.0 110.55 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' TYR . . . . . 0.441 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 75.2 m-85 -132.08 125.15 19.91 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.411 ' O ' ' HA3' ' A' ' 466' ' ' GLY . 67.4 Cg_endo -75.4 171.93 17.31 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.513 2.142 . . . . 0.0 111.909 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.82 87.41 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.353 . . . . 0.0 110.289 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.423 ' HB3' ' HG3' ' A' ' 477' ' ' LYS . 91.7 mt -75.48 -26.61 58.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.865 -175.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' LYS . . . . . 0.452 ' HE2' HD22 ' A' ' 464' ' ' LEU . 33.1 mmtp 66.11 26.21 10.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.08 0.552 . . . . 0.0 111.398 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 44.1 mtpt -100.62 158.63 31.53 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.306 -0.246 . . . . 0.0 110.982 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 10.1 Cg_endo -52.96 133.83 53.11 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.556 2.837 . . . . 0.0 112.558 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 0.1 OUTLIER -127.75 136.68 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.349 -176.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 10.5 t -82.29 152.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.61 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.586 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 55.1 m95 -109.12 107.36 17.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -124.54 125.19 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -62.36 -84.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.78 -63.05 1.11 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.49 168.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.52 56.07 4.98 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.135 2.556 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.3 p 50.96 99.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.573 0.749 . . . . 0.0 112.05 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -100.5 133.7 44.54 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-O 122.448 1.118 . . . . 0.0 111.351 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 448' ' ' ARG . 51.7 mtt-85 -68.54 133.54 48.7 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.578 -2.555 . . . . 0.0 111.395 -172.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 449' ' ' HIS . . . . . 0.423 ' CB ' HG23 ' A' ' 480' ' ' VAL . 2.6 m170 -101.57 119.45 38.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.912 171.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 477' ' ' LYS . 76.4 mt -66.85 125.66 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 478' ' ' PRO . 20.8 mtp180 -58.69 105.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.409 0.623 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 129.53 -23.27 4.83 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.168 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -97.97 138.35 35.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.95 -38.44 72.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.504 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 36.9 t 178.95 114.07 0.19 Allowed Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 456' ' ' PRO . . . . . 0.445 ' HG3' HD22 ' A' ' 461' ' ' LEU . 56.7 Cg_endo -71.48 2.81 4.13 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.17 2.58 . . . . 0.0 113.922 -175.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 81.4 mt -69.22 156.99 90.5 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 76.5 Cg_endo -82.56 16.2 24.41 Favored 'Cis proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.51 -1.454 . . . . 0.0 113.771 5.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 45.6 m-70 -80.25 144.93 32.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 109.942 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.4 mmm180 -100.21 110.14 22.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.248 -174.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.2 mp -86.21 117.82 25.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.093 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.87 -167.31 1.22 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.377 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 463' ' ' SER . . . . . 0.408 ' HA ' ' HE ' ' A' ' 448' ' ' ARG . 3.2 p -65.1 -16.2 63.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.84 -0.08 57.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.629 0.252 . . . . 0.0 110.96 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.97 61.2 3.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.731 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -174.22 158.03 26.29 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 20.9 p -101.4 118.41 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.497 0.648 . . . . 0.0 109.91 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.55 -35.11 62.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.705 -175.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -22.27 60.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 108.11 132.34 6.73 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.062 -168.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.672 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 28.2 tptp 150.17 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 125.852 1.661 . . . . 0.0 108.101 171.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -132.42 117.69 15.64 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.877 176.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.7 160.43 49.75 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 111.601 177.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -65.88 95.55 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.163 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.488 HD13 ' HE3' ' A' ' 477' ' ' LYS . 95.1 mt -85.48 -28.71 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.627 -175.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 476' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 476' ' ' LYS . 20.7 ttmm 57.8 28.03 15.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.772 0.796 . . . . 0.0 110.509 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.583 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 16.0 ptpt -96.88 164.22 18.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 86.1 Cg_exo -38.88 115.51 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.742 2.961 . . . . 0.0 112.737 176.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 136.67 54.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.408 -176.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 449' ' ' HIS . 0.1 OUTLIER -93.81 136.41 25.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.853 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -86.89 109.73 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -177.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -119.02 136.47 54.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.602 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 483' ' ' ARG . . . . . 0.414 ' HB3' ' H ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -95.66 -147.41 0.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.534 179.782 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 483' ' ' ARG . . . -69.68 136.41 27.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.819 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.215 -177.456 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 483' ' ' ARG . 20.2 p . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -95.76 142.74 27.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.589 ' CD ' ' HB ' ' A' ' 479' ' ' THR . 3.9 ttt180 -100.7 146.27 27.41 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.265 0.555 . . . . 0.0 111.632 -172.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -103.56 137.21 41.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.734 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 21.2 pt -87.54 13.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 109.802 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 451' ' ' ARG . 39.1 ttt85 69.4 88.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.531 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.08 60.22 1.14 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.259 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . 0.614 ' HG3' ' HG3' ' A' ' 456' ' ' PRO . 0.0 OUTLIER -136.91 1.74 2.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.807 0.337 . . . . 0.0 111.103 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 66.34 30.45 8.91 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.335 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 31.6 t 72.73 113.92 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.857 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.614 ' HG3' ' HG3' ' A' ' 453' ' ' GLU . 2.2 Cg_endo -82.51 21.41 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 113.683 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 53.8 mt -73.55 159.8 83.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.649 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 63.8 Cg_endo -88.14 21.5 26.63 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 113.455 2.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -83.02 143.43 30.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 110.067 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 117.81 32.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.912 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.3 mp -90.1 145.35 25.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.208 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -95.73 -167.25 1.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.281 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.518 ' HA ' HH11 ' A' ' 448' ' ' ARG . 3.3 p -68.92 -15.08 63.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.2 -3.77 57.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.264 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.74 4.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.58 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -166.96 166.49 39.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.814 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 25.6 p -114.1 124.07 51.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.195 0.497 . . . . 0.0 110.327 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 468' ' ' ARG . 6.4 mtp180 -52.09 -35.72 48.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.819 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.1 p -69.35 105.63 2.63 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -22.17 104.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.195 0 O-C-N 124.924 1.39 . . . . 0.0 115.355 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 56.5 tptt -172.85 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -0.807 . . . . 0.0 110.918 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -129.77 122.64 20.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.65 -167.83 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.125 2.55 . . . . 0.0 113.074 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 474' ' ' ASN . 0.9 OUTLIER -83.75 90.43 7.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.012 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.87 -30.05 18.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.52 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 21.1 tptm 53.2 77.99 0.16 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.756 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -123.72 165.01 25.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.816 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.46 86.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.242 1.961 . . . . 0.0 110.764 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.589 ' HB ' ' CD ' ' A' ' 448' ' ' ARG . 0.3 OUTLIER -87.98 132.3 34.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.654 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.48 132.52 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.048 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.482 ' CE3' ' HG3' ' A' ' 448' ' ' ARG . 54.0 m95 -76.4 109.96 10.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -118.21 125.74 50.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.394 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.625 ' HB2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -153.15 13.47 0.5 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.252 0.548 . . . . 0.0 110.004 173.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -79.23 -1.57 85.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.212 177.788 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 483' ' ' ARG . 90.8 m . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -111.33 141.56 44.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 51.7 mtt180 -73.97 153.13 39.88 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 111.102 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 482' ' ' ARG . 1.7 m-70 -124.8 119.61 29.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.092 170.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.49 134.9 29.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.18 99.89 0.15 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.191 0.52 . . . . 0.0 110.607 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 128.97 -9.7 6.31 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.36 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.25 139.17 34.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 110.563 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -79.12 -40.81 30.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.742 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 25.3 t 173.35 117.59 0.08 OUTLIER Pre-proline 0 N--CA 1.462 0.165 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' A' ' 459' ' ' HIS . 68.8 Cg_endo -72.83 -22.37 20.23 Favored 'Trans proline' 0 C--O 1.223 -0.23 0 C-N-CA 122.499 2.133 . . . . 0.0 114.748 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.0 mt -55.47 145.25 49.67 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.42 11.32 26.73 Favored 'Cis proline' 0 C--N 1.356 0.956 0 C-N-CA 123.819 -1.325 . . . . 0.0 113.718 4.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 2.6 m-70 -84.05 152.81 24.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -135.94 153.78 51.31 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.861 -0.524 . . . . 0.0 111.116 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.652 ' HB3' ' HA2' ' A' ' 465' ' ' GLY . 1.4 mm? -100.73 113.58 26.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -59.59 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.267 0.354 . . . . 0.0 110.715 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 5.9 p -148.28 -30.58 0.29 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.044 0.45 . . . . 0.0 109.794 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.13 -1.65 55.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.716 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 461' ' ' LEU . . . 79.81 47.8 6.98 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.139 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -141.53 150.86 22.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.538 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -103.95 128.91 51.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 117.191 0.495 . . . . 0.0 109.703 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -44.62 -36.07 2.89 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.838 0.712 . . . . 0.0 110.616 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.04 82.03 7.87 Favored 'General case' 0 C--O 1.303 3.882 0 CA-C-O 117.932 -1.032 . . . . 0.0 108.458 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 29.48 69.99 0.07 OUTLIER Glycine 0 C--N 1.304 -1.229 0 C-N-CA 128.494 2.949 . . . . 0.0 117.584 158.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 87.8 tttt -150.38 -80.45 0.12 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.579 0.689 . . . . 0.0 110.886 164.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.656 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 92.2 m-85 -68.41 124.13 89.18 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.42 170.31 10.59 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.61 2.207 . . . . 0.0 112.262 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.12 87.63 3.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.096 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 477' ' ' LYS . 95.3 mt -100.39 -29.15 12.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.9 tttm 59.09 49.17 9.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 475' ' ' LEU . 72.9 mmtt -90.85 157.98 42.77 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.81 109.62 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.243 2.629 . . . . 0.0 111.816 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.39 137.8 41.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.11 159.27 5.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.492 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 88.4 m95 -97.18 102.99 14.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.281 0.562 . . . . 0.0 111.352 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.48 ' HB2' ' CD2' ' A' ' 449' ' ' HIS . 33.6 mmt180 -112.38 120.24 40.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 122.209 1.004 . . . . 0.0 110.406 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.719 ' HB2' HG23 ' A' ' 446' ' ' THR . 10.5 tpt180 -145.17 -13.62 0.53 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.362 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -87.55 59.61 4.34 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.131 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.057 175.549 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 483' ' ' ARG . 28.4 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -92.13 144.16 25.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.173 -171.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.86 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 57.4 mtt-85 -85.16 140.29 31.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.18 -172.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.4 m170 -107.41 122.35 46.44 Favored 'General case' 1 C--N 1.212 -5.371 0 C-N-CA 127.15 2.18 . . . . 0.0 111.576 173.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 450' ' ' ILE . 3.0 mp -82.76 122.13 36.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 451' ' ' ARG . 10.8 mmm180 -49.45 100.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.577 0.548 . . . . 0.0 111.126 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 137.02 -30.5 2.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.237 -0.983 . . . . 0.0 113.241 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -113.14 156.28 23.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.229 0.514 . . . . 0.0 110.669 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.82 -78.13 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.643 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 23.0 t -145.36 120.77 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.0 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.472 ' CB ' HD21 ' A' ' 461' ' ' LEU . 28.6 Cg_exo -65.66 -8.88 20.69 Favored 'Trans proline' 0 N--CA 1.477 0.503 0 C-N-CA 123.681 2.921 . . . . 0.0 114.411 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.73 150.28 87.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.478 0.18 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 20.55 23.32 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.811 -1.329 . . . . 0.0 113.818 4.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -84.44 157.4 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.8 mpt_? -127.39 134.64 49.91 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.097 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -100.06 106.87 18.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 463' ' ' SER . 0.4 OUTLIER -67.25 -23.06 65.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.814 -175.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.59 ' N ' HD22 ' A' ' 462' ' ' ASN . 17.5 p -174.87 -76.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 476' ' ' LYS . 79.1 mt -70.46 4.53 2.29 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 94.74 16.06 43.66 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.486 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 472' ' ' TYR . . . -106.03 147.97 16.36 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.884 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 29.5 p -111.55 -10.9 14.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 71.93 -53.26 0.69 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.893 0.745 . . . . 0.0 111.915 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.7 -18.65 8.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 467' ' ' CYS . . . 133.22 127.63 2.8 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.075 -164.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 73.2 tttt 106.94 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 126.514 1.926 . . . . 0.0 109.777 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.552 ' HB3' ' HA2' ' A' ' 466' ' ' GLY . 78.3 m-85 -92.13 117.25 67.6 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.648 ' HD2' ' HG ' ' A' ' 475' ' ' LEU . 2.2 Cg_endo -83.03 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.984 2.456 . . . . 0.0 111.366 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 473' ' ' PRO . 11.3 m120 -125.33 -69.6 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.648 ' HG ' ' HD2' ' A' ' 473' ' ' PRO . 97.9 mt 71.14 -51.36 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.647 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . 0.53 ' HG3' HD22 ' A' ' 464' ' ' LEU . 88.2 tttt 68.73 61.63 0.34 Allowed 'General case' 0 N--CA 1.532 3.652 0 O-C-N 126.16 2.162 . . . . 0.0 108.096 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 475' ' ' LEU . 7.6 mptt -102.02 152.7 38.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.828 175.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 110.99 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.161 1.907 . . . . 0.0 111.288 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.86 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 19.4 p -94.28 132.1 39.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.529 . . . . 0.0 111.679 -174.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 2.7 t -96.74 133.44 38.17 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.238 0 CA-C-O 123.739 1.733 . . . . 0.0 110.558 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 33.2 m95 -78.62 109.96 13.31 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.811 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.446 ' HD2' ' C ' ' A' ' 481' ' ' TRP . 1.1 mpt_? -113.4 118.34 34.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.318 0.58 . . . . 0.0 111.587 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.422 ' HB3' HG22 ' A' ' 446' ' ' THR . 36.1 ptt180 -130.59 2.97 4.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.76 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -72.67 -16.81 77.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.123 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.247 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 483' ' ' ARG . 12.8 p . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -83.12 142.83 30.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.54 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.615 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 44.7 mtt180 -75.92 128.57 35.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.378 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.567 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.2 m170 -104.14 119.51 39.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.433 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.605 HG13 HD21 ' A' ' 461' ' ' LEU . 47.5 mt -69.52 125.42 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.04 95.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.204 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 138.85 -18.18 3.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.766 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.89 156.08 40.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 0.0 109.854 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -68.68 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 13.0 t -137.73 115.39 9.62 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 36.6 Cg_exo -61.62 -25.45 79.19 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.286 2.657 . . . . 0.0 113.754 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.432 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 92.9 mt -51.14 144.79 14.11 Favored Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 123.07 0.231 . . . . 0.0 111.069 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.89 15.71 12.83 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.945 -1.273 . . . . 0.0 114.099 5.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 91.3 m-70 -83.26 132.05 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 109.867 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -107.36 125.3 51.02 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 7.8 mp -85.02 137.23 33.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.432 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.83 -174.42 4.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.835 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 11.6 p -74.4 0.14 15.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 0.0 111.406 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 474' ' ' ASN . 91.8 mt -105.13 4.05 30.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.734 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.24 26.42 61.77 Favored Glycine 2 C--O 1.142 -5.603 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -133.01 -178.78 15.77 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 110.267 -2.967 . . . . 0.0 111.765 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 13.4 p -138.18 141.44 40.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 117.514 0.657 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 469' ' ' CYS . 71.8 ttt180 -55.75 147.85 17.86 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 1.6 p 108.31 -22.28 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.723 1.609 . . . . 0.0 109.542 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 85.9 36.81 9.82 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.115 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.632 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 1.1 tmtp? -95.11 -61.28 1.51 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.4 m-85 -99.71 118.79 61.34 Favored Pre-proline 0 C--O 1.167 -3.255 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.422 ' O ' HD12 ' A' ' 475' ' ' LEU . 59.6 Cg_endo -75.57 169.02 23.22 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.091 1.86 . . . . 0.0 111.04 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . 10.6 m120 -86.07 76.34 9.8 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.305 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 473' ' ' PRO . 4.0 mp -69.05 -25.36 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.676 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 65.7 28.54 11.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.78 150.99 46.93 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.23 130.44 34.15 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.432 2.088 . . . . 0.0 111.565 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.02 157.14 20.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.095 0.474 . . . . 0.0 111.739 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 28.1 t -84.93 140.28 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.22 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.615 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 8.3 m95 -92.51 106.86 18.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 0.0 112.012 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -135.56 118.17 15.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.67 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.4 ttt180 -100.3 -64.54 1.03 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.866 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -102.28 131.41 10.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.887 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.343 178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.93 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.1 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -97.3 148.76 22.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.182 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 448' ' ' ARG . 66.9 mtt-85 -83.67 142.55 30.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.624 0.726 . . . . 0.0 112.406 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.481 ' HB3' ' HA2' ' A' ' 452' ' ' GLY . 4.8 m-70 -118.28 116.98 27.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.968 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 475' ' ' LEU . 2.8 mp -59.8 105.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 451' ' ' ARG . 1.5 tpm_? 56.42 17.73 3.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.664 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 449' ' ' HIS . . . 78.12 43.92 12.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.566 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 -163.76 0.47 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -52.87 -69.32 0.12 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-O 123.053 1.406 . . . . 0.0 112.172 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 35.0 t 170.32 106.58 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 120.643 -1.285 . . . . 0.0 109.239 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.657 ' HB2' HD21 ' A' ' 461' ' ' LEU . 52.8 Cg_exo -59.2 -18.6 45.35 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.377 2.718 . . . . 0.0 114.406 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 63.7 mt -65.63 154.11 89.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.586 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 5.4 Cg_exo -77.52 7.97 19.12 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 124.227 -1.156 . . . . 0.0 114.141 7.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.502 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 92.1 m-70 -78.94 107.16 11.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 0.0 110.385 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -86.67 127.29 34.94 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.821 -170.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 456' ' ' PRO . 1.1 mm? -87.03 150.87 23.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.083 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.3 -52.76 4.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.389 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.8 p -156.07 -66.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.09 33.41 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.399 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.53 2.96 82.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.11 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -98.13 157.56 20.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.325 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 30.7 p -121.42 110.46 16.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.01 -19.56 19.2 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.57 -6.7 27.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 91.07 123.61 2.86 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.3 tmtm? 156.13 -75.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.43 1.492 . . . . 0.0 108.629 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -84.57 132.28 47.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.902 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.6 -164.64 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.18 2.587 . . . . 0.0 111.684 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.41 97.64 10.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 0.0 110.199 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 450' ' ' ILE . 4.6 mp -103.17 83.6 2.22 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -72.68 78.36 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.368 0.604 . . . . 0.0 109.88 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -149.54 138.66 12.65 Favored Pre-proline 0 C--O 1.212 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.456 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.67 102.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.873 3.049 . . . . 0.0 114.426 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.09 135.95 33.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.146 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.5 t -98.59 140.3 18.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.194 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -89.5 106.93 18.78 Favored 'General case' 1 C--N 1.232 -4.539 0 O-C-N 124.938 1.399 . . . . 0.0 113.428 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -118.67 116.84 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.046 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.93 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.6 ttt-85 -108.87 97.88 7.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.069 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 93.36 157.57 33.46 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.157 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -96.5 123.89 40.31 Favored 'General case' 1 N--CA 1.551 4.583 0 CA-C-O 124.454 2.073 . . . . 0.0 107.969 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.503 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 9.3 ptm180 -72.83 132.79 44.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.442 -2.163 . . . . 0.0 111.678 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 479' ' ' THR . 2.5 m-70 -90.87 154.78 19.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.519 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 475' ' ' LEU . 1.1 tp -90.52 -1.37 9.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.963 0.887 . . . . 0.0 108.974 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 73.38 92.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.392 -1.731 . . . . 0.0 111.772 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 101.4 42.79 2.29 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.206 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' A' ' 455' ' ' CYS . 0.0 OUTLIER -127.95 -164.81 1.41 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 455' ' ' CYS . . . -98.48 27.94 4.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.704 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.56 ' H ' ' HG2' ' A' ' 453' ' ' GLU . 46.4 t 71.75 118.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.856 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.703 ' HB3' HD21 ' A' ' 461' ' ' LEU . 54.5 Cg_exo -53.78 -31.7 62.76 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.589 2.859 . . . . 0.0 114.665 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.24 142.84 47.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.17 23.9 20.76 Favored 'Cis proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.58 -1.425 . . . . 0.0 114.302 5.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.3 151.15 19.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 109.62 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -123.03 128.65 50.46 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.44 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 456' ' ' PRO . 1.2 mm? -91.73 138.39 31.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.319 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.76 -177.87 5.1 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p -62.38 -15.2 47.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.7 3.36 52.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.486 0.184 . . . . 0.0 111.493 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 475' ' ' LEU . . . 87.29 9.86 72.19 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.25 171.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -109.28 171.55 15.37 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.803 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 12.2 p -126.85 148.24 49.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.684 0.742 . . . . 0.0 109.861 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -56.65 142.04 41.35 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 0.4 OUTLIER 84.22 141.92 0.06 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -170.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -72.56 59.35 1.62 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.102 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 469' ' ' CYS . 8.7 tmtm? -110.05 -62.02 1.57 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -107.43 124.85 33.85 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-O 120.553 0.216 . . . . 0.0 110.95 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.2 177.55 8.5 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.733 2.288 . . . . 0.0 111.652 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.37 95.17 1.71 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 450' ' ' ILE . 78.3 mt -109.42 93.77 4.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -82.22 16.63 1.92 Allowed 'General case' 1 CA--C 1.632 4.103 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.587 ' HG3' ' HD2' ' A' ' 478' ' ' PRO . 36.5 ttmt -68.4 142.47 94.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.155 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 477' ' ' LYS . 2.7 Cg_exo -35.72 99.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.575 3.517 . . . . 0.0 113.244 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 448' ' ' ARG . 3.4 p -83.14 127.59 33.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -92.34 111.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.241 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 97.9 m95 -75.58 105.43 6.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.904 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -124.19 134.76 53.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -142.46 30.15 1.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.166 0.984 . . . . 0.0 108.794 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.76 69.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.553 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.019 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.578 HG23 ' HB2' ' A' ' 483' ' ' ARG . 18.8 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -96.2 158.0 15.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.35 0.595 . . . . 0.0 111.261 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -88.39 150.41 23.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.552 -175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.1 m-70 -123.18 126.03 46.22 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.277 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.5 114.7 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -44.74 113.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.804 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.12 26.22 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.44 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -90.36 149.04 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.968 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -64.0 -62.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 42.0 t 179.6 106.96 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.86 -2.27 2.05 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.048 3.165 . . . . 0.0 115.135 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.85 150.77 75.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.231 -0.293 . . . . 0.0 110.246 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.01 28.35 12.28 Favored 'Cis proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.919 -1.284 . . . . 0.0 113.418 4.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -95.46 167.35 11.37 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 460' ' ' ARG . 39.3 ttp180 -141.84 124.1 15.6 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.586 -171.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -83.72 111.74 19.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.116 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -59.42 -38.93 81.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.98 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -164.78 -71.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 111.858 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.5 37.98 0.71 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.44 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.19 29.15 68.97 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.352 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -129.8 163.8 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.928 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.1 p -135.1 140.15 45.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 469' ' ' CYS . 37.9 ttp-105 -62.5 88.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.603 0.564 . . . . 0.0 110.85 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . 0.654 ' HB3' ' O ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER 160.28 157.01 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -74.28 56.88 2.39 Favored Glycine 0 C--N 1.308 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.154 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 1.8 tmtp? -123.39 -56.97 1.69 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.54 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 82.7 m-85 -118.54 112.1 37.49 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.391 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.53 -178.83 2.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.776 2.318 . . . . 0.0 111.279 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -74.64 80.22 2.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 110.316 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.88 75.59 9.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.785 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -75.62 79.2 2.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.247 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 0.0 OUTLIER -132.24 164.53 42.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 2.2 Cg_endo -41.93 103.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.244 2.629 . . . . 0.0 113.362 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 3.9 p -86.21 127.29 34.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.273 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 40.8 t -91.18 129.97 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.896 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -81.32 109.19 15.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.069 0.462 . . . . 0.0 110.897 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -132.63 123.55 26.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.077 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 446' ' ' THR . 36.9 ttt180 -120.04 -38.2 2.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.099 0.476 . . . . 0.0 109.908 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -104.35 144.22 15.81 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.016 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.63 178.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.441 HG21 ' HB3' ' A' ' 481' ' ' TRP . 9.5 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -93.89 139.68 30.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.291 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 448' ' ' ARG . 23.1 mtt180 -71.96 142.81 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.41 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -119.35 102.44 8.68 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.609 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 479' ' ' THR . 56.9 mt -65.31 136.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -59.91 105.08 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 122.68 -21.13 7.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.839 -0.695 . . . . 0.0 111.557 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.58 142.17 27.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -80.06 -47.47 14.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.221 0.534 . . . . 0.0 110.154 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 20.5 t -178.35 112.25 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 -4.27 11.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.166 2.578 . . . . 0.0 114.238 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.579 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 48.8 mt -60.68 152.01 69.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 83.4 Cg_endo -78.03 16.11 10.22 Favored 'Cis proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.042 -1.232 . . . . 0.0 114.278 8.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.579 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 52.8 m-70 -91.83 104.5 16.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -82.61 127.0 32.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.522 0.677 . . . . 0.0 110.192 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.432 HD12 ' HB3' ' A' ' 467' ' ' CYS . 7.5 mp -87.63 141.13 28.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.994 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -82.89 -176.58 6.39 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -65.69 -13.41 59.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.12 7.01 36.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.45 15.16 54.2 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.448 -0.882 . . . . 0.0 114.452 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.15 141.5 15.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 29.0 p -84.35 114.17 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.544 ' HA ' ' HE ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER -50.67 -32.8 20.26 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.584 0.552 . . . . 0.0 112.207 -174.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.13 -30.22 70.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 122.8 128.88 3.45 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.127 -171.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 77.2 tttt 148.59 -71.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.034 1.734 . . . . 0.0 108.942 169.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 67.0 m-85 -88.93 131.6 40.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.901 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 1.8 Cg_endo -82.71 175.53 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.997 2.465 . . . . 0.0 111.854 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -84.22 66.33 9.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 C-N-CA 127.305 2.242 . . . . 0.0 107.266 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.6 -5.95 57.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.987 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? 46.62 32.94 1.83 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.188 0.995 . . . . 0.0 112.964 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -70.43 156.45 91.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.364 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.14 126.68 21.04 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.997 2.464 . . . . 0.0 112.305 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 450' ' ' ILE . 16.7 p -140.65 140.61 35.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.034 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.7 142.21 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.441 ' HB3' HG21 ' A' ' 446' ' ' THR . 91.9 m95 -90.33 108.13 19.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.146 0.498 . . . . 0.0 111.075 -175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -109.74 133.32 53.27 Favored 'General case' 1 N--CA 1.372 -4.348 0 CA-C-O 116.791 -1.576 . . . . 0.0 111.814 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -134.23 5.35 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.512 1.505 . . . . 0.0 111.785 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -162.09 119.47 0.88 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.433 175.267 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 483' ' ' ARG . 15.2 m . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -118.06 135.57 54.1 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.393 -0.817 . . . . 0.0 110.18 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.619 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 10.1 mtm180 -78.93 138.94 38.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.493 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.65 119.96 41.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 479' ' ' THR . 49.0 mt -69.68 89.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.829 0.347 . . . . 0.0 110.212 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 58.4 -92.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.972 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -130.37 21.39 4.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.798 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.64 162.31 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.829 0.452 . . . . 0.0 110.114 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.01 163.64 5.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 18.5 t -65.02 131.66 95.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.063 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.589 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . 74.7 Cg_endo -85.14 17.84 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.899 2.399 . . . . 0.0 113.318 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 71.0 mt -87.13 155.35 54.98 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 51.0 Cg_endo -89.75 15.68 46.49 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.717 -1.368 . . . . 0.0 113.623 3.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.532 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 72.5 m-70 -68.94 -42.73 76.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 72.88 123.06 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.306 1.003 . . . . 0.0 111.138 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 41.2 mt -89.2 124.38 34.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -83.03 -171.58 3.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.8 p -50.63 -38.36 45.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.7 0.7 56.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.828 0.347 . . . . 0.0 111.918 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . 0.474 ' HA2' ' HE ' ' A' ' 448' ' ' ARG . . . 88.49 21.67 43.37 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.884 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -120.9 -172.31 14.51 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.1 p -126.05 121.34 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -52.63 -31.31 36.09 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.474 0.484 . . . . 0.0 111.828 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -24.78 67.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 109.39 134.26 6.95 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.101 -170.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 50.0 tttm 148.37 -65.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.82 1.648 . . . . 0.0 109.628 167.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -85.46 131.58 47.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.773 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.79 153.35 29.56 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.031 2.487 . . . . 0.0 112.865 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 474' ' ' ASN . 0.9 OUTLIER -71.04 99.13 1.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.04 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.418 HD13 ' HE2' ' A' ' 477' ' ' LYS . 89.5 mt -103.78 -27.43 12.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.407 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? 63.21 6.81 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 475' ' ' LEU . 53.4 mtmt -65.91 150.34 96.6 Favored Pre-proline 0 C--O 1.236 0.349 0 O-C-N 122.472 -0.142 . . . . 0.0 110.943 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.73 145.72 22.58 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.466 2.777 . . . . 0.0 112.756 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 450' ' ' ILE . 1.1 p -145.21 154.42 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.957 -171.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.11 132.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.619 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 91.2 m95 -84.31 102.8 12.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.556 . . . . 0.0 111.712 -174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.78 118.51 36.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.636 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.445 ' HA ' HG23 ' A' ' 446' ' ' THR . 18.1 mtp180 -58.31 -79.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.919 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -159.55 141.76 7.76 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.956 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.849 0 CA-C-O 119.061 -0.495 . . . . 0.0 109.929 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.633 HG23 ' HB2' ' A' ' 483' ' ' ARG . 8.2 m . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.64 141.05 29.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.414 0.626 . . . . 0.0 111.173 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 479' ' ' THR . 69.2 mtt180 -77.52 123.14 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.255 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -89.04 109.38 20.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.006 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.63 107.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.5 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 15.2 ptm180 -55.1 110.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.341 0.591 . . . . 0.0 110.937 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 130.66 -27.14 3.96 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -103.6 178.73 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -93.78 -76.84 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.206 0.527 . . . . 0.0 111.405 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.5 118.06 4.83 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.519 ' HB2' HD13 ' A' ' 461' ' ' LEU . 11.7 Cg_endo -58.32 -23.55 63.47 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.739 2.293 . . . . 0.0 114.002 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.424 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 72.5 mt -59.07 149.61 65.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.539 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.21 18.88 14.04 Favored 'Cis proline' 0 C--N 1.351 0.674 0 C-N-CA 124.128 -1.197 . . . . 0.0 114.138 6.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 41.6 m-70 -101.82 106.37 17.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -78.86 135.42 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.175 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.624 ' HG ' ' N ' ' A' ' 466' ' ' GLY . 6.8 mp -95.32 142.98 27.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.901 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.76 -167.11 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.2 p -78.16 26.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 476' ' ' LYS . 95.4 mt -121.61 -71.74 0.72 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.67 66.27 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 461' ' ' LEU . . . 175.61 155.22 12.42 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 459' ' ' HIS . 6.1 p -99.53 6.6 45.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.754 0.777 . . . . 0.0 111.886 -174.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 56.06 33.46 21.94 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.086 0.469 . . . . 0.0 111.25 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.4 p -177.9 131.87 0.15 Allowed 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.858 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 21.01 100.87 0.01 OUTLIER Glycine 0 C--O 1.242 0.594 0 O-C-N 124.758 1.286 . . . . 0.0 115.655 164.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 44.8 tttm 126.83 -64.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.43 1.492 . . . . 0.0 111.5 164.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 471' ' ' LYS . 83.5 m-85 -108.81 101.16 42.83 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -174.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.69 174.16 9.86 Favored 'Trans proline' 0 N--CA 1.466 -0.091 0 C-N-CA 122.572 2.181 . . . . 0.0 111.352 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . 0.477 HD22 ' HA3' ' A' ' 466' ' ' GLY . 13.7 m120 -83.58 97.32 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.596 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 79.9 mt -105.21 -24.38 12.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.14 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.7 mtpm? 65.25 -103.88 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.997 0.811 . . . . 0.0 110.149 -175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 75.9 mttt 62.28 169.72 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.174 0.59 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.9 Cg_endo -58.89 100.05 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.501 2.134 . . . . 0.0 112.067 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 448' ' ' ARG . 16.7 p -92.64 135.96 33.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.036 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.99 141.75 14.2 Favored 'Isoleucine or valine' 1 C--O 1.132 -5.103 0 C-N-CA 116.647 -2.021 . . . . 0.0 108.406 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -91.82 110.92 22.27 Favored 'General case' 0 N--CA 1.387 -3.617 0 O-C-N 128.789 3.805 . . . . 0.0 111.246 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -133.15 131.88 40.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.979 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.633 ' HB2' HG23 ' A' ' 446' ' ' THR . 28.0 ttp180 -123.38 -88.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.447 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -76.44 107.45 2.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.814 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.608 175.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 483' ' ' ARG . 17.8 p . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -97.97 146.88 25.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.21 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 461' ' ' LEU . 89.0 mtt180 -72.35 142.23 48.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.898 -168.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.793 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 8.6 m170 -121.31 158.15 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.397 169.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 453' ' ' GLU . 55.0 mt -100.52 136.92 29.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 478' ' ' PRO . 33.9 mtp180 -62.04 101.25 0.2 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.027 0.441 . . . . 0.0 110.774 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.53 6.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.904 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 450' ' ' ILE . 5.1 mm-40 -100.97 159.22 15.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.836 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -82.79 -45.99 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.538 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 49.1 t -174.28 122.53 0.38 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 31.4 Cg_exo -62.4 -31.01 81.16 Favored 'Trans proline' 0 CA--C 1.525 0.06 0 C-N-CA 122.587 2.191 . . . . 0.0 113.175 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.475 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 66.6 mt -56.03 147.22 45.81 Favored Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 123.297 0.373 . . . . 0.0 111.203 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.73 16.76 10.87 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.906 -1.289 . . . . 0.0 114.081 4.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.475 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 48.0 m-70 -88.65 141.74 28.27 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -106.14 146.52 30.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 65.3 mt -102.58 127.73 49.55 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.99 0.181 . . . . 0.0 110.995 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -58.69 -56.81 17.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.625 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 45.9 p -178.97 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.046 0.538 . . . . 0.0 109.747 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.03 12.25 9.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.898 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.7 56.52 3.83 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.651 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -156.6 168.74 33.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.213 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 31.7 p -137.71 124.44 21.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' A' ' 468' ' ' ARG . 4.3 mpt_? -55.62 -30.95 61.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.695 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 29.5 p -74.9 70.77 1.99 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.106 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.5 70.78 0.27 Allowed Glycine 0 N--CA 1.462 0.408 0 N-CA-C 115.199 0.84 . . . . 0.0 115.199 163.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.834 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 21.3 tptm -162.02 -72.97 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.073 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.588 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 46.8 m-85 -104.73 133.37 20.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.464 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.66 -177.37 2.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.842 2.362 . . . . 0.0 111.997 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -78.98 80.04 5.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.8 -15.2 59.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.742 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 58.36 68.82 0.79 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.975 0.416 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -132.4 143.33 48.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.663 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.409 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 30.9 Cg_exo -59.2 126.0 19.67 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.007 2.472 . . . . 0.0 111.091 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 20.3 p -79.5 134.75 36.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.994 0.426 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.793 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 46.2 t -84.82 126.07 40.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.248 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.507 ' HB3' ' OG1' ' A' ' 446' ' ' THR . 88.6 m95 -89.7 105.82 18.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.829 0.347 . . . . 0.0 111.558 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 482' ' ' ARG . 9.0 mmt180 -136.04 141.51 44.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.897 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.756 ' HB2' HG22 ' A' ' 446' ' ' THR . 47.0 ttt180 -139.23 134.02 32.13 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 81.58 138.84 2.63 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.849 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.659 178.716 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 483' ' ' ARG . 43.1 p . . . . . 0 C--O 1.238 0.449 0 CA-C-O 120.675 0.274 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.9 138.6 50.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.983 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.45 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 3.7 mtm180 -83.12 144.49 29.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.652 -172.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -112.7 121.69 45.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.05 117.7 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -51.8 105.49 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.425 0.631 . . . . 0.0 111.967 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 120.4 -23.78 7.91 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.46 152.35 23.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -65.52 -69.65 0.28 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 43.7 t -173.37 121.88 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -17.34 50.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.275 . . . . 0.0 113.529 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.447 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 67.5 mt -54.54 143.16 49.21 Favored Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.089 0.243 . . . . 0.0 111.133 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.06 18.37 14.61 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.643 -1.399 . . . . 0.0 114.426 7.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.447 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 27.8 m-70 -97.76 165.72 11.82 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.67 141.36 28.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -172.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -80.65 -174.8 4.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 13.1 p -58.72 -28.42 65.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.73 8.4 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.146 -0.346 . . . . 0.0 111.627 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.62 20.12 64.57 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.164 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.09 156.36 15.72 Favored Glycine 1 C--O 1.315 5.187 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.964 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 6.2 p -110.95 149.06 31.2 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 120.552 -1.558 . . . . 0.0 109.819 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.467 ' O ' ' SG ' ' A' ' 469' ' ' CYS . 90.2 mtt180 -58.85 156.74 10.82 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 468' ' ' ARG . 0.8 OUTLIER 87.49 -18.75 0.27 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.93 1.292 . . . . 0.0 111.294 -174.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.78 72.9 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 8.9 tmtm? -124.29 -43.1 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.52 123.86 33.15 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.01 164.52 31.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.595 2.196 . . . . 0.0 111.897 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.37 91.07 3.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.901 0.382 . . . . 0.0 110.1 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.78 -6.52 26.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.661 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? 46.77 37.25 4.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.462 1.105 . . . . 0.0 112.589 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 35.1 mtpt -84.56 162.17 51.54 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 50.1 Cg_exo -51.95 122.81 11.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.47 2.78 . . . . 0.0 112.103 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.61 143.49 48.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.855 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.07 158.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.45 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 75.4 m95 -101.95 113.85 27.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 0.0 111.139 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 36.9 mmt180 -111.97 128.27 56.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.55 ' HB3' ' CG2' ' A' ' 446' ' ' THR . 10.0 ptm180 -140.21 5.07 2.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.923 -177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -90.11 -5.98 69.74 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.422 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.81 -179.397 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 483' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . 0.423 ' HB2' ' NH1' ' A' ' 460' ' ' ARG . 36.0 p-80 -84.88 129.11 34.86 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.42 -171.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.653 ' NH1' ' HA ' ' A' ' 463' ' ' SER . 33.6 mtt85 -66.16 132.2 47.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.205 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.6 m170 -109.18 152.41 25.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.422 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 41.8 mt -91.74 146.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -68.76 80.34 0.29 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 0.0 110.718 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.12 49.81 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -162.55 136.28 6.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -70.32 -39.66 74.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.795 -178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 6.0 t 176.68 109.68 0.11 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 4.0 Cg_exo -75.37 10.6 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.293 2.662 . . . . 0.0 113.939 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.653 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 68.1 mt -73.97 161.75 77.11 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.9 Cg_endo -84.38 19.97 21.08 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 124.151 -1.187 . . . . 0.0 113.915 6.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -84.38 131.71 34.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.7 tpm_? -99.65 105.58 17.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.053 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 465' ' ' GLY . 7.6 mp -70.15 133.54 47.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.97 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.59 -163.66 1.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.653 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 8.2 p -60.63 -33.83 73.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.6 mt -92.17 -3.97 54.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.673 0.273 . . . . 0.0 111.641 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 461' ' ' LEU . . . 103.35 -16.49 52.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.319 -0.944 . . . . 0.0 113.187 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -73.62 152.76 46.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.609 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 14.2 p -111.24 25.06 12.12 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.088 -0.654 . . . . 0.0 111.129 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 74.44 -36.79 0.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 3.9 p -97.24 13.35 29.72 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 116.103 -2.239 . . . . 0.0 109.234 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 89.02 -28.88 6.27 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.852 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.543 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 7.4 tmtt? -47.29 -51.39 19.28 Favored 'General case' 0 N--CA 1.389 -3.501 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.543 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.3 m-85 -111.66 121.19 40.59 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 112.722 -2.035 . . . . 0.0 109.156 170.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.433 ' HG2' HD21 ' A' ' 475' ' ' LEU . 83.1 Cg_endo -86.09 167.28 9.48 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 112.302 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -75.16 95.19 3.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.281 0.563 . . . . 0.0 109.997 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.433 HD21 ' HG2' ' A' ' 473' ' ' PRO . 95.2 mt -84.99 -27.82 26.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.54 -175.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 476' ' ' LYS . 27.7 tptp 62.53 28.77 16.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.711 0.767 . . . . 0.0 110.736 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 43.4 mtmt -98.65 163.07 19.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.8 Cg_endo -57.57 118.33 5.19 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.573 2.182 . . . . 0.0 112.221 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 448' ' ' ARG . 11.8 p -97.99 146.38 25.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.966 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.4 t -92.32 134.91 28.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.967 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 448' ' ' ARG . 76.2 m95 -95.33 108.27 20.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.74 0.305 . . . . 0.0 110.994 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.29 134.87 54.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 110.633 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.485 ' HB2' HG23 ' A' ' 446' ' ' THR . 42.2 ttt-85 -130.29 102.99 6.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 98.73 154.78 28.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.832 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.301 178.43 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.2 p . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.861 0.363 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -132.4 146.12 51.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.973 0.416 . . . . 0.0 110.163 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.848 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 68.2 mtt180 -89.23 139.45 30.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.509 -176.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 25.9 m170 -98.62 133.6 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' A' ' 461' ' ' LEU . 12.5 tt -80.54 14.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.117 0.484 . . . . 0.0 111.66 -173.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 69.28 16.39 8.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.419 0.628 . . . . 0.0 110.688 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -146.55 -52.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.04 132.81 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.38 69.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.724 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 11.8 t -171.7 102.19 0.38 Allowed Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.4 38.04 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.815 3.01 . . . . 0.0 113.984 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 459' ' ' HIS . 59.8 mt -104.3 157.71 33.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.2 45.84 1.73 Allowed 'Cis proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.471 -1.054 . . . . 0.0 112.9 1.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 36.4 m-70 -94.38 -61.72 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.007 0.432 . . . . 0.0 109.923 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 81.78 126.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.028 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.848 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 55.5 mt -86.59 110.82 20.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.75 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -63.33 -62.95 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.521 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 7.6 p -152.89 -58.73 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.773 0.32 . . . . 0.0 111.403 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.44 19.02 0.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.42 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 74.89 36.16 48.07 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.694 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -119.74 176.54 16.17 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.269 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 22.1 p -142.23 126.37 17.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.697 0.249 . . . . 0.0 110.438 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -75.32 76.49 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.6 p 174.11 -2.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 95.57 123.5 4.17 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.761 -170.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 146.59 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.799 1.64 . . . . 0.0 109.414 164.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 465' ' ' GLY . 87.3 m-85 -101.9 123.37 44.02 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.353 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -90.24 -158.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.126 2.551 . . . . 0.0 111.23 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -86.76 83.77 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.127 0.489 . . . . 0.0 109.826 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.9 -39.39 12.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.371 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt 55.72 77.24 0.24 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.987 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.76 149.06 58.24 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.39 107.18 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.82 2.347 . . . . 0.0 111.824 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -105.12 140.93 37.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.235 0.541 . . . . 0.0 111.94 -172.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.8 t -93.31 131.98 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.515 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.58 110.82 20.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.016 0.436 . . . . 0.0 110.997 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -125.99 141.55 51.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.546 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 446' ' ' THR . 48.1 ttp180 -121.4 -55.51 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.433 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.3 130.06 10.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.916 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.803 175.744 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.874 HG22 ' HG2' ' A' ' 483' ' ' ARG . 10.1 p . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -112.88 176.71 4.9 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.93 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.942 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 49.3 mtt180 -117.86 143.32 46.4 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.49 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -110.05 138.14 46.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 11.2 tt -83.63 22.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.341 0.591 . . . . 0.0 111.055 -176.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 450' ' ' ILE . 8.8 ptm180 53.92 12.89 0.48 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.712 1.205 . . . . 0.0 112.889 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -149.45 31.44 1.14 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.55 152.04 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.47 -42.07 71.91 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 117.835 -1.546 . . . . 0.0 107.963 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 44.2 t -175.51 108.85 0.26 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 10.4 Cg_exo -73.79 29.9 0.32 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.549 2.832 . . . . 0.0 114.067 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.33 152.14 39.95 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.61 19.05 37.77 Favored 'Cis proline' 0 C--O 1.169 -2.93 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.956 2.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -65.67 -58.18 6.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 71.96 133.36 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.375 1.047 . . . . 0.0 111.27 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.9 mm? -86.18 130.74 34.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.222 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.66 47.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.672 0.272 . . . . 0.0 110.871 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 89.8 p 59.88 -1.88 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.971 1.308 . . . . 0.0 113.431 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.7 mt -107.29 4.93 27.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.21 67.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.446 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -125.1 177.38 16.92 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.413 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 29.9 p -125.79 121.77 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.48 -29.76 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 111.649 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.31 -9.14 57.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 96.12 124.87 4.64 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.147 -173.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.1 tmtp? 159.44 -48.01 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.83 1.652 . . . . 0.0 107.933 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.537 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 49.1 m-85 -123.26 128.43 25.28 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.703 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.75 157.57 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.329 2.019 . . . . 0.0 111.004 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.38 92.41 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 109.868 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.09 -6.34 45.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.274 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.4 mttm 64.3 28.65 13.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.861 0.362 . . . . 0.0 111.383 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 74.2 mmtt -89.5 140.99 28.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.4 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 477' ' ' LYS . 39.3 Cg_exo -61.77 115.19 2.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.063 2.509 . . . . 0.0 111.994 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 16.5 p -80.57 128.52 33.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.406 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.86 132.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.127 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -80.46 105.79 11.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.008 0.433 . . . . 0.0 111.807 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 19.0 mmt180 -126.02 139.15 53.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.469 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.874 ' HG2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -166.27 164.33 17.69 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.117 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 103.94 8.37 39.49 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.817 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -95.23 131.47 41.24 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.553 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.695 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 67.9 mtt180 -71.9 132.76 44.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.475 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.893 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.9 m170 -97.8 111.94 24.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.384 170.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.97 109.02 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -43.59 106.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.746 0.654 . . . . 0.0 111.687 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.45 -19.92 6.63 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.321 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -106.64 153.91 21.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.601 0.36 . . . . 0.0 110.169 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -81.15 -49.21 11.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.706 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 34.1 t -174.09 102.29 0.29 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.35 33.49 0.36 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.409 2.74 . . . . 0.0 114.22 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 33.2 mt -75.22 158.86 83.5 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 4.1 Cg_endo -86.77 33.66 5.57 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.255 -1.144 . . . . 0.0 113.206 3.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.432 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 87.8 m-70 -103.4 116.21 31.99 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.282 0.563 . . . . 0.0 110.205 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -95.96 121.4 37.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.132 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 2.5 mm? -82.54 135.62 35.05 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.902 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -77.18 -168.6 1.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.42 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.2 p -77.83 11.67 2.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.883 0.373 . . . . 0.0 111.665 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.425 HD22 ' HE2' ' A' ' 476' ' ' LYS . 84.8 mt -120.5 1.29 10.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.0 110.209 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 75.86 35.88 43.74 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.446 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -133.76 164.98 24.34 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -129.57 120.67 25.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.74 0.77 . . . . 0.0 110.882 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -46.88 -40.98 15.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 124.2 0.937 . . . . 0.0 110.806 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 26.0 p -69.04 74.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 32.45 75.89 0.04 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 124.151 0.907 . . . . 0.0 115.127 166.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.83 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 16.6 tppt? -167.92 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.994 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 82.1 m-85 -76.16 119.94 79.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 111.394 -172.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 97.9 Cg_endo -86.52 43.74 1.1 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.672 2.915 . . . . 0.0 113.11 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 63.08 94.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 111.311 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.0 mt -117.78 84.49 2.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . 0.425 ' HE2' HD22 ' A' ' 464' ' ' LEU . 6.8 mtpm? -62.07 95.01 0.06 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.45 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -144.08 155.66 58.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.274 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -50.48 124.35 13.07 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 111.58 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.507 HG21 ' HD3' ' A' ' 448' ' ' ARG . 0.9 OUTLIER -132.21 159.94 37.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.838 -171.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.893 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 49.0 t -96.09 141.28 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.846 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -100.51 106.8 18.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.111 0.482 . . . . 0.0 111.803 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -132.23 131.43 42.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.47 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 484' ' ' GLY . 2.7 ptp85 -96.42 -52.66 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.243 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 483' ' ' ARG . . . -133.22 155.18 21.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.449 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.032 -179.729 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.234 0.289 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -91.68 138.12 31.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.771 -168.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 39.7 mtt180 -71.24 130.08 40.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.686 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m170 -98.31 105.73 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.935 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.1 115.47 5.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -47.51 107.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.4 14.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.594 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.11 -5.15 58.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 110.967 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 62.6 -98.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.426 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 456' ' ' PRO . 35.7 t -127.04 97.08 32.93 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 455' ' ' CYS . 13.3 Cg_endo -57.48 -1.95 0.57 Allowed 'Trans proline' 0 N--CA 1.477 0.526 0 C-N-CA 124.255 3.304 . . . . 0.0 114.869 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.57 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 54.1 mt -61.62 152.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.317 0 O-C-N 122.159 -0.338 . . . . 0.0 110.09 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.47 25.94 4.83 Favored 'Cis proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.063 -1.224 . . . . 0.0 114.494 6.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.57 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 71.8 m-70 -96.56 134.81 39.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 45.3 ttp180 -118.86 124.93 48.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.106 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 1.8 mm? -91.38 138.36 31.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.933 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.415 ' O ' ' HD2' ' A' ' 448' ' ' ARG . 10.1 p30 -86.97 -171.78 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.8 p -68.14 -7.56 30.93 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.8 mt -95.2 -4.82 45.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 110.492 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.42 45.24 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.868 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -123.39 152.05 17.0 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.16 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 28.0 p -101.52 116.12 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.37 0.585 . . . . 0.0 110.582 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -49.04 -33.57 11.65 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.823 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.91 -13.01 61.26 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 98.13 124.66 5.04 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.837 -173.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 1.2 tmtp? 156.03 -55.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.256 1.422 . . . . 0.0 109.457 166.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 97.9 m-85 -97.92 125.62 43.53 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.98 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.11 167.39 27.47 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.824 2.349 . . . . 0.0 111.865 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.49 97.31 3.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -98.41 -20.13 17.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 39.1 mttm 67.95 -1.92 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.814 0.446 . . . . 0.0 112.053 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.69 152.17 96.53 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -170.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.96 125.43 18.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.494 2.796 . . . . 0.0 112.173 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.41 HG21 ' HB3' ' A' ' 448' ' ' ARG . 5.2 p -123.23 157.03 33.99 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 36.6 t -89.9 141.82 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.75 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.476 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 36.0 m95 -94.45 105.37 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.557 ' HG3' ' CE1' ' A' ' 449' ' ' HIS . 39.7 mmt180 -123.39 118.16 26.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -87.82 -48.86 7.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -140.17 171.94 23.69 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.023 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.177 -2.713 0 CA-C-O 122.309 1.052 . . . . 0.0 109.918 -179.657 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 483' ' ' ARG . 33.7 m . . . . . 0 C--O 1.231 0.097 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -92.38 144.15 25.67 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.08 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.51 ' HB3' ' CG2' ' A' ' 479' ' ' THR . 68.2 mtt180 -76.77 125.49 29.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.312 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.76 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 6.2 m170 -91.71 117.88 30.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.867 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 59.7 mt -72.78 115.94 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.695 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 13.3 ptm180 -57.33 101.86 0.08 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.609 0.718 . . . . 0.0 110.185 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.68 4.62 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.155 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.95 136.11 54.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.03 -60.54 3.62 Favored 'General case' 1 N--CA 1.349 -5.483 0 O-C-N 119.242 -2.162 . . . . 0.0 111.125 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.441 ' SG ' ' HG ' ' A' ' 457' ' ' LEU . 34.4 t -155.8 107.17 2.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.27 29.56 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.873 2.382 . . . . 0.0 113.877 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.679 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 42.0 mt -83.46 162.85 52.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.1 Cg_endo -84.94 18.38 27.02 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 124.32 -1.117 . . . . 0.0 113.346 3.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 76.3 m-70 -77.81 132.47 38.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.353 0.596 . . . . 0.0 110.267 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -94.42 108.58 20.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.098 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.8 mp -76.23 110.83 11.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.477 HD22 ' C ' ' A' ' 462' ' ' ASN . 0.2 OUTLIER -69.31 -178.55 1.37 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.075 175.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.3 p -68.92 -1.45 7.36 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.455 ' CB ' HD22 ' A' ' 474' ' ' ASN . 5.5 mp -98.23 5.8 48.05 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.205 -0.31 . . . . 0.0 111.034 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.81 49.57 22.7 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.853 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . 177.94 -165.51 35.1 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 19.0 p -145.69 128.36 16.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.16 0.48 . . . . 0.0 110.192 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.02 -22.75 61.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.163 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.07 -24.32 64.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.79 84.3 1.79 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.122 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -168.42 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.473 ' HE2' ' HB2' ' A' ' 459' ' ' HIS . 73.8 m-85 -124.74 117.37 26.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.42 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 2.9 Cg_exo -73.13 166.32 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.613 2.209 . . . . 0.0 111.883 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . 0.455 HD22 ' CB ' ' A' ' 464' ' ' LEU . 14.7 m120 -77.23 81.86 3.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.2 mt -106.87 -1.57 22.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.989 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 65.19 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.622 0.576 . . . . 0.0 110.485 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 63.04 152.36 0.11 Allowed Pre-proline 0 N--CA 1.466 0.332 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.695 ' HG2' ' HD3' ' A' ' 451' ' ' ARG . 28.0 Cg_endo -65.48 105.24 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.299 1.999 . . . . 0.0 111.208 171.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -113.79 144.27 43.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.43 -174.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 9.0 t -94.52 140.08 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.459 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -96.45 109.44 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.888 0.375 . . . . 0.0 111.888 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 482' ' ' ARG . 31.0 mmt180 -132.3 127.39 35.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 446' ' ' THR . 11.2 ptm180 -131.66 -1.32 3.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.575 0.226 . . . . 0.0 110.906 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -59.69 -26.94 63.23 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.492 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.343 175.905 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 483' ' ' ARG . 7.8 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -97.94 143.99 27.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.362 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -73.99 137.64 43.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.523 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 455' ' ' CYS . 1.5 m-70 -110.99 148.46 32.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.692 171.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 477' ' ' LYS . 22.3 mt -77.17 1.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.808 0.813 . . . . 0.0 109.597 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 57.71 78.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.319 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 154.46 -7.37 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.159 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -178.75 3.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.927 0.394 . . . . 0.0 110.466 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . 0.431 ' O ' ' HE1' ' A' ' 449' ' ' HIS . . . -83.49 -48.32 10.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 449' ' ' HIS . 19.1 t -178.74 119.81 0.24 Allowed Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.02 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.31 -2.0 10.53 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.195 2.597 . . . . 0.0 113.76 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 79.7 mt -68.25 159.03 82.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 91.4 Cg_endo -83.36 18.23 21.95 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.786 -1.339 . . . . 0.0 114.17 5.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.94 133.8 36.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 36.0 mtt180 -98.72 112.28 24.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.505 -171.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.7 mp -85.75 117.89 24.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.793 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 462' ' ' ASN . 0.2 OUTLIER -81.52 -176.54 6.09 Favored 'General case' 1 C--O 1.314 4.485 0 CA-C-O 123.508 1.623 . . . . 0.0 110.635 176.344 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 8.8 p -53.27 -30.21 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.353 -1.467 . . . . 0.0 112.891 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.35 7.3 29.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.02 54.3 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.262 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -162.42 168.85 37.53 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.5 p -117.13 113.91 22.95 Favored 'General case' 1 N--CA 1.366 -4.631 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.074 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -47.23 -38.38 12.09 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.815 0.697 . . . . 0.0 111.697 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.5 p -59.61 -22.54 61.97 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 111.46 125.03 4.6 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.872 -171.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 29.4 tptp 149.11 -75.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.601 1.56 . . . . 0.0 109.084 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -87.15 123.49 69.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.93 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.21 175.09 11.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.779 2.319 . . . . 0.0 111.939 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -74.77 85.68 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 0.0 110.438 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.17 -40.0 39.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.932 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 61.92 24.58 14.65 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.339 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 10.6 ptpt -81.45 165.92 41.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 11.4 Cg_endo -55.14 101.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.536 2.157 . . . . 0.0 112.046 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 449' ' ' HIS . 0.0 OUTLIER -102.54 139.32 38.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.418 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.26 153.37 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.0 111.559 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -92.51 104.54 16.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.512 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -127.65 125.28 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.017 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' A' ' 484' ' ' GLY . 4.3 ptp180 -110.05 -47.09 3.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.789 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 483' ' ' ARG . . . -91.14 139.17 14.67 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.846 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.102 174.604 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -99.07 145.04 27.54 Favored 'General case' 0 C--O 1.273 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.259 -174.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 22.7 mtp85 -87.18 157.85 19.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.645 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.654 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.0 OUTLIER -132.19 127.77 36.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.819 176.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.62 123.19 31.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -51.9 104.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.47 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 124.88 -17.02 7.25 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.5 140.3 29.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -76.02 -44.13 40.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.223 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 10.4 t -178.99 116.1 0.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.14 -10.8 28.58 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.023 2.482 . . . . 0.0 113.581 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.453 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 91.8 mt -59.39 153.16 50.45 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.695 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.36 19.15 13.98 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.851 5.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 96.8 m-70 -89.38 148.79 23.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.166 0.507 . . . . 0.0 110.112 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -121.29 121.31 37.42 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.021 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 8.5 mp -73.19 108.89 6.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 467' ' ' CYS . 1.1 p-10 -75.01 68.73 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.464 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.623 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 92.0 p 64.15 -39.62 0.22 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.296 1.438 . . . . 0.0 114.103 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 476' ' ' LYS . 39.7 mt -88.67 16.4 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.96 15.74 66.72 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.683 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -157.79 179.13 33.74 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.574 ' HA ' ' OD1' ' A' ' 462' ' ' ASN . 17.6 p -129.16 117.48 20.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.4 0.6 . . . . 0.0 110.026 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -68.84 97.19 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.208 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 470' ' ' GLY . 12.5 p -168.3 -41.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.886 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 469' ' ' CYS . . . 136.8 47.35 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.844 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 472' ' ' TYR . 16.9 tptm -140.13 -55.43 0.54 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.804 0.335 . . . . 0.0 110.55 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . 0.441 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 75.2 m-85 -132.08 125.15 19.91 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.411 ' O ' ' HA3' ' A' ' 466' ' ' GLY . 67.4 Cg_endo -75.4 171.93 17.31 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.513 2.142 . . . . 0.0 111.909 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.82 87.41 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.353 . . . . 0.0 110.289 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.423 ' HB3' ' HG3' ' A' ' 477' ' ' LYS . 91.7 mt -75.48 -26.61 58.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.865 -175.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . 0.452 ' HE2' HD22 ' A' ' 464' ' ' LEU . 33.1 mmtp 66.11 26.21 10.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.08 0.552 . . . . 0.0 111.398 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 44.1 mtpt -100.62 158.63 31.53 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.306 -0.246 . . . . 0.0 110.982 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 10.1 Cg_endo -52.96 133.83 53.11 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.556 2.837 . . . . 0.0 112.558 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 0.1 OUTLIER -127.75 136.68 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.349 -176.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 10.5 t -82.29 152.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.61 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.586 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 55.1 m95 -109.12 107.36 17.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -124.54 125.19 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -62.36 -84.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.78 -63.05 1.11 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.49 168.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.243 0.544 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -100.5 133.7 44.54 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-O 122.448 1.118 . . . . 0.0 111.351 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 448' ' ' ARG . 51.7 mtt-85 -68.54 133.54 48.7 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.578 -2.555 . . . . 0.0 111.395 -172.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 449' ' ' HIS . . . . . 0.423 ' CB ' HG23 ' A' ' 480' ' ' VAL . 2.6 m170 -101.57 119.45 38.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.912 171.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 477' ' ' LYS . 76.4 mt -66.85 125.66 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 478' ' ' PRO . 20.8 mtp180 -58.69 105.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.409 0.623 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 129.53 -23.27 4.83 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.168 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -97.97 138.35 35.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.95 -38.44 72.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.504 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 36.9 t 178.95 114.07 0.19 Allowed Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 456' ' ' PRO . . . . . 0.445 ' HG3' HD22 ' A' ' 461' ' ' LEU . 56.7 Cg_endo -71.48 2.81 4.13 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.17 2.58 . . . . 0.0 113.922 -175.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 81.4 mt -69.22 156.99 90.5 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 76.5 Cg_endo -82.56 16.2 24.41 Favored 'Cis proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.51 -1.454 . . . . 0.0 113.771 5.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 45.6 m-70 -80.25 144.93 32.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 109.942 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.4 mmm180 -100.21 110.14 22.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.248 -174.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.2 mp -86.21 117.82 25.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.093 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.87 -167.31 1.22 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.377 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . 0.408 ' HA ' ' HE ' ' A' ' 448' ' ' ARG . 3.2 p -65.1 -16.2 63.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.84 -0.08 57.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.629 0.252 . . . . 0.0 110.96 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.97 61.2 3.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.731 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -174.22 158.03 26.29 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 20.9 p -101.4 118.41 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.497 0.648 . . . . 0.0 109.91 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.55 -35.11 62.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.705 -175.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -22.27 60.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 108.11 132.34 6.73 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.062 -168.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.672 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 28.2 tptp 150.17 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 125.852 1.661 . . . . 0.0 108.101 171.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -132.42 117.69 15.64 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.877 176.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.7 160.43 49.75 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 111.601 177.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -65.88 95.55 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.163 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.488 HD13 ' HE3' ' A' ' 477' ' ' LYS . 95.1 mt -85.48 -28.71 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.627 -175.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 476' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 476' ' ' LYS . 20.7 ttmm 57.8 28.03 15.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.772 0.796 . . . . 0.0 110.509 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.583 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 16.0 ptpt -96.88 164.22 18.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 86.1 Cg_exo -38.88 115.51 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.742 2.961 . . . . 0.0 112.737 176.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 136.67 54.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.408 -176.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 449' ' ' HIS . 0.1 OUTLIER -93.81 136.41 25.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -86.89 109.73 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -177.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -119.02 136.47 54.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.602 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 483' ' ' ARG . . . . . 0.414 ' HB3' ' H ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -95.66 -147.41 0.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.534 179.782 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 483' ' ' ARG . . . -69.68 136.41 27.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.819 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.215 -177.456 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -93.31 175.86 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.848 2.365 . . . . 0.0 112.566 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 483' ' ' ARG . 20.2 p -81.79 134.46 35.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -95.76 142.74 27.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.589 ' CD ' ' HB ' ' A' ' 479' ' ' THR . 3.9 ttt180 -100.7 146.27 27.41 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.265 0.555 . . . . 0.0 111.632 -172.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -103.56 137.21 41.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.734 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 21.2 pt -87.54 13.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 109.802 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 451' ' ' ARG . 39.1 ttt85 69.4 88.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.531 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.08 60.22 1.14 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.259 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . 0.614 ' HG3' ' HG3' ' A' ' 456' ' ' PRO . 0.0 OUTLIER -136.91 1.74 2.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.807 0.337 . . . . 0.0 111.103 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 66.34 30.45 8.91 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.335 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 31.6 t 72.73 113.92 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.857 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.614 ' HG3' ' HG3' ' A' ' 453' ' ' GLU . 2.2 Cg_endo -82.51 21.41 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 113.683 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 53.8 mt -73.55 159.8 83.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.649 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 63.8 Cg_endo -88.14 21.5 26.63 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 113.455 2.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -83.02 143.43 30.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 110.067 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 117.81 32.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.912 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.3 mp -90.1 145.35 25.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.208 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -95.73 -167.25 1.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.281 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.518 ' HA ' HH11 ' A' ' 448' ' ' ARG . 3.3 p -68.92 -15.08 63.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.2 -3.77 57.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.264 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.74 4.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.58 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -166.96 166.49 39.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.814 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 25.6 p -114.1 124.07 51.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.195 0.497 . . . . 0.0 110.327 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 468' ' ' ARG . 6.4 mtp180 -52.09 -35.72 48.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.819 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.1 p -69.35 105.63 2.63 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -22.17 104.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.195 0 O-C-N 124.924 1.39 . . . . 0.0 115.355 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 56.5 tptt -172.85 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -0.807 . . . . 0.0 110.918 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -129.77 122.64 20.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.65 -167.83 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.125 2.55 . . . . 0.0 113.074 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 474' ' ' ASN . 0.9 OUTLIER -83.75 90.43 7.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.012 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.87 -30.05 18.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.52 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 21.1 tptm 53.2 77.99 0.16 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.756 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -123.72 165.01 25.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.816 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.46 86.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.242 1.961 . . . . 0.0 110.764 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.589 ' HB ' ' CD ' ' A' ' 448' ' ' ARG . 0.3 OUTLIER -87.98 132.3 34.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.654 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.48 132.52 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.048 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.482 ' CE3' ' HG3' ' A' ' 448' ' ' ARG . 54.0 m95 -76.4 109.96 10.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -118.21 125.74 50.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.394 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.625 ' HB2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -153.15 13.47 0.5 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.252 0.548 . . . . 0.0 110.004 173.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -79.23 -1.57 85.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.212 177.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.37 -29.54 85.81 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.163 2.575 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 483' ' ' ARG . 90.8 m -153.78 134.95 14.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -111.33 141.56 44.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 51.7 mtt180 -73.97 153.13 39.88 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 111.102 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 482' ' ' ARG . 1.7 m-70 -124.8 119.61 29.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.092 170.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.49 134.9 29.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.18 99.89 0.15 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.191 0.52 . . . . 0.0 110.607 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 128.97 -9.7 6.31 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.36 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.25 139.17 34.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 110.563 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -79.12 -40.81 30.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.742 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 25.3 t 173.35 117.59 0.08 OUTLIER Pre-proline 0 N--CA 1.462 0.165 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' A' ' 459' ' ' HIS . 68.8 Cg_endo -72.83 -22.37 20.23 Favored 'Trans proline' 0 C--O 1.223 -0.23 0 C-N-CA 122.499 2.133 . . . . 0.0 114.748 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.0 mt -55.47 145.25 49.67 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.42 11.32 26.73 Favored 'Cis proline' 0 C--N 1.356 0.956 0 C-N-CA 123.819 -1.325 . . . . 0.0 113.718 4.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 2.6 m-70 -84.05 152.81 24.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -135.94 153.78 51.31 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.861 -0.524 . . . . 0.0 111.116 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.652 ' HB3' ' HA2' ' A' ' 465' ' ' GLY . 1.4 mm? -100.73 113.58 26.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -59.59 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.267 0.354 . . . . 0.0 110.715 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 5.9 p -148.28 -30.58 0.29 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.044 0.45 . . . . 0.0 109.794 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.13 -1.65 55.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.716 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 461' ' ' LEU . . . 79.81 47.8 6.98 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.139 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -141.53 150.86 22.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.538 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -103.95 128.91 51.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 117.191 0.495 . . . . 0.0 109.703 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -44.62 -36.07 2.89 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.838 0.712 . . . . 0.0 110.616 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.04 82.03 7.87 Favored 'General case' 0 C--O 1.303 3.882 0 CA-C-O 117.932 -1.032 . . . . 0.0 108.458 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 29.48 69.99 0.07 OUTLIER Glycine 0 C--N 1.304 -1.229 0 C-N-CA 128.494 2.949 . . . . 0.0 117.584 158.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 87.8 tttt -150.38 -80.45 0.12 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.579 0.689 . . . . 0.0 110.886 164.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.656 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 92.2 m-85 -68.41 124.13 89.18 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.42 170.31 10.59 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.61 2.207 . . . . 0.0 112.262 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.12 87.63 3.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.096 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 477' ' ' LYS . 95.3 mt -100.39 -29.15 12.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.9 tttm 59.09 49.17 9.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 475' ' ' LEU . 72.9 mmtt -90.85 157.98 42.77 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.81 109.62 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.243 2.629 . . . . 0.0 111.816 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.39 137.8 41.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.11 159.27 5.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.492 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 88.4 m95 -97.18 102.99 14.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.281 0.562 . . . . 0.0 111.352 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.48 ' HB2' ' CD2' ' A' ' 449' ' ' HIS . 33.6 mmt180 -112.38 120.24 40.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 122.209 1.004 . . . . 0.0 110.406 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.719 ' HB2' HG23 ' A' ' 446' ' ' THR . 10.5 tpt180 -145.17 -13.62 0.53 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.362 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -87.55 59.61 4.34 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.131 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.057 175.549 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.019 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.56 178.96 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.619 2.213 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 483' ' ' ARG . 28.4 p -64.68 146.74 54.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 173.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -92.13 144.16 25.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.173 -171.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.86 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 57.4 mtt-85 -85.16 140.29 31.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.18 -172.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.4 m170 -107.41 122.35 46.44 Favored 'General case' 1 C--N 1.212 -5.371 0 C-N-CA 127.15 2.18 . . . . 0.0 111.576 173.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 450' ' ' ILE . 3.0 mp -82.76 122.13 36.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 451' ' ' ARG . 10.8 mmm180 -49.45 100.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.577 0.548 . . . . 0.0 111.126 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 137.02 -30.5 2.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.237 -0.983 . . . . 0.0 113.241 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -113.14 156.28 23.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.229 0.514 . . . . 0.0 110.669 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.82 -78.13 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.643 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 23.0 t -145.36 120.77 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.0 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.472 ' CB ' HD21 ' A' ' 461' ' ' LEU . 28.6 Cg_exo -65.66 -8.88 20.69 Favored 'Trans proline' 0 N--CA 1.477 0.503 0 C-N-CA 123.681 2.921 . . . . 0.0 114.411 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.73 150.28 87.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.478 0.18 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 20.55 23.32 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.811 -1.329 . . . . 0.0 113.818 4.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -84.44 157.4 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.8 mpt_? -127.39 134.64 49.91 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.097 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -100.06 106.87 18.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 463' ' ' SER . 0.4 OUTLIER -67.25 -23.06 65.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.814 -175.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.59 ' N ' HD22 ' A' ' 462' ' ' ASN . 17.5 p -174.87 -76.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 476' ' ' LYS . 79.1 mt -70.46 4.53 2.29 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 94.74 16.06 43.66 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.486 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 472' ' ' TYR . . . -106.03 147.97 16.36 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.884 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 29.5 p -111.55 -10.9 14.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 71.93 -53.26 0.69 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.893 0.745 . . . . 0.0 111.915 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.7 -18.65 8.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 133.22 127.63 2.8 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.075 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 472' ' ' TYR . 73.2 tttt 106.94 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 126.514 1.926 . . . . 0.0 109.777 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.552 ' HB3' ' HA2' ' A' ' 466' ' ' GLY . 78.3 m-85 -92.13 117.25 67.6 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.648 ' HD2' ' HG ' ' A' ' 475' ' ' LEU . 2.2 Cg_endo -83.03 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.984 2.456 . . . . 0.0 111.366 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 473' ' ' PRO . 11.3 m120 -125.33 -69.6 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.648 ' HG ' ' HD2' ' A' ' 473' ' ' PRO . 97.9 mt 71.14 -51.36 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.647 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . 0.53 ' HG3' HD22 ' A' ' 464' ' ' LEU . 88.2 tttt 68.73 61.63 0.34 Allowed 'General case' 0 N--CA 1.532 3.652 0 O-C-N 126.16 2.162 . . . . 0.0 108.096 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 475' ' ' LEU . 7.6 mptt -102.02 152.7 38.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.828 175.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 110.99 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.161 1.907 . . . . 0.0 111.288 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.86 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 19.4 p -94.28 132.1 39.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.529 . . . . 0.0 111.679 -174.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 2.7 t -96.74 133.44 38.17 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.238 0 CA-C-O 123.739 1.733 . . . . 0.0 110.558 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 33.2 m95 -78.62 109.96 13.31 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.811 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.446 ' HD2' ' C ' ' A' ' 481' ' ' TRP . 1.1 mpt_? -113.4 118.34 34.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.318 0.58 . . . . 0.0 111.587 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.422 ' HB3' HG22 ' A' ' 446' ' ' THR . 36.1 ptt180 -130.59 2.97 4.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.76 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -72.67 -16.81 77.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.123 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.247 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.14 -169.51 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.402 2.068 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 483' ' ' ARG . 12.8 p -66.26 127.69 33.21 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -83.12 142.83 30.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.54 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.615 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 44.7 mtt180 -75.92 128.57 35.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.378 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.567 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.2 m170 -104.14 119.51 39.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.433 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.605 HG13 HD21 ' A' ' 461' ' ' LEU . 47.5 mt -69.52 125.42 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.04 95.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.204 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 138.85 -18.18 3.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.766 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.89 156.08 40.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 0.0 109.854 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -68.68 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 13.0 t -137.73 115.39 9.62 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 36.6 Cg_exo -61.62 -25.45 79.19 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.286 2.657 . . . . 0.0 113.754 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.432 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 92.9 mt -51.14 144.79 14.11 Favored Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 123.07 0.231 . . . . 0.0 111.069 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.89 15.71 12.83 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.945 -1.273 . . . . 0.0 114.099 5.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 91.3 m-70 -83.26 132.05 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 109.867 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -107.36 125.3 51.02 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 7.8 mp -85.02 137.23 33.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.432 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.83 -174.42 4.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.835 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 11.6 p -74.4 0.14 15.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 0.0 111.406 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 474' ' ' ASN . 91.8 mt -105.13 4.05 30.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.734 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.24 26.42 61.77 Favored Glycine 2 C--O 1.142 -5.603 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -133.01 -178.78 15.77 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 110.267 -2.967 . . . . 0.0 111.765 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 13.4 p -138.18 141.44 40.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 117.514 0.657 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 469' ' ' CYS . 71.8 ttt180 -55.75 147.85 17.86 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 1.6 p 108.31 -22.28 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.723 1.609 . . . . 0.0 109.542 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 85.9 36.81 9.82 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.115 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.632 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 1.1 tmtp? -95.11 -61.28 1.51 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.4 m-85 -99.71 118.79 61.34 Favored Pre-proline 0 C--O 1.167 -3.255 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.422 ' O ' HD12 ' A' ' 475' ' ' LEU . 59.6 Cg_endo -75.57 169.02 23.22 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.091 1.86 . . . . 0.0 111.04 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . 10.6 m120 -86.07 76.34 9.8 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.305 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 473' ' ' PRO . 4.0 mp -69.05 -25.36 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.676 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 65.7 28.54 11.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.78 150.99 46.93 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.23 130.44 34.15 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.432 2.088 . . . . 0.0 111.565 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.02 157.14 20.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.095 0.474 . . . . 0.0 111.739 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 28.1 t -84.93 140.28 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.22 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.615 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 8.3 m95 -92.51 106.86 18.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 0.0 112.012 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -135.56 118.17 15.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.67 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.4 ttt180 -100.3 -64.54 1.03 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.866 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -102.28 131.41 10.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.887 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.343 178.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -91.51 -173.25 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.77 2.313 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.93 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.1 p -70.94 129.33 38.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -97.3 148.76 22.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.182 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 448' ' ' ARG . 66.9 mtt-85 -83.67 142.55 30.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.624 0.726 . . . . 0.0 112.406 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.481 ' HB3' ' HA2' ' A' ' 452' ' ' GLY . 4.8 m-70 -118.28 116.98 27.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.968 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 475' ' ' LEU . 2.8 mp -59.8 105.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 451' ' ' ARG . 1.5 tpm_? 56.42 17.73 3.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.664 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 449' ' ' HIS . . . 78.12 43.92 12.68 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.566 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 -163.76 0.47 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -52.87 -69.32 0.12 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-O 123.053 1.406 . . . . 0.0 112.172 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 35.0 t 170.32 106.58 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 120.643 -1.285 . . . . 0.0 109.239 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.657 ' HB2' HD21 ' A' ' 461' ' ' LEU . 52.8 Cg_exo -59.2 -18.6 45.35 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.377 2.718 . . . . 0.0 114.406 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 63.7 mt -65.63 154.11 89.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.586 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 5.4 Cg_exo -77.52 7.97 19.12 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 124.227 -1.156 . . . . 0.0 114.141 7.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.502 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 92.1 m-70 -78.94 107.16 11.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 0.0 110.385 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -86.67 127.29 34.94 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.821 -170.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 456' ' ' PRO . 1.1 mm? -87.03 150.87 23.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.083 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.3 -52.76 4.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.389 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.8 p -156.07 -66.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.09 33.41 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.399 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.53 2.96 82.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.11 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -98.13 157.56 20.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.325 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 30.7 p -121.42 110.46 16.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.01 -19.56 19.2 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.57 -6.7 27.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 91.07 123.61 2.86 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.3 tmtm? 156.13 -75.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.43 1.492 . . . . 0.0 108.629 166.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -84.57 132.28 47.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.902 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.6 -164.64 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.18 2.587 . . . . 0.0 111.684 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.41 97.64 10.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 0.0 110.199 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 450' ' ' ILE . 4.6 mp -103.17 83.6 2.22 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -72.68 78.36 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.368 0.604 . . . . 0.0 109.88 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -149.54 138.66 12.65 Favored Pre-proline 0 C--O 1.212 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.456 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.67 102.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.873 3.049 . . . . 0.0 114.426 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.09 135.95 33.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.146 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.5 t -98.59 140.3 18.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.194 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -89.5 106.93 18.78 Favored 'General case' 1 C--N 1.232 -4.539 0 O-C-N 124.938 1.399 . . . . 0.0 113.428 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -118.67 116.84 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.046 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.93 ' HB2' HG22 ' A' ' 446' ' ' THR . 45.6 ttt-85 -108.87 97.88 7.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.069 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 93.36 157.57 33.46 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.157 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -84.29 -172.06 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.608 2.205 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 131.64 47.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -96.5 123.89 40.31 Favored 'General case' 1 N--CA 1.551 4.583 0 CA-C-O 124.454 2.073 . . . . 0.0 107.969 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.503 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 9.3 ptm180 -72.83 132.79 44.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.442 -2.163 . . . . 0.0 111.678 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 479' ' ' THR . 2.5 m-70 -90.87 154.78 19.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.519 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 475' ' ' LEU . 1.1 tp -90.52 -1.37 9.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.963 0.887 . . . . 0.0 108.974 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 73.38 92.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.392 -1.731 . . . . 0.0 111.772 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 101.4 42.79 2.29 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.206 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' A' ' 455' ' ' CYS . 0.0 OUTLIER -127.95 -164.81 1.41 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 455' ' ' CYS . . . -98.48 27.94 4.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.704 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.56 ' H ' ' HG2' ' A' ' 453' ' ' GLU . 46.4 t 71.75 118.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.856 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.703 ' HB3' HD21 ' A' ' 461' ' ' LEU . 54.5 Cg_exo -53.78 -31.7 62.76 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.589 2.859 . . . . 0.0 114.665 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.24 142.84 47.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.17 23.9 20.76 Favored 'Cis proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.58 -1.425 . . . . 0.0 114.302 5.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.3 151.15 19.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 109.62 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -123.03 128.65 50.46 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.44 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 456' ' ' PRO . 1.2 mm? -91.73 138.39 31.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.319 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.76 -177.87 5.1 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p -62.38 -15.2 47.32 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.7 3.36 52.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.486 0.184 . . . . 0.0 111.493 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 475' ' ' LEU . . . 87.29 9.86 72.19 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.25 171.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -109.28 171.55 15.37 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.803 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 12.2 p -126.85 148.24 49.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.684 0.742 . . . . 0.0 109.861 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -56.65 142.04 41.35 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 471' ' ' LYS . 0.4 OUTLIER 84.22 141.92 0.06 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -170.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -72.56 59.35 1.62 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.102 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 469' ' ' CYS . 8.7 tmtm? -110.05 -62.02 1.57 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -107.43 124.85 33.85 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-O 120.553 0.216 . . . . 0.0 110.95 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.2 177.55 8.5 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.733 2.288 . . . . 0.0 111.652 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.37 95.17 1.71 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 450' ' ' ILE . 78.3 mt -109.42 93.77 4.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -82.22 16.63 1.92 Allowed 'General case' 1 CA--C 1.632 4.103 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.587 ' HG3' ' HD2' ' A' ' 478' ' ' PRO . 36.5 ttmt -68.4 142.47 94.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.155 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 477' ' ' LYS . 2.7 Cg_exo -35.72 99.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.575 3.517 . . . . 0.0 113.244 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 448' ' ' ARG . 3.4 p -83.14 127.59 33.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -92.34 111.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.241 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.503 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 97.9 m95 -75.58 105.43 6.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.904 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -124.19 134.76 53.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -142.46 30.15 1.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.166 0.984 . . . . 0.0 108.794 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.76 69.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.553 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.019 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.3 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.61 -173.47 1.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.757 2.304 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.578 HG23 ' HB2' ' A' ' 483' ' ' ARG . 18.8 m -65.74 126.75 29.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -96.2 158.0 15.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.35 0.595 . . . . 0.0 111.261 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -88.39 150.41 23.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.552 -175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.1 m-70 -123.18 126.03 46.22 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.277 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.5 114.7 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -44.74 113.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.804 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.12 26.22 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.44 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -90.36 149.04 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.968 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -64.0 -62.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 42.0 t 179.6 106.96 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.86 -2.27 2.05 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.048 3.165 . . . . 0.0 115.135 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.85 150.77 75.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.231 -0.293 . . . . 0.0 110.246 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.01 28.35 12.28 Favored 'Cis proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.919 -1.284 . . . . 0.0 113.418 4.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -95.46 167.35 11.37 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 460' ' ' ARG . 39.3 ttp180 -141.84 124.1 15.6 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.586 -171.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.2 mm? -83.72 111.74 19.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.116 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -59.42 -38.93 81.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.98 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -164.78 -71.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 111.858 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.5 37.98 0.71 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.44 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.19 29.15 68.97 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.352 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -129.8 163.8 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.928 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.1 p -135.1 140.15 45.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 469' ' ' CYS . 37.9 ttp-105 -62.5 88.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.603 0.564 . . . . 0.0 110.85 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . 0.654 ' HB3' ' O ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER 160.28 157.01 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -74.28 56.88 2.39 Favored Glycine 0 C--N 1.308 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.154 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 1.8 tmtp? -123.39 -56.97 1.69 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.54 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 82.7 m-85 -118.54 112.1 37.49 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.391 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.53 -178.83 2.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.776 2.318 . . . . 0.0 111.279 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -74.64 80.22 2.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 110.316 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.88 75.59 9.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.785 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -75.62 79.2 2.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.247 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 0.0 OUTLIER -132.24 164.53 42.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 2.2 Cg_endo -41.93 103.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.244 2.629 . . . . 0.0 113.362 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 3.9 p -86.21 127.29 34.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.273 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 40.8 t -91.18 129.97 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.896 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -81.32 109.19 15.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.069 0.462 . . . . 0.0 110.897 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -132.63 123.55 26.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.077 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 446' ' ' THR . 36.9 ttt180 -120.04 -38.2 2.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.099 0.476 . . . . 0.0 109.908 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -104.35 144.22 15.81 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.016 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.63 178.837 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -86.53 -163.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.411 2.074 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.441 HG21 ' HB3' ' A' ' 481' ' ' TRP . 9.5 m -100.08 126.38 46.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -93.89 139.68 30.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.291 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 448' ' ' ARG . 23.1 mtt180 -71.96 142.81 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.41 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -119.35 102.44 8.68 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.609 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 479' ' ' THR . 56.9 mt -65.31 136.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -59.91 105.08 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 122.68 -21.13 7.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.839 -0.695 . . . . 0.0 111.557 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.58 142.17 27.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -80.06 -47.47 14.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.221 0.534 . . . . 0.0 110.154 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 20.5 t -178.35 112.25 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 -4.27 11.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.166 2.578 . . . . 0.0 114.238 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.579 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 48.8 mt -60.68 152.01 69.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 83.4 Cg_endo -78.03 16.11 10.22 Favored 'Cis proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.042 -1.232 . . . . 0.0 114.278 8.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.579 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 52.8 m-70 -91.83 104.5 16.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -82.61 127.0 32.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.522 0.677 . . . . 0.0 110.192 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.432 HD12 ' HB3' ' A' ' 467' ' ' CYS . 7.5 mp -87.63 141.13 28.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.994 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -82.89 -176.58 6.39 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.4 p -65.69 -13.41 59.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.1 mt -104.12 7.01 36.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.45 15.16 54.2 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.448 -0.882 . . . . 0.0 114.452 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.15 141.5 15.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 29.0 p -84.35 114.17 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.544 ' HA ' ' HE ' ' A' ' 468' ' ' ARG . 0.6 OUTLIER -50.67 -32.8 20.26 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.584 0.552 . . . . 0.0 112.207 -174.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.13 -30.22 70.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 122.8 128.88 3.45 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.127 -171.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 77.2 tttt 148.59 -71.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.034 1.734 . . . . 0.0 108.942 169.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 67.0 m-85 -88.93 131.6 40.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.901 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 1.8 Cg_endo -82.71 175.53 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.997 2.465 . . . . 0.0 111.854 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -84.22 66.33 9.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 C-N-CA 127.305 2.242 . . . . 0.0 107.266 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.6 -5.95 57.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.987 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? 46.62 32.94 1.83 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.188 0.995 . . . . 0.0 112.964 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -70.43 156.45 91.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.364 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.14 126.68 21.04 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.997 2.464 . . . . 0.0 112.305 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 450' ' ' ILE . 16.7 p -140.65 140.61 35.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.034 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.7 142.21 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.441 ' HB3' HG21 ' A' ' 446' ' ' THR . 91.9 m95 -90.33 108.13 19.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.146 0.498 . . . . 0.0 111.075 -175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -109.74 133.32 53.27 Favored 'General case' 1 N--CA 1.372 -4.348 0 CA-C-O 116.791 -1.576 . . . . 0.0 111.814 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -134.23 5.35 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.512 1.505 . . . . 0.0 111.785 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -162.09 119.47 0.88 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.433 175.267 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.252 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.06 52.76 3.55 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.079 2.52 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 483' ' ' ARG . 15.2 m 69.96 164.84 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -118.06 135.57 54.1 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.393 -0.817 . . . . 0.0 110.18 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.619 ' HG2' ' CZ3' ' A' ' 481' ' ' TRP . 10.1 mtm180 -78.93 138.94 38.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.493 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.65 119.96 41.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 479' ' ' THR . 49.0 mt -69.68 89.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.829 0.347 . . . . 0.0 110.212 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 58.4 -92.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.972 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -130.37 21.39 4.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.798 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.64 162.31 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.829 0.452 . . . . 0.0 110.114 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.01 163.64 5.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 18.5 t -65.02 131.66 95.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.063 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.589 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . 74.7 Cg_endo -85.14 17.84 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.899 2.399 . . . . 0.0 113.318 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 71.0 mt -87.13 155.35 54.98 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 51.0 Cg_endo -89.75 15.68 46.49 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.717 -1.368 . . . . 0.0 113.623 3.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.532 ' CE1' ' HD2' ' A' ' 471' ' ' LYS . 72.5 m-70 -68.94 -42.73 76.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 72.88 123.06 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.306 1.003 . . . . 0.0 111.138 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 41.2 mt -89.2 124.38 34.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -83.03 -171.58 3.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 2.8 p -50.63 -38.36 45.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.7 0.7 56.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.828 0.347 . . . . 0.0 111.918 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . 0.474 ' HA2' ' HE ' ' A' ' 448' ' ' ARG . . . 88.49 21.67 43.37 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.884 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -120.9 -172.31 14.51 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.1 p -126.05 121.34 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -52.63 -31.31 36.09 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.474 0.484 . . . . 0.0 111.828 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -24.78 67.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 109.39 134.26 6.95 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.101 -170.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 50.0 tttm 148.37 -65.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.82 1.648 . . . . 0.0 109.628 167.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -85.46 131.58 47.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.773 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.79 153.35 29.56 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.031 2.487 . . . . 0.0 112.865 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 474' ' ' ASN . 0.9 OUTLIER -71.04 99.13 1.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.04 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.418 HD13 ' HE2' ' A' ' 477' ' ' LYS . 89.5 mt -103.78 -27.43 12.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.407 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? 63.21 6.81 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 475' ' ' LEU . 53.4 mtmt -65.91 150.34 96.6 Favored Pre-proline 0 C--O 1.236 0.349 0 O-C-N 122.472 -0.142 . . . . 0.0 110.943 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -50.73 145.72 22.58 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.466 2.777 . . . . 0.0 112.756 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 450' ' ' ILE . 1.1 p -145.21 154.42 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.957 -171.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.11 132.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.619 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 91.2 m95 -84.31 102.8 12.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.556 . . . . 0.0 111.712 -174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.78 118.51 36.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.636 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.445 ' HA ' HG23 ' A' ' 446' ' ' THR . 18.1 mtp180 -58.31 -79.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.919 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -159.55 141.76 7.76 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.956 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.849 0 CA-C-O 119.061 -0.495 . . . . 0.0 109.929 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.026 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.82 32.96 0.51 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.854 2.369 . . . . 0.0 112.425 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.633 HG23 ' HB2' ' A' ' 483' ' ' ARG . 8.2 m 69.82 118.22 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.52 -171.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.64 141.05 29.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.414 0.626 . . . . 0.0 111.173 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 479' ' ' THR . 69.2 mtt180 -77.52 123.14 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.255 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -89.04 109.38 20.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.006 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.63 107.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.5 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 15.2 ptm180 -55.1 110.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.341 0.591 . . . . 0.0 110.937 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 130.66 -27.14 3.96 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -103.6 178.73 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -93.78 -76.84 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.206 0.527 . . . . 0.0 111.405 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.5 118.06 4.83 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.519 ' HB2' HD13 ' A' ' 461' ' ' LEU . 11.7 Cg_endo -58.32 -23.55 63.47 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.739 2.293 . . . . 0.0 114.002 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.424 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 72.5 mt -59.07 149.61 65.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.539 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.21 18.88 14.04 Favored 'Cis proline' 0 C--N 1.351 0.674 0 C-N-CA 124.128 -1.197 . . . . 0.0 114.138 6.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 41.6 m-70 -101.82 106.37 17.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -78.86 135.42 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.175 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.624 ' HG ' ' N ' ' A' ' 466' ' ' GLY . 6.8 mp -95.32 142.98 27.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.901 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.76 -167.11 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.2 p -78.16 26.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 476' ' ' LYS . 95.4 mt -121.61 -71.74 0.72 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.67 66.27 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 461' ' ' LEU . . . 175.61 155.22 12.42 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 459' ' ' HIS . 6.1 p -99.53 6.6 45.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.754 0.777 . . . . 0.0 111.886 -174.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 56.06 33.46 21.94 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.086 0.469 . . . . 0.0 111.25 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 28.4 p -177.9 131.87 0.15 Allowed 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.858 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 21.01 100.87 0.01 OUTLIER Glycine 0 C--O 1.242 0.594 0 O-C-N 124.758 1.286 . . . . 0.0 115.655 164.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 44.8 tttm 126.83 -64.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.43 1.492 . . . . 0.0 111.5 164.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 471' ' ' LYS . 83.5 m-85 -108.81 101.16 42.83 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -174.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.69 174.16 9.86 Favored 'Trans proline' 0 N--CA 1.466 -0.091 0 C-N-CA 122.572 2.181 . . . . 0.0 111.352 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . 0.477 HD22 ' HA3' ' A' ' 466' ' ' GLY . 13.7 m120 -83.58 97.32 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.596 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 79.9 mt -105.21 -24.38 12.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.14 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.7 mtpm? 65.25 -103.88 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.997 0.811 . . . . 0.0 110.149 -175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 75.9 mttt 62.28 169.72 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.174 0.59 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.9 Cg_endo -58.89 100.05 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.501 2.134 . . . . 0.0 112.067 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 448' ' ' ARG . 16.7 p -92.64 135.96 33.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.036 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.99 141.75 14.2 Favored 'Isoleucine or valine' 1 C--O 1.132 -5.103 0 C-N-CA 116.647 -2.021 . . . . 0.0 108.406 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -91.82 110.92 22.27 Favored 'General case' 0 N--CA 1.387 -3.617 0 O-C-N 128.789 3.805 . . . . 0.0 111.246 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -133.15 131.88 40.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.979 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.633 ' HB2' HG23 ' A' ' 446' ' ' THR . 28.0 ttp180 -123.38 -88.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.447 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -76.44 107.45 2.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.814 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.608 175.929 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.12 -161.48 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 483' ' ' ARG . 17.8 p -81.4 -178.9 7.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -97.97 146.88 25.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.21 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 461' ' ' LEU . 89.0 mtt180 -72.35 142.23 48.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.898 -168.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.793 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 8.6 m170 -121.31 158.15 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.397 169.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 453' ' ' GLU . 55.0 mt -100.52 136.92 29.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 478' ' ' PRO . 33.9 mtp180 -62.04 101.25 0.2 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.027 0.441 . . . . 0.0 110.774 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.53 6.99 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.904 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 450' ' ' ILE . 5.1 mm-40 -100.97 159.22 15.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.836 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -82.79 -45.99 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.538 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 49.1 t -174.28 122.53 0.38 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 31.4 Cg_exo -62.4 -31.01 81.16 Favored 'Trans proline' 0 CA--C 1.525 0.06 0 C-N-CA 122.587 2.191 . . . . 0.0 113.175 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.475 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 66.6 mt -56.03 147.22 45.81 Favored Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 123.297 0.373 . . . . 0.0 111.203 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.73 16.76 10.87 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.906 -1.289 . . . . 0.0 114.081 4.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.475 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 48.0 m-70 -88.65 141.74 28.27 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -106.14 146.52 30.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 65.3 mt -102.58 127.73 49.55 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.99 0.181 . . . . 0.0 110.995 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -58.69 -56.81 17.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.625 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 45.9 p -178.97 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.046 0.538 . . . . 0.0 109.747 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.03 12.25 9.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.898 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 77.7 56.52 3.83 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.651 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 472' ' ' TYR . . . -156.6 168.74 33.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.213 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 31.7 p -137.71 124.44 21.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' A' ' 468' ' ' ARG . 4.3 mpt_? -55.62 -30.95 61.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.695 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 29.5 p -74.9 70.77 1.99 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.106 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.5 70.78 0.27 Allowed Glycine 0 N--CA 1.462 0.408 0 N-CA-C 115.199 0.84 . . . . 0.0 115.199 163.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.834 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 21.3 tptm -162.02 -72.97 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.073 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.588 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 46.8 m-85 -104.73 133.37 20.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.464 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.66 -177.37 2.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.842 2.362 . . . . 0.0 111.997 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -78.98 80.04 5.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.8 -15.2 59.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.742 -175.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 58.36 68.82 0.79 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.975 0.416 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -132.4 143.33 48.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.663 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.409 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 30.9 Cg_exo -59.2 126.0 19.67 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.007 2.472 . . . . 0.0 111.091 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 20.3 p -79.5 134.75 36.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.994 0.426 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.793 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 46.2 t -84.82 126.07 40.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.248 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.507 ' HB3' ' OG1' ' A' ' 446' ' ' THR . 88.6 m95 -89.7 105.82 18.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.829 0.347 . . . . 0.0 111.558 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 482' ' ' ARG . 9.0 mmt180 -136.04 141.51 44.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.897 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.756 ' HB2' HG22 ' A' ' 446' ' ' THR . 47.0 ttt180 -139.23 134.02 32.13 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 81.58 138.84 2.63 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.849 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.659 178.716 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.212 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.533 ' HG2' HH22 ' A' ' 460' ' ' ARG . 60.3 Cg_endo -76.26 -170.46 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.341 2.028 . . . . 0.0 112.159 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 483' ' ' ARG . 43.1 p -73.48 175.95 6.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.052 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.9 138.6 50.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.983 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.45 ' HD2' ' CH2' ' A' ' 481' ' ' TRP . 3.7 mtm180 -83.12 144.49 29.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.652 -172.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -112.7 121.69 45.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.05 117.7 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -51.8 105.49 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.425 0.631 . . . . 0.0 111.967 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 120.4 -23.78 7.91 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.46 152.35 23.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -65.52 -69.65 0.28 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 43.7 t -173.37 121.88 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -17.34 50.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.275 . . . . 0.0 113.529 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.447 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 67.5 mt -54.54 143.16 49.21 Favored Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.089 0.243 . . . . 0.0 111.133 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.06 18.37 14.61 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.643 -1.399 . . . . 0.0 114.426 7.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.447 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 27.8 m-70 -97.76 165.72 11.82 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.533 HH22 ' HG2' ' A' ' 445' ' ' PRO . 5.3 ptm180 -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.67 141.36 28.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -172.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -80.65 -174.8 4.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 13.1 p -58.72 -28.42 65.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.73 8.4 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.146 -0.346 . . . . 0.0 111.627 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.62 20.12 64.57 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.164 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -119.09 156.36 15.72 Favored Glycine 1 C--O 1.315 5.187 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.964 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 6.2 p -110.95 149.06 31.2 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 120.552 -1.558 . . . . 0.0 109.819 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -58.85 156.74 10.82 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 87.49 -18.75 0.27 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.93 1.292 . . . . 0.0 111.294 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.78 72.9 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 8.9 tmtm? -124.29 -43.1 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.52 123.86 33.15 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.01 164.52 31.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.595 2.196 . . . . 0.0 111.897 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.37 91.07 3.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.901 0.382 . . . . 0.0 110.1 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.78 -6.52 26.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.661 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? 46.77 37.25 4.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.462 1.105 . . . . 0.0 112.589 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 35.1 mtpt -84.56 162.17 51.54 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 50.1 Cg_exo -51.95 122.81 11.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.47 2.78 . . . . 0.0 112.103 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.61 143.49 48.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.855 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.07 158.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.45 ' CH2' ' HD2' ' A' ' 448' ' ' ARG . 75.4 m95 -101.95 113.85 27.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 0.0 111.139 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 36.9 mmt180 -111.97 128.27 56.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.55 ' HB3' ' CG2' ' A' ' 446' ' ' THR . 10.0 ptm180 -140.21 5.07 2.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.923 -177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -90.11 -5.98 69.74 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.422 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.81 -179.397 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -86.79 169.2 7.94 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.186 2.591 . . . . 0.0 112.107 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 483' ' ' ARG . 0.2 OUTLIER -59.67 116.77 4.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . 0.423 ' HB2' ' NH1' ' A' ' 460' ' ' ARG . 36.0 p-80 -84.88 129.11 34.86 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.42 -171.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.653 ' NH1' ' HA ' ' A' ' 463' ' ' SER . 33.6 mtt85 -66.16 132.2 47.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.205 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.6 m170 -109.18 152.41 25.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.422 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 41.8 mt -91.74 146.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -68.76 80.34 0.29 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 0.0 110.718 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.12 49.81 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -162.55 136.28 6.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -70.32 -39.66 74.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.795 -178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 6.0 t 176.68 109.68 0.11 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 4.0 Cg_exo -75.37 10.6 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.293 2.662 . . . . 0.0 113.939 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.653 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 68.1 mt -73.97 161.75 77.11 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.9 Cg_endo -84.38 19.97 21.08 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 124.151 -1.187 . . . . 0.0 113.915 6.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -84.38 131.71 34.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.7 tpm_? -99.65 105.58 17.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.053 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 465' ' ' GLY . 7.6 mp -70.15 133.54 47.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.97 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.59 -163.66 1.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.653 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 8.2 p -60.63 -33.83 73.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.6 mt -92.17 -3.97 54.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.673 0.273 . . . . 0.0 111.641 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 461' ' ' LEU . . . 103.35 -16.49 52.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.319 -0.944 . . . . 0.0 113.187 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -73.62 152.76 46.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.609 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 14.2 p -111.24 25.06 12.12 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.088 -0.654 . . . . 0.0 111.129 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 74.44 -36.79 0.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 3.9 p -97.24 13.35 29.72 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 116.103 -2.239 . . . . 0.0 109.234 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 89.02 -28.88 6.27 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.852 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.543 ' HD2' ' CE2' ' A' ' 472' ' ' TYR . 7.4 tmtt? -47.29 -51.39 19.28 Favored 'General case' 0 N--CA 1.389 -3.501 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.543 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 93.3 m-85 -111.66 121.19 40.59 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 112.722 -2.035 . . . . 0.0 109.156 170.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.433 ' HG2' HD21 ' A' ' 475' ' ' LEU . 83.1 Cg_endo -86.09 167.28 9.48 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 112.302 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -75.16 95.19 3.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.281 0.563 . . . . 0.0 109.997 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.433 HD21 ' HG2' ' A' ' 473' ' ' PRO . 95.2 mt -84.99 -27.82 26.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.54 -175.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 476' ' ' LYS . 27.7 tptp 62.53 28.77 16.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.711 0.767 . . . . 0.0 110.736 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 43.4 mtmt -98.65 163.07 19.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 13.8 Cg_endo -57.57 118.33 5.19 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.573 2.182 . . . . 0.0 112.221 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 448' ' ' ARG . 11.8 p -97.99 146.38 25.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.966 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.4 t -92.32 134.91 28.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.967 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 448' ' ' ARG . 76.2 m95 -95.33 108.27 20.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.74 0.305 . . . . 0.0 110.994 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.29 134.87 54.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 110.633 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.485 ' HB2' HG23 ' A' ' 446' ' ' THR . 42.2 ttt-85 -130.29 102.99 6.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 98.73 154.78 28.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.832 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.301 178.43 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.315 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -88.26 -164.21 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.94 2.427 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 483' ' ' ARG . 2.2 p -69.12 165.39 20.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -132.4 146.12 51.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.973 0.416 . . . . 0.0 110.163 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.848 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 68.2 mtt180 -89.23 139.45 30.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.509 -176.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 25.9 m170 -98.62 133.6 42.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' A' ' 461' ' ' LEU . 12.5 tt -80.54 14.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.117 0.484 . . . . 0.0 111.66 -173.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 69.28 16.39 8.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.419 0.628 . . . . 0.0 110.688 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -146.55 -52.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.04 132.81 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.38 69.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.724 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 11.8 t -171.7 102.19 0.38 Allowed Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.4 38.04 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.815 3.01 . . . . 0.0 113.984 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 459' ' ' HIS . 59.8 mt -104.3 157.71 33.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.2 45.84 1.73 Allowed 'Cis proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.471 -1.054 . . . . 0.0 112.9 1.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 36.4 m-70 -94.38 -61.72 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.007 0.432 . . . . 0.0 109.923 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 81.78 126.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.028 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.848 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 55.5 mt -86.59 110.82 20.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.75 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -63.33 -62.95 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.521 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 448' ' ' ARG . 7.6 p -152.89 -58.73 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.773 0.32 . . . . 0.0 111.403 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.44 19.02 0.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.42 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 472' ' ' TYR . . . 74.89 36.16 48.07 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.694 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -119.74 176.54 16.17 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.269 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 459' ' ' HIS . 22.1 p -142.23 126.37 17.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.697 0.249 . . . . 0.0 110.438 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -75.32 76.49 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.6 p 174.11 -2.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 95.57 123.5 4.17 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.761 -170.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 146.59 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.799 1.64 . . . . 0.0 109.414 164.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 465' ' ' GLY . 87.3 m-85 -101.9 123.37 44.02 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.353 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -90.24 -158.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.126 2.551 . . . . 0.0 111.23 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -86.76 83.77 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.127 0.489 . . . . 0.0 109.826 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.9 -39.39 12.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.371 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt 55.72 77.24 0.24 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.987 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.76 149.06 58.24 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.39 107.18 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.82 2.347 . . . . 0.0 111.824 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -105.12 140.93 37.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.235 0.541 . . . . 0.0 111.94 -172.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 33.8 t -93.31 131.98 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.515 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.58 110.82 20.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.016 0.436 . . . . 0.0 110.997 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -125.99 141.55 51.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.546 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 446' ' ' THR . 48.1 ttp180 -121.4 -55.51 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.433 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.3 130.06 10.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.916 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.803 175.744 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.24 148.46 34.39 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.535 2.157 . . . . 0.0 113.266 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.874 HG22 ' HG2' ' A' ' 483' ' ' ARG . 10.1 p -116.41 114.88 24.89 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -112.88 176.71 4.9 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.93 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.942 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 49.3 mtt180 -117.86 143.32 46.4 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.49 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -110.05 138.14 46.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 11.2 tt -83.63 22.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.341 0.591 . . . . 0.0 111.055 -176.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 450' ' ' ILE . 8.8 ptm180 53.92 12.89 0.48 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.712 1.205 . . . . 0.0 112.889 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . -149.45 31.44 1.14 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.55 152.04 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.47 -42.07 71.91 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 117.835 -1.546 . . . . 0.0 107.963 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 456' ' ' PRO . 44.2 t -175.51 108.85 0.26 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 455' ' ' CYS . 10.4 Cg_exo -73.79 29.9 0.32 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.549 2.832 . . . . 0.0 114.067 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.33 152.14 39.95 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.61 19.05 37.77 Favored 'Cis proline' 0 C--O 1.169 -2.93 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.956 2.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -65.67 -58.18 6.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.997 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 71.96 133.36 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.375 1.047 . . . . 0.0 111.27 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 1.9 mm? -86.18 130.74 34.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.222 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.66 47.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.672 0.272 . . . . 0.0 110.871 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 89.8 p 59.88 -1.88 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.971 1.308 . . . . 0.0 113.431 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.7 mt -107.29 4.93 27.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.21 67.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.446 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -125.1 177.38 16.92 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.413 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 29.9 p -125.79 121.77 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.48 -29.76 37.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 111.649 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.31 -9.14 57.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 96.12 124.87 4.64 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.147 -173.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 2.1 tmtp? 159.44 -48.01 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.83 1.652 . . . . 0.0 107.933 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.537 ' HB2' ' HA2' ' A' ' 466' ' ' GLY . 49.1 m-85 -123.26 128.43 25.28 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.703 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.75 157.57 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.329 2.019 . . . . 0.0 111.004 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.38 92.41 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 109.868 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.09 -6.34 45.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.274 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 60.4 mttm 64.3 28.65 13.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.861 0.362 . . . . 0.0 111.383 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 74.2 mmtt -89.5 140.99 28.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.4 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 477' ' ' LYS . 39.3 Cg_exo -61.77 115.19 2.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.063 2.509 . . . . 0.0 111.994 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 16.5 p -80.57 128.52 33.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.406 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.86 132.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.127 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -80.46 105.79 11.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.008 0.433 . . . . 0.0 111.807 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 482' ' ' ARG . 19.0 mmt180 -126.02 139.15 53.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.469 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.874 ' HG2' HG22 ' A' ' 446' ' ' THR . 0.0 OUTLIER -166.27 164.33 17.69 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.117 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 103.94 8.37 39.49 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.817 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.21 165.74 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.242 2.628 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.5 m -58.8 140.57 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -95.23 131.47 41.24 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.553 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.695 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 67.9 mtt180 -71.9 132.76 44.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.475 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.893 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 3.9 m170 -97.8 111.94 24.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.384 170.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.97 109.02 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -43.59 106.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.746 0.654 . . . . 0.0 111.687 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 125.45 -19.92 6.63 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.321 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -106.64 153.91 21.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.601 0.36 . . . . 0.0 110.169 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -81.15 -49.21 11.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.706 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 34.1 t -174.09 102.29 0.29 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.35 33.49 0.36 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.409 2.74 . . . . 0.0 114.22 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 33.2 mt -75.22 158.86 83.5 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 4.1 Cg_endo -86.77 33.66 5.57 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.255 -1.144 . . . . 0.0 113.206 3.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.432 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 87.8 m-70 -103.4 116.21 31.99 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.282 0.563 . . . . 0.0 110.205 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -95.96 121.4 37.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.132 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 2.5 mm? -82.54 135.62 35.05 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.902 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -77.18 -168.6 1.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.42 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 11.2 p -77.83 11.67 2.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.883 0.373 . . . . 0.0 111.665 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.425 HD22 ' HE2' ' A' ' 476' ' ' LYS . 84.8 mt -120.5 1.29 10.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.0 110.209 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 75.86 35.88 43.74 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.446 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -133.76 164.98 24.34 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.6 p -129.57 120.67 25.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.74 0.77 . . . . 0.0 110.882 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -46.88 -40.98 15.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 124.2 0.937 . . . . 0.0 110.806 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 26.0 p -69.04 74.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 32.45 75.89 0.04 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 124.151 0.907 . . . . 0.0 115.127 166.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.83 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 16.6 tppt? -167.92 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.994 171.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 82.1 m-85 -76.16 119.94 79.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 111.394 -172.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 97.9 Cg_endo -86.52 43.74 1.1 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.672 2.915 . . . . 0.0 113.11 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 63.08 94.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 111.311 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.0 mt -117.78 84.49 2.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . 0.425 ' HE2' HD22 ' A' ' 464' ' ' LEU . 6.8 mtpm? -62.07 95.01 0.06 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.45 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -144.08 155.66 58.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.274 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -50.48 124.35 13.07 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 111.58 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.507 HG21 ' HD3' ' A' ' 448' ' ' ARG . 0.9 OUTLIER -132.21 159.94 37.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.838 -171.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.893 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 49.0 t -96.09 141.28 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.846 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -100.51 106.8 18.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.111 0.482 . . . . 0.0 111.803 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -132.23 131.43 42.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.47 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 484' ' ' GLY . 2.7 ptp85 -96.42 -52.66 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.243 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 483' ' ' ARG . . . -133.22 155.18 21.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.449 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.032 -179.729 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 154.16 68.18 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.638 2.225 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 6.4 m -54.31 123.92 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -91.68 138.12 31.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.771 -168.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 461' ' ' LEU . 39.7 mtt180 -71.24 130.08 40.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.686 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 2.7 m170 -98.31 105.73 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.935 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.1 115.47 5.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -47.51 107.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.4 14.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.594 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.11 -5.15 58.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 110.967 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . 62.6 -98.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.426 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 456' ' ' PRO . 35.7 t -127.04 97.08 32.93 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 455' ' ' CYS . 13.3 Cg_endo -57.48 -1.95 0.57 Allowed 'Trans proline' 0 N--CA 1.477 0.526 0 C-N-CA 124.255 3.304 . . . . 0.0 114.869 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.57 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 54.1 mt -61.62 152.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.317 0 O-C-N 122.159 -0.338 . . . . 0.0 110.09 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.47 25.94 4.83 Favored 'Cis proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.063 -1.224 . . . . 0.0 114.494 6.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.57 ' N ' ' HA ' ' A' ' 457' ' ' LEU . 71.8 m-70 -96.56 134.81 39.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 45.3 ttp180 -118.86 124.93 48.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.106 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 448' ' ' ARG . 1.8 mm? -91.38 138.36 31.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.933 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.415 ' O ' ' HD2' ' A' ' 448' ' ' ARG . 10.1 p30 -86.97 -171.78 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.8 p -68.14 -7.56 30.93 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.8 mt -95.2 -4.82 45.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 110.492 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.42 45.24 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.868 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -123.39 152.05 17.0 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.16 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 460' ' ' ARG . 28.0 p -101.52 116.12 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.37 0.585 . . . . 0.0 110.582 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -49.04 -33.57 11.65 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.823 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.91 -13.01 61.26 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 98.13 124.66 5.04 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.837 -173.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 470' ' ' GLY . 1.2 tmtp? 156.03 -55.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.256 1.422 . . . . 0.0 109.457 166.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 471' ' ' LYS . 97.9 m-85 -97.92 125.62 43.53 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.98 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.11 167.39 27.47 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.824 2.349 . . . . 0.0 111.865 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.49 97.31 3.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 96.0 mt -98.41 -20.13 17.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 39.1 mttm 67.95 -1.92 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.814 0.446 . . . . 0.0 112.053 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.69 152.17 96.53 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -170.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.96 125.43 18.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.494 2.796 . . . . 0.0 112.173 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.41 HG21 ' HB3' ' A' ' 448' ' ' ARG . 5.2 p -123.23 157.03 33.99 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 36.6 t -89.9 141.82 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.75 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.476 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 36.0 m95 -94.45 105.37 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.557 ' HG3' ' CE1' ' A' ' 449' ' ' HIS . 39.7 mmt180 -123.39 118.16 26.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -87.82 -48.86 7.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -140.17 171.94 23.69 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.023 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.177 -2.713 0 CA-C-O 122.309 1.052 . . . . 0.0 109.918 -179.657 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.66 23.53 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.62 2.213 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 483' ' ' ARG . 33.7 m 67.32 110.0 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -170.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -92.38 144.15 25.67 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.08 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.51 ' HB3' ' CG2' ' A' ' 479' ' ' THR . 68.2 mtt180 -76.77 125.49 29.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.312 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.76 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 6.2 m170 -91.71 117.88 30.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.867 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 59.7 mt -72.78 115.94 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.695 ' HD3' ' HG2' ' A' ' 478' ' ' PRO . 13.3 ptm180 -57.33 101.86 0.08 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.609 0.718 . . . . 0.0 110.185 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.68 4.62 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.155 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.95 136.11 54.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -61.03 -60.54 3.62 Favored 'General case' 1 N--CA 1.349 -5.483 0 O-C-N 119.242 -2.162 . . . . 0.0 111.125 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.441 ' SG ' ' HG ' ' A' ' 457' ' ' LEU . 34.4 t -155.8 107.17 2.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.27 29.56 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.873 2.382 . . . . 0.0 113.877 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.679 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 42.0 mt -83.46 162.85 52.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 1.1 Cg_endo -84.94 18.38 27.02 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 124.32 -1.117 . . . . 0.0 113.346 3.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 472' ' ' TYR . 76.3 m-70 -77.81 132.47 38.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.353 0.596 . . . . 0.0 110.267 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -94.42 108.58 20.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.098 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.8 mp -76.23 110.83 11.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.477 HD22 ' C ' ' A' ' 462' ' ' ASN . 0.2 OUTLIER -69.31 -178.55 1.37 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.075 175.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 4.3 p -68.92 -1.45 7.36 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.455 ' CB ' HD22 ' A' ' 474' ' ' ASN . 5.5 mp -98.23 5.8 48.05 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.205 -0.31 . . . . 0.0 111.034 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.81 49.57 22.7 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.853 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . 177.94 -165.51 35.1 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 19.0 p -145.69 128.36 16.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.16 0.48 . . . . 0.0 110.192 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.02 -22.75 61.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.163 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.07 -24.32 64.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.79 84.3 1.79 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.122 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -168.42 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.473 ' HE2' ' HB2' ' A' ' 459' ' ' HIS . 73.8 m-85 -124.74 117.37 26.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.42 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 472' ' ' TYR . 2.9 Cg_exo -73.13 166.32 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.613 2.209 . . . . 0.0 111.883 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . 0.455 HD22 ' CB ' ' A' ' 464' ' ' LEU . 14.7 m120 -77.23 81.86 3.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.2 mt -106.87 -1.57 22.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.989 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 65.19 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.622 0.576 . . . . 0.0 110.485 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 63.04 152.36 0.11 Allowed Pre-proline 0 N--CA 1.466 0.332 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.695 ' HG2' ' HD3' ' A' ' 451' ' ' ARG . 28.0 Cg_endo -65.48 105.24 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.299 1.999 . . . . 0.0 111.208 171.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' A' ' 448' ' ' ARG . 0.0 OUTLIER -113.79 144.27 43.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.43 -174.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 9.0 t -94.52 140.08 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.459 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -96.45 109.44 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.888 0.375 . . . . 0.0 111.888 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 482' ' ' ARG . 31.0 mmt180 -132.3 127.39 35.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 446' ' ' THR . 11.2 ptm180 -131.66 -1.32 3.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.575 0.226 . . . . 0.0 110.906 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -59.69 -26.94 63.23 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.492 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.343 175.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -92.89 -158.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.059 2.506 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 483' ' ' ARG . 7.8 p -61.95 120.19 10.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.069 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -97.94 143.99 27.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.362 -175.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -73.99 137.64 43.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.523 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 455' ' ' CYS . 1.5 m-70 -110.99 148.46 32.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.692 171.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 477' ' ' LYS . 22.3 mt -77.17 1.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.808 0.813 . . . . 0.0 109.597 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 57.71 78.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.319 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 154.46 -7.37 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.159 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -178.75 3.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.927 0.394 . . . . 0.0 110.466 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . 0.431 ' O ' ' HE1' ' A' ' 449' ' ' HIS . . . -83.49 -48.32 10.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 449' ' ' HIS . 19.1 t -178.74 119.81 0.24 Allowed Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.02 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.31 -2.0 10.53 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.195 2.597 . . . . 0.0 113.76 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 79.7 mt -68.25 159.03 82.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 91.4 Cg_endo -83.36 18.23 21.95 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.786 -1.339 . . . . 0.0 114.17 5.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.94 133.8 36.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 36.0 mtt180 -98.72 112.28 24.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.505 -171.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.7 mp -85.75 117.89 24.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.793 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 462' ' ' ASN . 0.2 OUTLIER -81.52 -176.54 6.09 Favored 'General case' 1 C--O 1.314 4.485 0 CA-C-O 123.508 1.623 . . . . 0.0 110.635 176.344 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 8.8 p -53.27 -30.21 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.353 -1.467 . . . . 0.0 112.891 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.35 7.3 29.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.02 54.3 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.262 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -162.42 168.85 37.53 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 29.5 p -117.13 113.91 22.95 Favored 'General case' 1 N--CA 1.366 -4.631 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.074 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -47.23 -38.38 12.09 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.815 0.697 . . . . 0.0 111.697 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.5 p -59.61 -22.54 61.97 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 111.46 125.03 4.6 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.872 -171.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 29.4 tptp 149.11 -75.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.601 1.56 . . . . 0.0 109.084 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -87.15 123.49 69.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.93 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.21 175.09 11.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.779 2.319 . . . . 0.0 111.939 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -74.77 85.68 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 0.0 110.438 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.17 -40.0 39.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.932 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 61.92 24.58 14.65 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.339 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 10.6 ptpt -81.45 165.92 41.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 11.4 Cg_endo -55.14 101.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.536 2.157 . . . . 0.0 112.046 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 449' ' ' HIS . 0.0 OUTLIER -102.54 139.32 38.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.418 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.26 153.37 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.0 111.559 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -92.51 104.54 16.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.512 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -127.65 125.28 39.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.017 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' A' ' 484' ' ' GLY . 4.3 ptp180 -110.05 -47.09 3.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.789 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 483' ' ' ARG . . . -91.14 139.17 14.67 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.846 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.102 174.604 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' A' ' 446' ' ' THR . 74.4 Cg_endo -89.78 34.04 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.99 2.46 . . . . 0.0 112.255 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 445' ' ' PRO . 25.1 m 75.83 128.52 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.78 0.675 . . . . 0.0 110.148 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -99.07 145.04 27.54 Favored 'General case' 0 C--O 1.273 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.259 -174.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 479' ' ' THR . 22.7 mtp85 -87.18 157.85 19.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.645 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.654 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . 1.0 OUTLIER -132.19 127.77 36.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.819 176.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.62 123.19 31.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -51.9 104.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.47 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 124.88 -17.02 7.25 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.5 140.3 29.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 455' ' ' CYS . . . -76.02 -44.13 40.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.223 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 454' ' ' ALA . 10.4 t -178.99 116.1 0.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.14 -10.8 28.58 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.023 2.482 . . . . 0.0 113.581 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.453 ' HA ' ' N ' ' A' ' 459' ' ' HIS . 91.8 mt -59.39 153.16 50.45 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.695 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.36 19.15 13.98 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.851 5.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 96.8 m-70 -89.38 148.79 23.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.166 0.507 . . . . 0.0 110.112 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -121.29 121.31 37.42 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.021 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 8.5 mp -73.19 108.89 6.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 467' ' ' CYS . 1.1 p-10 -75.01 68.73 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.464 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.623 ' HA ' ' NH1' ' A' ' 448' ' ' ARG . 92.0 p 64.15 -39.62 0.22 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.296 1.438 . . . . 0.0 114.103 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 476' ' ' LYS . 39.7 mt -88.67 16.4 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.96 15.74 66.72 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.683 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -157.79 179.13 33.74 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.574 ' HA ' ' OD1' ' A' ' 462' ' ' ASN . 17.6 p -129.16 117.48 20.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.4 0.6 . . . . 0.0 110.026 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -68.84 97.19 0.81 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.208 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 470' ' ' GLY . 12.5 p -168.3 -41.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.886 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 469' ' ' CYS . . . 136.8 47.35 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.844 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 472' ' ' TYR . 16.9 tptm -140.13 -55.43 0.54 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.804 0.335 . . . . 0.0 110.55 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . 0.441 ' CD2' ' HG3' ' A' ' 471' ' ' LYS . 75.2 m-85 -132.08 125.15 19.91 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.411 ' O ' ' HA3' ' A' ' 466' ' ' GLY . 67.4 Cg_endo -75.4 171.93 17.31 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.513 2.142 . . . . 0.0 111.909 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.82 87.41 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.353 . . . . 0.0 110.289 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.423 ' HB3' ' HG3' ' A' ' 477' ' ' LYS . 91.7 mt -75.48 -26.61 58.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.865 -175.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . 0.452 ' HE2' HD22 ' A' ' 464' ' ' LEU . 33.1 mmtp 66.11 26.21 10.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.08 0.552 . . . . 0.0 111.398 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 478' ' ' PRO . 44.1 mtpt -100.62 158.63 31.53 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.306 -0.246 . . . . 0.0 110.982 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 477' ' ' LYS . 10.1 Cg_endo -52.96 133.83 53.11 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.556 2.837 . . . . 0.0 112.558 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 448' ' ' ARG . 0.1 OUTLIER -127.75 136.68 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.349 -176.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 449' ' ' HIS . 10.5 t -82.29 152.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.61 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.586 ' CZ3' ' HG2' ' A' ' 448' ' ' ARG . 55.1 m95 -109.12 107.36 17.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -124.54 125.19 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -62.36 -84.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -92.78 -63.05 1.11 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.49 168.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 444' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.52 56.07 4.98 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.135 2.556 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.3 p 50.96 99.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.573 0.749 . . . . 0.0 112.05 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 447' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -100.5 133.7 44.54 Favored 'General case' 0 C--O 1.189 -2.097 0 CA-C-O 122.448 1.118 . . . . 0.0 111.351 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 448' ' ' ARG . 51.7 mtt-85 -68.54 133.54 48.7 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.578 -2.555 . . . . 0.0 111.395 -172.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 449' ' ' HIS . . . . . 0.423 ' CB ' HG23 ' A' ' 480' ' ' VAL . 2.6 m170 -101.57 119.45 38.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.912 171.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 477' ' ' LYS . 76.4 mt -66.85 125.66 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 478' ' ' PRO . 20.8 mtp180 -58.69 105.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.409 0.623 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 129.53 -23.27 4.83 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.168 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 453' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -97.97 138.35 35.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 454' ' ' ALA . . . . . . . . . . . . . . . -70.95 -38.44 72.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.504 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 455' ' ' CYS . . . . . . . . . . . . . 36.9 t 178.95 114.07 0.19 Allowed Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 456' ' ' PRO . . . . . 0.445 ' HG3' HD22 ' A' ' 461' ' ' LEU . 56.7 Cg_endo -71.48 2.81 4.13 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.17 2.58 . . . . 0.0 113.922 -175.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 458' ' ' PRO . 81.4 mt -69.22 156.99 90.5 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 457' ' ' LEU . 76.5 Cg_endo -82.56 16.2 24.41 Favored 'Cis proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.51 -1.454 . . . . 0.0 113.771 5.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 467' ' ' CYS . 45.6 m-70 -80.25 144.93 32.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 109.942 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 467' ' ' CYS . 6.4 mmm180 -100.21 110.14 22.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.248 -174.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 466' ' ' GLY . 10.2 mp -86.21 117.82 25.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.093 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.87 -167.31 1.22 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.377 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . 0.408 ' HA ' ' HE ' ' A' ' 448' ' ' ARG . 3.2 p -65.1 -16.2 63.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.84 -0.08 57.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.629 0.252 . . . . 0.0 110.96 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.97 61.2 3.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.731 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 461' ' ' LEU . . . -174.22 158.03 26.29 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 471' ' ' LYS . 20.9 p -101.4 118.41 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.497 0.648 . . . . 0.0 109.91 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.55 -35.11 62.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.705 -175.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -22.27 60.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 471' ' ' LYS . . . 108.11 132.34 6.73 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.062 -168.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.672 ' HB3' ' SG ' ' A' ' 467' ' ' CYS . 28.2 tptp 150.17 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 125.852 1.661 . . . . 0.0 108.101 171.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 472' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -132.42 117.69 15.64 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.877 176.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.7 160.43 49.75 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 111.601 177.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 474' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -65.88 95.55 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.163 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.488 HD13 ' HE3' ' A' ' 477' ' ' LYS . 95.1 mt -85.48 -28.71 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.627 -175.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 476' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 476' ' ' LYS . 20.7 ttmm 57.8 28.03 15.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.772 0.796 . . . . 0.0 110.509 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.583 ' HB2' ' HD2' ' A' ' 478' ' ' PRO . 16.0 ptpt -96.88 164.22 18.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 477' ' ' LYS . 86.1 Cg_exo -38.88 115.51 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.742 2.961 . . . . 0.0 112.737 176.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 479' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 136.67 54.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.408 -176.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 449' ' ' HIS . 0.1 OUTLIER -93.81 136.41 25.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -86.89 109.73 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -177.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -119.02 136.47 54.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.602 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 483' ' ' ARG . . . . . 0.414 ' HB3' ' H ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -95.66 -147.41 0.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.534 179.782 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 483' ' ' ARG . . . -69.68 136.41 27.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.819 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.215 -177.456 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 486' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 487' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_